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ABSTRACT
Irritant contact dermatitis (ICD) is a very common occupational skin disease but its
pathogenesis remains poorly understood. The application of topical irritants was
used to study cellular mechanisms of ICD, by sampling tissue from skin biopsies,
suction blisters and skin window chambers.
The early (up to 6h) and late (up to 48h) histopathological changes were
investigated in patients following the application of 80% nonanoic acid (NA) and 5%
sodium lauryl sulphate (SLS). The irritants were titrated on volunteers to produce
similar grades ofmild erythema for the two irritants. SLS caused minimal early
damage but induced parakeratosis and spongiosis at 24h. SLS also induced a
prominent dermal neutrophilic infiltrate and epidermal infiltration. In contrast, NA
induced basal cell layer apoptosis without significant inflammatory infiltration.
These cells were later shown to be Langerhans cells (LC).
The different patterns of epidermal damage prompted the quantification of
the cytokines IL-8 (a neutrophil chemoattractant) and IL-la (a key pro-inflammatory
cytokine) by ELISA in suction blister fluid in patients and volunteers after irritation
with NA and SLS. It was shown that NA induced IL-la upto 24h post irritation, but
minimal IL-8. SLS, however, induced IL-8 at 6 and 24h. This result was in keeping
with the histopathological findings above.
Another aspect of ICD studied was the investigation of LC after NA irritation
by confocal microscopy, in both volunteers and patients with ICD. There was a
marked reduction of LC in both groups, but greater in patients. The morphology of
the LC was altered with a reduction in both the number and lengths of dendrites with
time after irritation.
The final study looked at the effect of SLS irritation on the activation of
neutrophils using skin window chambers. It was shown that this technique was
suitable for collecting neutrophils from the skin but flow cytometry analysis of the
neutrophil activation markers (cell surface antigens) showed no differences between
control and irritated sites.
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CHAPTER 1. INTRODUCTION
1.1 Irritant contact dermatitis - definitions and concepts
Irritant contact dermatitis (ICD) has usually been defined as an inflammatory
reaction following non-immunologically mediated damage to the skin (Wilkinson,
1992). The exposure may be a solitary one such as a chemical, resulting in acute
inflammation. Some substances are only toxic under certain conditions e.g. under
occlusion or only when the stratum corneum has been breached. The duration and
nature of exposure required to elicit a transient inflammatory response varies
considerably between irritants. The clinical spectrum of acute irritant dermatitis
ranges from a mild irritant reaction with transient erythema or scaling to a more
severe picture with swelling, vesiculation and even necrosis.
The concept of chronic ICD was first proposed by Malten (1981) who
considered that it developed as a result of repeated chemical or physical insult to the
skin. Physical factors such as heat, cold and friction can contribute to its chronicity.
Once the skin barrier has been broken, milder irritants, scratching or rubbing may
perpetuate the dermatitis. Thus chronic ICD may result from a series of exposures
which individually are not sufficient to cause irritant dermatitis but when occurring
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Figl.l Cumulative insult dermatitis adapted from Malten 1981
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Diagnosis of chronic irritant contact dermatitis
The diagnosis of ICD is not straightforward, as irritant, constitutional and allergic
factors may coexist. Many studies of irritant dermatitis do not mention a working
definition which can lead to incorrect comparisons of data. Two notable exceptions
are Malten (1981) and Rietschel (1990), both of whom listed criteria which should be
fulfilled to establish a diagnosis of ICD.
Malten (1981)- all criteria have to be fulfilled
Clinical
1. Eczematous inflammation which is relatively static
2. Absence of vesicles and oozing
History
1. No personal or family history of atopy
2. No history of psoriasis
3. Overexposure to external factors (occupational* or non-occupational)
e.g. mechanical: gardening, wringing
physico-chemical: shampoos
chemical: paint removers, bleach
Investigations
1. Patch testing reveals no relevant positive allergic reaction




In this list it was stated that no arbitrary number ofmajor or minor features need to
be present for establishing the diagnosis. The greater the number of features present,
the more likely the diagnosis of ICD.
Subjective
Major criteria
1. Onset of symptoms minutes to hours after exposure
2. Pain and stinging greater than itching
Minor criteria
1. Onset within two weeks of exposure
2. Other people in the environment similarly affected
Objective
Major
1. Erythema, hyperkeratosis or Assuring greater than vesiculation
2. Glazed or scalded appearance of skin
3. Healing occurs after withdrawal of exposure to substance
4. Patch test negative
Minor
1. Sharp delineation of dermatitis
2. Evidence of gravitational effect e.g. dripping effect
3. Lack of tendency to spread (on sequential examinations)
4. Vesicles related closely to patches of erythema
Wilkinson (1987) drew attention to important clinical patterns of hand dermatitis (see
Fig 1.2 below) which suggest an irritant aetiology. Dermatitis affecting the dorsa
and lateral palms were more commonly irritant in origin. The apron distribution is





PLATE 1.1 Irritant hand dermatitis affecting dorsa of fingers
PLATE 1.2 Close up of same patient above showing web space involvement
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PLATE 1.3 Irritant hand dermatitis affecting fingers and distal palm (apron pattern)
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apron and pulp patterns were due to irritants in the majority, whereas a ring pattern
or web space involvement was exclusively irritant in origin.
Plates 1.1 and 1.2 show dorsal finger and web space dermatitis. Plates 1.3 and 1.4
show the apron pattern.
In order to understand the magnitude of the clinical problem of ICD it is first
necessary to look at the epidemiological data.
1.2 The epidemiology of irritant contact dermatitis
An occupational skin disease is defined as 'a pathological condition of the skin for
which occupational exposure can be shown to be a major causal or contributory
factor' (Lane, 1942). In the United Kingdom occupational skin disease statistics are
recorded by the Health & Safety Commission, a body which is under the auspices of
the Health and Safety Executive. There are two recent sources of statistics for
occupational skin disease. The first of these, carried out in 1995, the Survey of Self-
reported Work-related Ill-Health (SWI95) found a prevalence of 97,000 reported
cases of skin disease caused by or made worse by work (Health and Safety
Commission, 1997a). To put this figure in context, it is much less common than
musculoskeletal disorders (1.4 million cases) but nearly three times more common
than vibration white finger (37000 cases). The second is the EPI-DERM project
which was set up in 1993 by the University of Manchester to monitor work-related
skin disorders. This scheme collects data from both occupational physicians and
consultant dermatologists. It has to be remembered that such specialised reporting
schemes may well underestimate the true figures as many workers may not go further
than the general practitioner when seeking medical help. Using estimates of the
working population from the Labour Force Survey, in the period May 1993 - Dec
1996, it was calculated that 0.62 per 10,000 new cases of occupational disease per
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year (0.28/10000 reported by dermatologists and 0.34/10000 reported by
occupational physicians), were due to skin disease (Health and Safety Commission,
1997). Of these almost 80% occurred as a result of contact dermatitis. Irritant
dermatitis accounted for between 38% (males) and 49% (females) of this sub group
(Health and Safety Commission, 1996). The commonest occupations associated with
contact dermatitis are hairdressers and beauticians, chemical operatives and health
associates (Health and Safety Commission, 1997b). Occupational dermatoses have a
significant morbidity, resulting in a loss of 132,000 working days per year in
England and Wales compared with the most common cause of lost productivity-
musculoskeletal disorders (4.3 million days) (Davies, 1994).
There have been relatively few population-based studies on the incidence and
prevalence of ICD as allergic contact dermatitis (ACD) and ICD have usually been
grouped together. In addition these studies have been hospital rather than population
based. The prevalence of hand dermatitis in population based studies has varied
from 2-11 % (Diepgen, 1995). The reasons for this wide variation include different
definitions for the disease and different methods for ascertainment of cases (e.g.
postal questionnaire or direct examination). One population based study of particular
note looked at the incidence of ICD in employees in Northern Bavaria (Diepgen,
1995). Over a 3 year period all cases of occupational skin disease were recorded and
the total number of employees in this time calculated from the data held by the State
Institute of Labour and Occupation. The 3 year incidence rate of ICD in hairdressers
was 270 per 10,000 employees, compared with an incidence rate in bricklayers of 8
per 10,000 employees. ICD was the main cause of occupational disease in bakers,
cooks and confectioners.
Different groups have looked at the frequency of ICD in hospital patients
suffering from hand dermatitis. In a retrospective study of 190 patients with hand
dermatitis, 27% were due to ICD, 42% due to atopic dermatitis and 23% due to
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allergic contact dermatitis (Frosch, 1992). Similar figures were found by Baurle et al
(1985), who found that 24.2% of 683 patients with hand dermatitis had ICD. Meding
(1980), using a postal questionnaire, estimated a point- prevalence of hand eczema to
be 5.4% in a population sample of 20,000. Clinical examination of 1585 of this
sample revealed a relatively high percentage of hand eczema due to ICD-35%. This
may have resulted from the inclusion ofmild cases of ICD which the author felt
would be missed unless a thorough examination was performed.
'Housewife's dermatitis' is top of the list of different occupations most
susceptible to ICD (Cronin, 1985). In occupations where wet work is involved e.g.
cleaning, nursing and hairdressing, there is a high prevalence of ICD, mainly
affecting women (Fregert, 1975; Cronin, 1985). In men, occupational contact
dermatitis is commonly seen in employees of the construction and engineering
industries. However, it is not clear what percentage is due to ICD and how much is
due to ACD. If one strictly applies some of the criteria used to define irritant
dermatitis, then almost 100% of people exposed in occupations such as food
handling, hairdressing and construction have slight irritant contact hand dermatitis.
In fact most employees in such occupations do not seek medical attention as they feel
the symptoms are not serious and are thought to be normal for that job.
1.3 Prognosis of contact dermatitis
The prognosis of an occupational dermatitis is influenced by many variables.
ICD in general terms has a better outcome than ACD. Fregert (1975) in his series of
555 patients found that, after three years, 26% ofwomen with ICD cleared,
compared with 16% of those with ACD. The corresponding figures for men were
31% and 24% respectively. Overall the dermatitis (including ACD and ICD) had
healed in 25% and intermittent symptoms were still present in 50%. A postal
questionnaire 5-year follow-up survey of 53 patients, 5years after being diagnosed as
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having ICD indicated that 30.6% of patients had cleared completely, and that there
was some improvement in 82.4% (Fitzgerald, 1995).
Referring to ACD, Burrows (1981) stressed that the type of contact sensitiser was
also important. Patients with nickel and chromate allergy had a poor prognosis
whereas those with rubber and epoxy allergy had a more favourable outcome. A
change of employment may not necessarily improve the prognosis (Fregert, 1975) as
someone with, for example, nickel allergy would still be open to non-occupational
contact.
Factors indicating a better prognosis include age under 40, early diagnosis
and treatment (Burrows, 1981). In recent times, high levels of unemployment and
lack of retraining opportunities reduce the chances of getting a different job.
The likelihood of developing an irritant dermatitis depends upon the
individual and these factors will be examined in further detail.
1.4 The susceptibility to skin irritation
1. Endogenous factors
There are several host-related factors that affect cutaneous susceptibility to irritation.
Age is a factor which has been studied by examining trans-epidermal water loss
(TEWL) as an indicator of barrier function. The peak of TEWL occurs in childhood
and then levels out between 18-50 years of age, before falling to its lowest value by
70 years (Leveque et al, 1984). The fall in TEWL is not site dependent and occurs
on all parts of the body in a constant manner. However, it was shown that with age,
the thighs, forearms, upper back and abdomen have the largest differences (almost
50% greater in the young age group) in irritant reactivity to sodium lauryl sulphate
(SLS) (Cua et al, 1990a). The site variation ofTEWL responses may be important in
the understanding of clinical irritant dermatitis. Regional differences in TEWL show
that higher levels occur on the palms and ankle compared with the forearm or upper
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back (Cua, 1990b). Intra-site variation is also relevant as there is a significant fall in
TEWL from the wrist to the elbow (Panisset, 1992).
An individual's race is another important variable in irritant responses. Black
and Latin races have a higher TEWL response to SLS irritation, in contrast to whites.
The same is not true for erythema (Berardesca et al, 1988).
The sex of an individual appears to be of little significance in susceptibility
to SLS irritation with both basal and post irritation TEWL values showing no
difference between males and females (Lammintausta et al, 1988a). Females do vary
in reactivity during the menstrual cycle, with increased reactivity on day 1 compared
with day 10 (Agner, 1991b). Hormonal influences on both the mediators of
inflammation and hydration of the stratum corneum could explain such differences
within the cycle (Berardesca et al, 1989).
The presence of a pre-existing dermatitis, whether active or quiescent,
modulates irritant responses. Patients with an active dermatitis had a greater irritant
response to SLS irritation compared with controls. Conditions other than dermatitis
e.g. xerosis can cause similar responses to SLS (Lammintausta et al, 1988b).
An important group, which merit separate attention are atopic individuals.
Berardesca et al found that TEWL on the uninvolved forearm skin of atopics was
higher than equivalent sites in non-atopics (Berardesca et al, 1990). This would
suggest that atopics may have a damaged or disrupted skin barrier which is not
clinically apparent. One possible explanation is the reduction in intercellular lipids,
especially ceramides (Imokawa et al, 1991) which alters the balance between inter-
and intracellular lipids, leading to a decrease in the size of corneocytes (Berardesca,
1994). Other aspects of atopy will now be considered in more detail.
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Atopy and contact dermatitis
The study of atopic individuals has revealed various intrinsic vulnerabilities to
external factors. The most consistent clinical feature is a diminished threshold for
skin irritation. The groups of irritants, which have been tested, have varied from
soaps and detergents to alkalis (Nilzen, 1962). The reduced threshold for skin
irritation is worse at sites where dermatitis is common (e.g. hands, behind knees,
fronts of elbows) and during exacerbations of dermatitis. In terms of occupational
skin disease, this is very important, as repeated exposure to marginal irritants will
provoke a clinical dermatitis initially among those individuals with a lowered
threshold for irritation i.e. atopics (Shmunes, 1986).
Atopic subjects also have intrinsically dry skin. Winter weather provokes
exacerbations and chapping of the skin is common in work environments that
combine low humidity and low temperature. The irritability of atopic skin may also
be due to mechanical provocation. Intolerance to wool was recognised during World
War II when wool blankets and uniforms were issued. Davies reported 110/670
(16%) of admissions to hospital involved wool intolerance (Davies, 1944). Hanifin
also lists wool intolerance as a specific minor criterion for the diagnosis of atopic
dermatitis (Hanifin, 1983). In the workplace, sanding, cutting or breakage of fibre
glass of critical diameters (3.5pm) affect atopic individuals in the same manner as
wool (Shmunes, 1984).
It is generally felt that contact dermatitis (both allergic and irritant) occurs
more frequently in patients with atopic dermatitis (AD) than in normal people. As
long ago as 1937, it was shown that routine patch tests in patients with various
dermatoses, revealed that the incidence of reactions in AD patients did not
significantly differ from the incidence seen in patients with other dermatoses
(Rostenburg, 1937). One possible explanation for their low frequency of positive
reactions could be that tar, one of the most common sensitisers in atopics, was not
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included in their patch test series. In addition, neomycin sensitivity had yet to be
described (Epstein, 1964). The numerous studies, which have tried to address this
issue have not really clarified the picture. Table 1.1 summarises the major studies.
Comparisons between the studies are hampered by the different diagnostic criteria
used in the diagnosis ofAD. Some studies used clinical criteria alone whilst others
used a history ofAD and only three used the strict Hanifin and Rajka criteria
(Hanifin, 1980). Another drawback was that some groups only used one allergen.
Uehara et al (1989) only used one allergen, dinitro-chlorobenzene (DNCB), but
managed to sensitize 100% of patients by using high doses ofDNCB. If the studies
which are comparable (i.e. Magnusson, Cronin, Forsbeck and Rystedt) are combined
this would imply approximately 22-35% of atopics have a positive contact sensitivity
but a control population have a positive sensitivity in 29-45%. Hence there appears
to be no apparent difference in the development of positive patch reaction between
normal people and atopic individuals.
Despite the drawbacks of patch testing as a model for real life exposure to
irritants and contact allergens, it still serves as a useful clinical method by which the
diagnosis of allergic contact dermatitis can be established. AD patients with the
longest history of severe symptoms had the highest frequency of positive reactions
(Lammintausta et al, 1992). Some other points are worthy of note in the same study.
Allergic reactions to nickel were more frequent in the younger subjects whereas both
fragrance sensitivity and chromate sensitivity increased with age. Irritant reactions
(macular erythema) varied from 24-40% of the atopics, being highest in the older
atopic group. The commonest substances to elicit an irritant reaction were
formaldehyde, fragrance mix and propylene glycol.
13
































































































* patientswithsuspectedcon actderma itis;apatienithp oriasis;bh l ynormalv unteers;.s.-st ddoto
One would surmise that contact allergens readily penetrate traumatised skin
compared with intact skin in atopics. However, Rystedt's findings do not bear this
out (Rystedt, 1985a). She looked at two different groups of patients with AD- one
severe and the other mild. The percentage of positive allergic patch test reactions
were very similar in both groups (severe, 17% and mild, 23%). It could be that,
because of a defect in cell-mediated immunity in atopics (see below), individuals are
not often sensitised in spite of damaged skin. The higher prevalence of hand eczema,
in patients with contact sensitivity(42%) compared with those without hand eczema
(23%), would suggest that in some patients, hand eczema is mainly the result of
contact sensitisation. Previous work has shown that irritants play a more significant
role than contact sensitivity in the development of hand eczema in patients with
atopic dermatitis in childhood (Forsbeck et al, 1983; Rystedt, 1985b).
Moller (1959) showed that in patients with atopic dermatitis, abnormalities of
the barrier layer occur in both the normal and clinically affected skin. In atopic skin,
there is an increased transepidermal water loss (Blank, 1952). Irritation from many
allergens and non-allergens placed on or over the skin is commonplace although the
exact nature of this barrier abnormality is unknown. In histological sections of skin
affected by atopic dermatitis, the stratum granulosum layer is thickened. Cutaneous
inflammation and an increased local skin temperature may alter the normal skin
barrier. Sweat glands in atopic skin have an increased sensitivity to acetylcholine
(Blaylock, 1976). A novel approach to examining the irritability of atopic skin
compared with non-atopic skin was performed by Gehring (1990). He incubated
frozen sections of skin biopsies taken from these two groups with different irritants
and recorded the swelling of the stratum corneum, optical loss of nuclei and
structural damage of the epidermis. This technique should enable one to examine the
pure toxic effect of the irritant on the epidermal structure. Seven different irritants
caused more damage in the atopics and significantly increased (absolute) swelling of
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the stratum corneum. He concluded that increased irritability in AD must be due to a
reduced resistance of the whole epidermis and not just a reduced barrier function.
However, a major criticism of such a conclusion is that the result was based on only
2 atopic dermatitis patients and 10 volunteers.
Even though clinical findings in AD patients point towards defective cell-
mediated immunity (e.g. susceptibility to certain viral infections and dermatophyte
infections) it is not clear whether the low incidence of allergic contact sensitivity in
AD is primary or secondary to the disease. A DNCB challenge study by Uehara et al
(1989) showed that sensitisation decreased with increasing severity of atopic
dermatitis (clinically), suggesting it is secondary to the disease process. The
mechanisms by which this lowered sensitisation is effected have yet to be elucidated.
The responsiveness of lymphocytes to antigens (in-vitro) is reduced as is the number
and activity of natural killer cells (Jensen, 1985). However, it should be remembered
that lymphocyte abnormalities vary with the activity of the dermatitis (Champion et
al, 1992).
From the large variation in frequency of contact sensitivity seen i.e. 15-57%
(see Table 1.1), it is quite clear that finding suitable control groups is important.
Thus a control group of healthy normal volunteers would be more appropriate than
patients attending the dermatology department for another problem such as psoriasis.
In most cases the atopic patients have the longest history of dermatitis and
consequently have the greatest chance of becoming sensitised. An age-sex matched
control group would be almost impossible to obtain. A few studies of contact
sensitivity in normal volunteers are thus useful for comparison. Magnusson (1979)
tested 274 normal volunteers with the ICDRG standard series ofwhich 22% (60/274)
showed one or more positive reactions. Only one study compared the incidence of
sensitisation in AD patients (15%) with age-matched healthy normal volunteers
(61%), although only one allergen- rhus oleoresin- was tested (Jones et al, 1973).
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In clinical practice, however, comparison with patients with non-atopic
dermatitis is more important. One could therefore conclude that most of the evidence
indicates that even though atopic dermatitis patients are less frequently sensitised
than non-atopic dermatitis patients - 30% and 42% respectively (Table 1.1) - 3 out of
10 patients with AD will have one or more contact allergies. This should alert
clinicians to consider patch testing most patients with atopic dermatitis, especially
with increasing age.
2. Exogenous factors
The exogenous factors, which influence the irritant response of human skin, include
the type of irritant, its penetration and mode of exposure. Of these, the most
important is the inherent toxicity of the chemical. The mode of action of the three
irritants chosen for this study will be discussed.
Sodium lauryl sulphate (SLS) (CFL-(CEL) ioCH2OS03Na)
H H o
H Q (CH2)-jo C 0 S O Na
O
H H
The model most widely used in the study of experimental irritant contact dermatitis
is SLS irritation. Sodium lauryl sulphate is an anionic surfactant which is used as an
emulsifier in different pharmaceutical vehicles, cosmetics and some foods (Nikitakis
et al, 1991). It has always been believed that SLS works as a surfactant by removing
stratum comeum lipids, which promote TEWL. Fulmer et al showed that SLS did
not alter the total quantity of stratum corneum lipids, but changed the type of lipid,
by reducing the long chain free fatty acids (C22-28)(Fulmer et al, 1986). More
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recently it was shown that the increase in TEWL after SLS is due to increased
stratum corneum hydration through spongiosis (Leveque et al, 1993; Wilhelm et al,
1993). Moreover any extraction of lipids was felt to be minimal and only occurred in
the early phase of SLS irritation. Hydration is possibly increased by the alteration of
the secondary and tertiary structures of keratin which allows new water-binding sites
to become available (Rhein et al, 1986). Other groups have confirmed the normal
lipid content in the upper stratum corneum after application of SLS but found
premature keratinisation and damage to lipids in the lower layers of the stratum
corneum (Fartasch et al, 1991). SLS also increases epidermal turnover (Fisher,
1975) and is pro-inflammatory being both chemokinetic and chemotactic for
polymorphonuclear leucocytes (Frosch, 1987).
One should not forget that a single application of SLS does not reflect the
cumulative open application of surfactants in real life. A model such as the soap
chamber test (Frosch, 1979) was designed to discriminate the irritancy potential
among soaps. A Duhring chamber is used to expose the irritant on the forearm for 5
days, initially for 24h and then 6h daily on the subsequent days. More recently the
arm-immersion model attempts to simulate the reactivity of skin damaged by wet
work and housework. This procedure uses repeated immersion of the forearm in an
agitated solution of SLS at a constant temperature until a pre-determined alteration of
skin appearance is reached. This compromised skin acts as the baseline on which
irritants can then be applied (Allenby et al, 1993)
Another factor of great importance in SLS irritation, demonstrated by Agner et
al (1989), is the quality and purity of SLS used. The inclusion of additional Cio, C14,
Ci6 and Cis chains confers a lower irritancy potential (as measured by clinical
grading, TEWL, blood flow and oedema) when compared with SLS which is >99%
pure (i.e. C12 chains only). This probably explains why the concentration of SLS




H C (CH2)8 C
H OH
It was Bjorneberg, whilst studying irritant reactions in patients with hand dermatitis,
who realised that it was impossible to predict the magnitude of the skin reaction to
one primary irritant by knowing the intensity of the reaction to another irritant
(Bjorneberg, 1968). During a study of the irritancy of various free fatty acids in the
pathophysiology of acne, the C8-C12 fatty acids were found to be the most irritating
(Stillman et al, 1975). It was by chance that nonanoic acid was chosen from this
group as a model irritant for study. The following qualitative criteria were deemed
desirable for a chemical to be classified as a model topical irritant
(Wahlberg, 1980):
• positive reactions in 90% of the population
• reproducibile
• a known chemical structure
• non-volatile or solid
• no extreme pH's
• not an allergen
• no systemic toxicity
• non-scarring
• easily read skin reactions.
Nonanoic acid (pelargonic acid) is a C9 fatty acid and is usually tested in the vehicle
propan-l-ol. When its potential for irritation was being investigated, NA was
applied under patch test occlusion at concentrations of 5-40% to healthy volunteers
and 5-100% to patients with a suspected allergic contact dermatitis. Results showed
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a dose response curve with 98% of volunteers reacting to 39.9%NA but no response
to the vehicle, propan-l-ol, alone. The reactions were monomorphic with typical
well-defined erythema confined to the patch test site. Similar responses were elicited
in dermatitis patients. It was concluded that NA fulfilled all the above criteria
(Wahlberg, 1980). In subsequent studies the irritancy ofNA was more predictable
compared with the irritant Benzalkonium chloride (Wahlberg et al, 1985). It was for
these reasons that NA has been widely adopted as a model irritant in experimental
irritant dermatitis.
Dithranol(DL)
Dithranol (anthralin) has been used in the treatment of psoriasis for over a century,
but its use has been limited by the inflammation and staining which it causes. Its
mode of action is diverse and has yet to be fully elucidated. Dithranol has selective
antiproliferative effects on human epidermal keratinocytes in vitro. It suppresses
transcription of transforming growth factor-a mRNA (TGF-a mRNA) by
keratinocytes and reduces epidermal growth factor (EGF) receptor binding by
reducing the affinity of the EGF receptor for its ligands. Both TGF-a and EGF
receptor expression is correlated with epidermal hyperplasia in lesional psoriatic
epidermis (Gottlieb et al, 1992). Dithranol also changes the pattern of keratin
expression by reducing the proliferation-associated keratins K6, K16 and K17 and
increasing the differentiation keratins K1, K2 and K10. The effect of dithranol on T-
lymphocytes in psoriatic epidermis is to significantly reduce the CD8+ population
(Gottlieb et al, 1995). The other main effect of dithranol is to inhibit
polymorphonuclear neutrophil chemotaxis and the subsequent release of reactive
oxygen species from stimulated neutrophils (Mahrle et al, 1994).
In order to understand dithranol irritation its chemical structure needs to be
appreciated. Dithranol is based on the anthracene nucleus (Fig 1.3a) and exists in the
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anthrone form (Fig 1.3b) which is in equilibrium with the tautomeric form, 1,8,9-
tri-hydroxyanthracene (Fig 1.3c). There are two unstable points in the anthracene
nucleus at the hydroxyl groups at Cj and C8 (*) and the reactive hydrogen atoms at
C10-






Oxidation of anthralin by light or air yields an active free radical before oxidation to
anthraquinone and anthraquinone dimer. The hydroperoxyl radical reacts with
different bases to form the superoxide anion (Ashton et al, 1983)- Fig 1.4
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Fig 1-4 Dithranol - mechanism of free radical formation
anthralin free radical
anthraquinone dimer
*0 0 H + B HB+ + 02"~
hydroperoxyl radical
The superoxide anion ((V-) is responsible for dithranol irritation and is known to be
toxic to tissues (Mustakallio, 1981). Various attempts at reducing the erythema
induced by dithranol have produced good results with free radical scavengers such as
a-tocopherol, retinol palmitate and butylated hydroxyanisole (Finnen et al, 1984).
The mechanism by which free radicals induce an inflammatory response is unclear
but a non-enzymatic effect on arachidonic acid leading to the formation of the pro¬
inflammatory prostaglandins PGE2 and PGF2a may be responsible.
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As irritants act in different ways, the detection of irritant responses can also be
measured by a variety of instruments. These tools are being used to make objective
assessments of irritation.
1.5 Evaluation of irritant patch tests
Experimental irritant patch testing is frequently employed to simulate irritant contact
dermatitis. Over the last ten years several different non-invasive measurement
procedures have been developed to quantify irritant patch test reactions. The
components of the irritant response include erythema, oedema and barrier disruption.
Numerous comparative studies have tried to find the gold standard for irritant patch
test measurement. The following table (adapted from Lee, 1995) shows different
techniques and the functions which they measure.
Bioengineering method Parameter measured
Evaporimetry Transepidermal water loss
Laser Doppler flow velocimetry Blood flow
Ultrasound Thickness
Colorimetry Erythema
Impedance, conductance, capacitance Hydration
The visual scoring system for assessing an irritant reaction is open to criticism as it is
subjective and liable to marked inter-observer variation. It does however, have the
advantage of taking into account both epidermal changes (e.g. crusting and scaling)
and inflammatory changes (e.g. erythema and oedema).
Evaporimetry records the total evaporation ofwater from the skin and the
diffusion rate is dependent on the ambient relative humidity, ambient and skin
temperature and the integrity of the stratum corneum. When the probe is applied
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over the skin, a gap of approximately 1Omm between the skin surface and the end of
the probe is formed. It is across this gap that the water vapour pressure gradient is
measured i.e. the transepidermal water loss. Any changes in the surroundings or
even draughts can alter the readings obtained. For the irritant SLS, a positive dose
response is consistently found when TEWL measurement is used (Serup, 1987;
Agner, 1990a). As for the irritant NA, evaporimetry has not been so successful
which probably reflects the fact that NA only influences the barrier to a minor degree
(Agner, 1990a).
One of the methods for assessing erythema is by skin colour reflectance. The
Commission Internationale de l'Eclairage (CIE) standardised a tristimulus colour
system where colour is expressed as a 3-dimensional co-ordinate (see below).
White
The a*-axis represents the colour range from green (-) to red (+); the b*-axis
represents the colour range from blue (-) to yellow (+). L* expresses the brightness
of reflected light ranging from black (low values) to white (high values). The a*
value has been shown to have a good correlation with visual scoring of irritant
reactions (Agner, 1990b) and with different doses of SLS (Wilhelm et al, 1989). In
comparative studies, the sensitivity of colorimetry was not as high as for
evaporimetry (Agner, 1990b). The benefits of colorimetry however, include its
reproducibility and ease of use in the clinical setting (Wilhelm et al, 1989).
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The other major tool for the investigation of erythema is laser doppler
flowmetry (LDF). The extent of erythema, as a reactive increase of cutaneous blood
flow, can be quantified with a laser doppler flowmeter. Light from a laser source is
transmitted to the skin through an optical fibre and reflected with a frequency shift
(Doppler effect) from moving blood cells. The machine records the blood flow as
the product of the number of erythrocytes encountered and their mean velocity. The
output of the flowmeter is proportional to the cutaneous blood flow (de Boer et al,
1989). Good LDF positive dose responses for SLS (Nilsson et al, 1982; Staberg,
1988) and negative dose responses (Blanken et al, 1986) highlight the difficulty with
LDF measurement. This may in part be due to patchy erythema (Freeman, 1984).
Ultrasound scanning has the advantage that, unlike TEWL measurement, no
pre-conditioning of the subject is necessary (Agner, 1992). The principle of
ultrasound is that the interval between the echo from the skin surface and the
interface between the dermis and subcutaneous fat is a measure of the thickness of
the skin. The inherent variation of skin thickness limits the accuracy of thickness
(and therefore oedema) results. Seidenari has shown a good correlation between
TEWL values and B-mode (2-dimensional) ultrasound after SLS irritation
(Seidenari, 1992). The expense of the equipment and the time taken to become
proficient in its use, limits wider uptake of this method routinely.
In order to understand the immunological and cellular effects of irritant induced
inflammation, some basic aspects of the skin immune system and neutrophil biology
will be discussed.
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1.6 The skin immune system
The idea that the epidermis is more than just a barrier has been developed over the
last 15 years. The concept is based on different epidermal cells being able to exert
autocrine, paracrine and endocrine influences. These effects are modulated by the
secretion of cytokines. Cytokines are low molecular weight regulatory glycoproteins
which are produced transiently and are active at picomolar concentrations. They
exert their effects via specific cell surface receptors (Luger , 1990). After a cytokine
binds to the target cell receptor, this can trigger a cascade of cellular events that
includes the release of further cytokines which may possibly mediate further release
of the initiating cytokine (Sauder, 1990). Keratinocytes(KC) which compromise the
largest cell population of the epidermis, are a rich source of cytokines. However
other epidermal cells are capable of secreting cytokines, such as Langerhans cells,
melanocytes and Merkel cells (Ansel et al, 1990). Some of the important KC
cytokines are shown below:
Interleukins IL-1, IL-6, IL-8
Colony stimulating factors Granulocyte macrophage colony
stimulating factor (GM-CSF)
Others Tumour necrosis factor-alpha (TNF-a)
Transforming growth factors alpha and
beta (TGF-a, TGF-p)
Of these cytokines, IL-1, IL-8 and TNF-a will be discussed in more detail.
IL-1 (Ansel et al, 1990; Luger, 1990)
Interleukin-1 was one of the original cytokines studied and exists in two forms, IL-
la and IL-1 (3. These two sub-types are encoded by distinct genes on Chromosome
26
2. Although there is only 27% sequence homology between the sub-types, they share
the same biological activity. KC mainly produce IL-la, whereas macrophages
produce IL-1 (3. Since both forms bind to the same receptor (IL-1R) with identical
affinity and have the same biological activity, this differential production by cells is
of no biological significance. Keratinocytes constitutively synthesise IL-1 but its
synthesis can be induced by numerous different stimuli such as ultraviolet radiation
(UVR), and by cytokines produced by tumour cells, fibroblasts and endothelial cells.
Within normal epidermis, it is stored in keratinocytes. IL-1 is eliminated by normal
desquamation and following injury to the epidermis, both newly synthesised and pre¬
formed IL-1 is released. Some of its effects on different cells are summarised below.
IL-1 effect on
T cells Stimulates mitogen responsiveness, IL-2 secretion
Stimulates GM-CSF and IL-2R expression
Macrophages Activated to synthesise PGE2
Increases cytokine production
Increases cytotoxicity
Fibroblasts Induces production of collagen
Endothelium Induces expression of ICAM-1 leading to
lymphocyte, monocyte and neutrophil adherence
Acute phase of inflammation Fever, muscle proteolysis
Synthesis of acute phase proteins and
hypoalbuminaemia
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IL-1 Receptor antagonist (IL-lRA)fAustyn, 1993)
IL-1 receptor antagonist has structural homology with IL-1 P and is synthesised by
keratinocytes and macrophages. It binds to the IL-1 receptors blocking their
function. IL-IRA may have physiological significance by limiting IL-1 activity. In
humans there are two IL-1 receptors, types I and II, both of which bind IL-1a ,
IL-1 p and IL-1RA. However, only type I receptors can signal and type II could
function as an IL-1 antagonist. Thus IL-1RA and type II IL-1 receptor expression
may be part of the normal homeostatic response to an excess of IL-1a and p.
IL-8 fLueer. 19901
Interleukin-8 is a pro-inflammatory cytokine and is a member of a group of
chemoattractant factors which includes monocyte chemoattractant and activating
factor (M-CAF) and macrophage inflammatory protein. IL-8 is produced by many
cell types, including monocytes, fibroblasts, KC, and endothelial cells and is also
found in increased amounts in psoriatic epidermis.
IL-8 is chemotactic for polymorphonuclear cells (PMN) and activates
neutrophil degranulation, enzyme release and respiratory burst. It also modulates the
adhesion of neutrophils to vascular endothelial cells by inducing MAC-1 expression
on the surface of neutrophils. IL-8 is also chemotactic for basophils causing a
release of histamine and leukotrienes. Unlike IL-1, IL-8 does not produce fever,
acute phase proteins or ICAM-1 expression on endothelial cells.
TNF-q (Luger, 1990)
During the study of tumour breakdown, the mediator which led to tumour necrosis
and cachexia was called cachexin or TNF-a. A different lymphocyte derived
cytotoxic mediator previously known as lymphotoxin, has been renamed as TNF-
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p. These two proteins are distinct antigenically but bind to a common receptor and
have similar biological activity. TNF-a is initially produced as an inactive peptide
but is cleaved at several sites to produce the active moiety.
It is produced by numerous cells including KC, macrophages, T and B
lymphocytes, fibroblasts and some epidermal carcinoma cell lines. The synthesis
and release of significant amounts of TNF by epidermal cells, is induced by IL-1,
IL-6, ultraviolet radiation (UVR) and the tumour promotor phorbol myristate acetate.
One of the most important biological effects of human TNF is the stimulation
of production of PGE2 , IL-1 and IL-6 leading to fever. TNF activates neutrophils,
eosinophils, macrophages and the production of prostaglandins and collagenase by
synovial cells and fibroblasts. It also induces MHC class I and class II antigens and
ICAM-1 expression on endothelial cells. The effects on T-lymphocytes include
expression of IL-2 receptors and IL-2 production.
Interferon- gamma ("IFN-y) fHalloran PF, 1993)
Human IFN-y is coded by a single gene copy of 4 exons on Chromosome 12. The
peptide (M.Wt-17 kDa) is glycosylated and dimerised to form the active protein. It
is produced by activated T cells triggered by the T cell receptor (TCR), natural killer
cells and even keratinocytes (Howie et al, 1996).
IFN-y has particular effects on gene expression in many cells, especially on
those coding MHC class I and II, adhesion molecules and other cytokines. T cell
release of IFN-y can be stimulated by oxazolone (a skin sensitiser), superantigens
and other infectious agents. IL-2 and other cytokines including IFN-y can induce
natural killer (NK) and T cell release of IFN-y. The self amplification by IFN-
y recruits non-specific T cells to augment production of IFN-y by specific T cells.
The advantage of the systemic effects of IFN-y is that a local infection will increase
MHC and adhesion molecule expression in all tissues and so enhance immune
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surveillance of a potential spread of infection. The following summarises the key
effects of IFN-y:
i) regulation of membrane molecule synthesis and expression
• role in normal MHC class II expression
• induction ofMHC class I and class I transcription
• induces ICAM-1
ii) induction of other cytokines
• expression ofTNF-a and its receptor
iii) proinflammatory
• macrophage migration inhibition and activation
• nitric oxide production by macrophages (suppressing T cell proliferation)
iv) immune regulation
• B cell immunoglobulin secretion
• suppresses TH2 cells and antagonises TH2 cytokines
1.7 The role of cytokines in inflammation
As has been discussed previously, cytokines initiate their biological action by
interacting with target cells bearing cell surface cytokine receptors. The final
response to a particular cytokine is determined by the interactions between
synergistic and antagonistic cytokines. They provide the communication between
infiltrating inflammatory cells and resident cutaneous cells. Over the last decade
more evidence has accumulated that KC have an active and key role in inflammation
in vivo in both mice and humans. The major element central to this belief is the
ability of KC to respond to diverse environmental insults by producing TNF-a and
IL1-P (Nickoloff, 1993)(see Fig 1.5 below).
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Fig. 1.5 Immunological function of keratinocvtes in response to diverse
environmental triggers (adapted from Nickoloff, 1993)
ENVIRONMENTAL CHALLENGES
UVR Chemical irritants Allergens Tumour promotors Infections
IMMUNOLOGICAL CHARACTERISTICS OF KERATINOCYTES
Function 1 Function 2 Function 3
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T cell mediated effects
on epidermal keratinocytes
Elimination of virus
Removal of transfected cells
influx of T cells, APCs
Previous explanations of contact hypersensitivity have suggested that low molecular
weight haptens bind to a carrier protein and are processed by Langerhans (antigen
presenting) cells which transport the complex to a local draining lymph node, where
an antigen-specific T cell proliferative response is mounted . The latter still occurs
in the new model, but it occurs long after keratinocytes release TNF-a and
ILl-p. These cytokines stimulate neighbouring endothelial cells to express adhesion
molecules such as E-Selectin (previously known as endothelial adhesion
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molecule-1), vascular adhesion molecule-1(VCAM-1) and intercellular adhesion
molecule-1 (ICAM-1). This paracrine stimulation of endothelial cells by KC may
then facilitate chemotactic factors such as IL-8 and M-CAF and the subsequent
influx ofmemory T cells from the circulation (Nickoloff, 1993).
Within normal uninflamed skin, ICAM-1 is weakly expressed on the surface
ofmicrovascular endothelial cells. The discovery of ICAM-1 as the ligand for
lymphocyte function associated antigen-1 (LFA-1) on T lymphocytes explained the
intimate molecular and cellular relationship between KC, ICAM-1 expression and
intraepidermal accumulation of T cells (Kupper, 1989).
Molecular models of inflammatory skin disease postulate that a breakdown in the
regulation of growth factor production and signal transduction results in abnormal
proliferation and cell behaviour (McKenzie, 1990). Cytokine production whether it
be in abnormal amounts or a failure of cytokine regulation are being investigated in
inflammatory dermatoses. For instance, very high levels of IL-1 are found in
cutaneous T cell lymphoma; increased levels of IL-6 and IL-8 in psoriasis. The
mechanisms of inflammation in ICD at the molecular and cellular level are poorly
defined. Different groups have shown that the abrogation of epidermal barrier by a
non-specific irritant stimulus (tape-stripping, Wood et al 1992; Nickoloff, 1994) and
the model irritant SLS (Hunziker et al, 1992) leads to the production of
TNF-a. Willis et al have shown that ICAM-1 is upregulated in the presence of
LFA+ leucocytes in irritant reactions (Willis et al, 1991). When one compares ICD
with ACD, ICAM-1 expression is a predominant feature of ICD whereas HLA-DR
expression is usually seen in ACD. Since ICAM-1 expression is upregulated by
TNF-a, the latter is believed to be a key mediator of inflammation in ICD.
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1.8 The role of neutrophils in inflammation
Acute inflammation involves the combination of a variety of cellular and humoral
mechanisms leading to a rapid change in vascular permeability, changes in blood
flow and the accumulation of leucocytes. Monocytes and neutrophils are the main
leucocytes mobilised. The injurious effects of such cells have been implicated in the
pathogenesis of various inflammatory diseases. However, inflammation has a
beneficial role as a defence mechanism against such agents and this host response
usually results in resolution with minimal tissue damage (Haslett et al, 1989). The
study of the resolution phase of acute inflammation may add to the understanding of
the pathogenesis of chronic inflammation as in chronic irritant dermatitis.
The role of the neutrophil is of particular interest. It is the first cell to migrate
to the site of 'attack' and subsequent inflammatory processing such as monocyte
migration, may depend on neutrophil accumulation. The contents of neutrophils are
toxic to cells but can also break down matrix proteins into molecules which
themselves are chemotactic. The fate of the neutrophil after this initiation and
amplification is interesting as it must be removed from the inflamed site before
resolution occurs.
When inflamed skin is injected with radiolabelled neutrophils and probed for
their detection, it has been demonstrated that neutrophil migration ceases very early
in the acute phase (2-4h). Neutrophils have been observed in early severe irritant
reactions (Lever, 1990) but in very much smaller numbers in biopsies from skin after
mild experimental irritant reactions (Willis et al, 1986). As skin biopsies provide a
snapshot ofwhat is a dynamic process, the use of skin window chambers allows in-
vivo collection of neutrophils. This technique has previously shown a significant
neutrophil influx in irritant reactions induced in volunteers. Skin windows have been
modified for this thesis to examine neutrophil surface markers which indicate their
state of activation and fate after experimental irritation.
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Previous dogma has stated that dead neutrophils eventually disintegrate in the
tissue, but now there is an alternative hypothesis which is that intact neutrophils are
engulfed by macrophages at the inflamed site. In-vitro studies have demonstrated
that macrophages, attracted to the site or derived from monocytes were capable of
neutrophil (aged in-vitro) ingestion. There is now good evidence that with time,
increasing numbers of neutrophils undergo one form of programmed cell death
(apoptosis) with characteristic morphological changes and chromatin fragmentation
(Savill et al, 1989).
Neutrophil adhesion to endothelial cells is an early event in the inflammatory
response and is a pre-requisite for leucocyte accumulation. In-vitro and in-vivo
studies have now established the different molecules that mediate this important
interaction between neutrophils and vascular endothelium (Springer, 1995- see figs




Fig. 1.6 Neutrophil adhesion to vascular endothelium (from Springer, 1995)
Three sequential steps provide the traffic signals that regulate the localization of
neutrophils in the endothelium of vasculature. Selectins that bind the carbohydrate
moieties of mucin-like molecules are responsible for tethering of a neutrophil to the
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vessel wall and rolling adhesion (step 1). This allows the neutrophils to come into
contact with chemoattractants that are either displayed on or released from the lining
of the vessel wall. The binding of chemoattractants to neutrophil surface receptors
leads to transduction signals that activate integrin adhesiveness (step 2). The
integrins can then bind to Immunoglobulin superfamily members on the
endothelium, thereby increasing firm adhesion and neutrophil arrest (step 3). Further
directional cues from chemoattractants and use of integrins for traction enables
neutrophils to migrate out of the vascular endothelium into the surrounding tissue.
The interaction at the molecular level is shown below (Fig 1.7)
PMN
| Tethering | | Rolling 1 Activation | Firm adhesion | | Transmigration
Fig. 1.7 Schematic representation ofmolecular interaction between neutrophil and
vascular endothelium. PAF, platelet aggregating factor; LFA-1, lymphocyte
associated antigen-1; PSGLl, P-selectin glycoprotein ligand-1; ICAM, intercellular
adhesion molecule;7TM, 7 transmembrane (personal communication from Dr. I.
Dransfield)
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Thus the distinct distribution of receptors on leucocyte subsets (neutrophils) for
signals found on endothelium, regulates selection of which subset emigrates at the
site of inflammation.
The central purpose of this study is to define better the inflammatory and
immunological responses in the pathogenesis of chronic irritant dermatitis. In order
to do this the studies will determine the nature of the early inflammatory events in
acute reactions in both patients with ICD and in healthy volunteers. The studies were
performed on material derived from skin biopsies, suction blisters and skin window
chamber fluid before and after the application of irritant patch tests. The following
hypotheses will be tested:
1. The pathogenesis of irritant reactions is related to the degree of epidermal
damage.
2. The initial damage caused by irritants, results in rapid secretion of cytokines
known to be chemotactic for neutrophils and macrophages.
3. The damage may then be increased by accumulation, activation and secretion of
enzymic contents by neutrophils.
4. Further epidermal damage results in local production of IFN-y, which results in




1. To define the histopathological changes in the skin during the early phase of
irritant contact dermatitis.
2. To examine the changes in Langerhans cells (LC) following the induction of an
experimental irritant contact dermatitis.
3. To quantify the pro-inflammatory epidermal cytokines following the induction of
an experimental irritant contact dermatitis.
4. To examine the fate ofneutrophils in irritant contact dermatitis.
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CHAPTER 2 : MATERIALS AND METHODS
2.1 Patient Selection
The Contact Dermatitis (Royal Infirmary, Edinburgh) clinic was the main source of
patients selected for the different studies. The patch test proforma records were
examined retrospectively and letters sent out to those patients in whom a diagnosis of
ICD had been made. The other method of recruiting patients was by screening
referrals to the contact clinic with hand dermatitis. These patients were fast-tracked
with earlier appointments made for patch testing.
Table 2.1 Criteria used for the diagnosis of chronic irritant dermatitis. A person with
chronic dermatitis for >6 weeks plus a minimum of one criterion from each category
had to be fulfilled.
History • occupational exposure






• erythema , hyperkeratosis or Assuring
• glazed, scalded appearance of skin
if hand dermatitis (See fig 1.2): the above plus
• ring pattern,
• pulpitis
• dorsa of hands affected
Patch tests Negative (or non relevant positive reaction)
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The diagnostic criteria discussed previously (see pp 2-3) were adapted to provide a
simple and usable list of criteria which could be applied when screening potential
subjects in the clinic (see Table 2.1) and were used for the recruitment of volunteers
with ICD in all the studies presented in this thesis. The use of a combination of the
history, clinical and patch test findings is more appropriate than the often used
definition of ICD- contact dermatitis with negative patch testing. The UK Working
Party diagnostic criteria were adopted for the determination of an atopic individual as
shown below:
UK Working Party diagnostic criteria (modifiedfrom Williams et al, 1994)
1. History of itchy skin condition
2. Three of :-
onset before age 2
history of flexural involvement
history of asthma or hay fever
history of dry skin
visible flexural eczema
The subjects had the studies explained to them and were given the subject
information sheet (Appx. 1). Signed consent from the subjects was obtained prior to
all studies. The subject's General Practitioner was kept informed of their intention to
participate by a letter similar to the subject information sheet.
Normal healthy volunteers were recruited from the general public and from staff
members in the departments ofDermatology and Pathology. Ethical approval for all




During the screening of prospective subjects, all patients had patch testing to the
European Standard battery of allergens and any extra allergens which may have been
relevant to the patient's occupation. For example, perfumes and flavours for chefs
and food handlers. The assessment was carried out in the standard way at 48 and 96
hours.
2.2.2 Irritant patch testing
i. Histopathology/immunohistochemistrv studies
The irritants were applied under occlusion using 8mm Finn® chambers to the volar
aspect of the forearm of subjects in the configuration shown below.
Patch A= Irritant 1 or 24h
Patch B= Irritant 6 or 48h
Patch C= Vehicle of irritant
An attempt was made to keep the distance between the patches greater than 2cm and
sites A, B and C were rotated at random for each subject. In the majority of patients
the non-dominant arm was used for the irritant patches.
40
ii. Suction blister studies (see Plate 2.1)
The patch tests were applied in such a way to
fit the special cups. Four 8mm patches
containing the irritant nonanoic acid were
applied under occlusion to each forearm to
maximise the yield of blister fluid. The patches
were kept in place for either 1,6 or 24hours.
2.2.3 Assessment of irritant reactions
Patches were removed and left to equilibrate with the surroundings for one hour
(except in suction blister studies). The reactions were assessed clinically using the
clinical grading scale shown.
0 - no reaction 1 - faint erythema 2- well defined erythema
3- palpable or indurated erythema
4- vesiculation and/or necrosis
2.3 Irritants
The three irritants chosen for the different studies were nonanoic acid, sodium lauryl
sulphate and dithranol. Willis et al (1989) tested a panel of irritants under patch test
occlusion to determine the concentrations needed to elicit mild or moderate erythema
on the skin of normal healthy volunteers. This was important in the present work
because less severe reactions may give clues about the pathology of the earlier stages
of chronic inflammation. Pilot studies were carried out with different concentrations
of the three irritants above.
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PLATE 2.1 Irritant reactions with NA prior to raising suction blisters
PLATE 2.2 Suction blisters raised at site of irritation
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The sources of the irritants and their vehicles are shown below:
Purity Source
Sodium lauryl sulphate 99% BDH, Poole, Dorset.
Nonanoic acid 99.5-100% BDH, Poole, Dorset.
Dithranol BP grade Hillcress Pharmaceuticals, Burnley.
Yellow soft paraffin BP grade Thornton & Cross, Leeds.
Propan-l-ol (Analar) 99.5% BDH, Poole, Dorset.
2.3.1 Irritant Pilot studies
Aim To find those concentrations of irritants which will elicit a positive
reaction in over 75% of subjects tested
Subjects All subjects were normal healthy volunteers from the department of
Dermatology or the Contact clinic.
Methods Finn chambers of different diameters were applied under occlusion to
the volar aspect of the forearm for 24-48 hours.
Study No. 1: 12mm chambers
Study No.2: 8mm "
Study No.3: 8mm "
Patches were removed and read visually after 30 minutes.
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Test irritants
The following concentrations of the irritants were tested :
Sodium lauryl sulphate in distilled water (w/v): 2%, 5%
Nonanoic acid in propan-1 ol (v/v): 80%
Dithranol in yellow soft paraffin (w/w): 0.01%, 0.02%, 0.04%, 0.06%
Results
A positive reaction was a site with a well defined erythema or palpable erythema.
Study No.l (12mm)
Irritant Volume/weight no. of subjects No. positive (%)
SLS 2% 30pl 14 7 (50)
SLS 5% 30pl 14 10 (71)
Dithranol 0.01% 35mg 11 5 (45)
Dithranol 0.02% 35mg 11 9 (82)
Study No.2 (8mm)
Irritant Volume/weight no. of subjects No. positive (%)
SLS 5% 15)0.1 23 19 (83)
Nonanoic acid 80% 15pl 10 9 (90)
Dithranol 0.02% 25mg 27 7 (26)
Study No.3 (8mm)
Irritant Volume/weight no. of subjects No. positive (%)
Dithranol 0.04% 25mg 12 8 (66)
Dithranol 0.06% 25mg 12 11 (92)
See Plates 2.3 and 2.4
44
PLATE 2.3 Dose response for NA irritation, 25-80% NA in propan-l-ol
PLATE 2.4 Dose response for SLS irritation, 2-5% SLS in water.
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Conclusions
Willis's group had previously shown that 2% SLS, 80% NA and 0.02% dithranol
resulted in positive irritant reactions in over 75% of normal volunteers (Willis et al,
1989). The above results show the influence of area on the reaction. The volume (or
weight) of irritant required for the 12mm chamber was extrapolated by calculating
the volume/area of the 8mm Finn chamber. The larger Finn chambers probably
required a greater volume of SLS to achieve a higher percentage of responders. I
could not explain the marked variation in response to dithranol between the 12 and
8mm patches.
The final concentrations adopted for the studies were 80% nonanoic acid, 5%
sodium lauryl sulphate and 0.06% dithranol.
2.4 Bioengineering methods for assessment of irritation
The following methods were appraised by trials on volunteers and the author.
Laser Doppler Flowmetry (LDF)
The principle has been discussed earlier. The
problem with LDF is the flux variation within a
test patch site. The erythema in a 8mm patch is
not always uniform especially in early reactions
(shaded region). The probe (P) has a diameter
of 2mm and as the schematic diagram
illustrates, the site of probe placement can be
crucial to the reading.
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Scanning laser Doppler
This more sophisticated device overcomes the
main problem of simple LDF by scanning the
whole patch and has the added advantage of
measurement without the need to apply any
pressure on the subject. Its major drawback
apart from its great expense was the time taken
to set up the apparatus. These factors led to this
method being abandoned.
Digital image analysis
The Seescan photographic image analysis system (already in the department of
Dermatology) was adapted to take digital images of a test colour (white silk) and its
optical density compared with the optical density of irritant patch test sites. This
method was technically both difficult and cumbersome for the patient, to be used on
a regular basis.
Diastron colorimetry
This instrument had previously been used in the investigation of the weal and flare
response to histamine injections. The probe was extremely sensitive to the pressure
applied to the skin making it difficult to obtain good reproducibility of readings.
Minolta colorimetry
Following the appraisal of the above instruments it was felt the Minolta CR300
Chroma meter was the most suitable method of irritation assessment because of:
• the ease of use in the clinic setting
• the low inter-reading variation
• the speed with which repeated readings could be undertaken.
Unfortunately the machine was not available for the early subjects.
(See introduction p24 for discussion of the principle of colorimetry)
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The machine was calibrated against the standard white tile supplied by the
manufacturer, prior to each set of readings for a subject. An initial reading was taken
from adjacent forearm skin before measurements of the irritant patch test site in
triplicate. This was repeated for each of the sites A, B and C (see p40). The change
in erythema (Aa* value) was calculated by subtracting the adjacent normal skin value
from the irritated site value. See Plates 2.5 and 2.6
2.5 Tissue sampling
2.5.1 Punch Biopsy
The irritant patch test sites were cleaned with an antiseptic solution and infiltrated
with 1% lignocaine and adrenaline in a ring pattern around the edge of the site. Each
site was biopsied with a 6mm disposable biopsy punch (Stiefel) including the
clinically unaffected skin on the contralateral forearm. The latter served as the
subjects own control.
All biopsies were coded prior to analysis in the laboratory so that laboratory
research staffwere unaware of the time of biopsy or whether it was an irritant or
control biopsy. Tissue biopsy samples were fixed in 5% formalin in phosphate
buffered saline. Three-micron sections were cut and stained with standard
haematoxylin and eosin. All sections were mounted in Pertex.
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PLATE 2.5 Minolta CR-300 Chroma meter with adjacent white calibration tile
PLATE 2.6 The measurement of erythema on the forearm with the Minolta CR-300
49
2.5.2 Suction Blisters
Unlike the immunohistochemical study, the subjects who required suction blisters
had the apparatus applied to their skin immediately after the irritant patches were
removed.
The suction blister technique is based on the Dermovac® used by Kiistala
(1968). Two plastic cups were attached via plastic tubing and a Y-connector to a
hand operated suction pump. Previous experience with this instrument showed that a
negative pressure of 30mmHg was adequate to raise suction blisters (see Plate 2.2).
The time taken to form blisters ranged from 1-1.5 hours. The cups were removed
and the blister fluid withdrawn with a syringe and stored at -40°C. The epidermal
blister roofs were carefully excised and snap-frozen in liquid Nitrogen (-196°C).
The roofs were later used in the confocal microscopy study.
2.6 ELISA assays
Principles
Solid phase ELISA were used, which are designed to measure IL-la, IL-8 and IFN-
y in tissue culture media, serum, plasma and other biological fluids. The assays
employ a quantitative sandwich enzyme immunoassay. A monoclonal antibody
specific for the cytokine, is coated onto a microtitre plate. Standards and test
samples are pipetted into the wells and any cytokine present is bound by the
immobilised antibody. Any unbound proteins are washed away after which an
enzyme-linked polyclonal antibody specific for the cytokine is added to 'sandwich'
any cytokine immobilised at the first incubation. Any unbound antibody-enzyme
reagent is washed away and a substrate solution is added to the wells. A colour
develops which is proportional to the amount of cytokine bound in initial step. For
IFN-y a tertiary antibody (biotin-labelled donkey-anti-goat Ig) is used and a
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streptavidin-peroxidase reaction converts a chromagen which changes the
absorbance of the solution.
An optical density standard curve is calculated using the standard at different
concentrations. The test sample optical densitiy is read against the standard curve,
allowing the concentration of the cytokine in the unknown test sample to be
calculated.
2.6.1 IL-lafOuantikine. R&D Systems. Abingdon, UK)
Reagents
1. 20ml of the wash buffer concentrate was diluted with distilled water to prepare
500ml of wash buffer.
2. The colour reagents A and B were mixed in equal volumes to form the substrate 15
minutes prior to use. 200ql of the mixture was required per well.
3. IL-la standard was reconstituted with the appropriate calibrator diluent and
diluted in the concentrations 250 pg/ml, 125 pg/ml, 62.5 pg/ml, 31.3 pg/ml, 15.6
pg/ml, 7.8 pg/ml, 3.9 pg/ml and 0 pg/ml.
Assay procedure
1. 200ql of the standard or test sample was added to each well and the plate is
covered with an adhesive strip and incubated for 2 hours at room temperature.
2. Each well was washed twice with the buffer via an automatic washer.
3. 200pl of IL-la conjugate was added and left to incubate for 1 hour at room
temperature.
4. The wash as in step 2 was repeated.
5. 200pl of the substrate was added to each well and incubated at room temperature
for 20 minutes.
6. 50pl of the stop solution was added to each well and the plate tapped gently to
ensure complete mixing.
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7. The optical density of each well was read using a spectrophotometer set to 450nm
with a wavelength correction set to 540nm.
The sensitivity of the assay i.e. the minimum detectable dose of IL-la, was 0.2pg/ml.
2.6.2 IL-8 (Quantikine, R&D Systems. Abingdon. UK)
Reagents
1. Wash buffer and colour reagents were prepared as for IL-la - see above.
2. IL-8 standards were reconstituted with appropriate calibrator diluent and diluted to
2000pg/ml, lOOOpg/ml, 500pg/ml, 250pg/ml, 125pg/ml, 62.5pg/ml, 31.2pg/ml and
Opg/ml.
Assay procedure
1. 100pl of the assay diluent was added to each well.
2. 1 OOju.1 of the standard or sample was added to the well and mixed gently for lmin.
The plate was covered and left to incubate for 2 hours at room temperature.
3. Each well was washed twice with an automated washer.
4. 200pl of IL-8 conjugate was added and left to incubate for a further 2 hours at
room temperature.
5. The wash was repeated as in step 3.
6. 200jul of substrate solution was added to each well and incubated for 20min.
7. 50pl of stop solution was added.
8. The optical density of each well was read using a spectrophotometer set to 450nm
with a wavelength correction set to 540nm.
The sensitivity of the assay was 18.1pg/ml.
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2.6.3 IFN-y (Genzyme Corporation, Cambridge. USA-)
Reagents
1. The primary antibody was coded by the manufacturer.
2. IFN-y standards were reconstituted with the appropriate diluent to 6400pg/ml,
3200pg/ml, 1600pg/ml, 800pg/ml, 400pg/ml, 200pg/ml, lOOpg/ml and Opg/ml.
3. The secondary antibody was polyclonal goat anti-human IFN-y.
4. The tertiary antibody was polyclonal anti-goat -biotin.
5. Streptavidin-peroxidase.
6. Substrate buffer and OPD (chromagen).
7. 2N sulphuric acid as stop solution.
Assay procedure
1. The microtitre wells were coated with the primary antibody and incubated
overnight at 4°C.
2. The coating antibody was washed twice with an automated washer and blotted
dry.
3. lOOpl of the standard or sample was added to each well. The plate was covered
and left to incubate for 2 hours at 37°C.
4. The wells were aspirated and washed as in 2.
5. lOOpl of the diluted secondary antibody was added to each well and incubated at
room temperature for 2 hours.
6. The wash was repeated as in step 4.
7. 1 OOjlxI of the diluted tertiary antibody was added to each well and incubated at
room temperature for 45min.
8. The wash was repeated as in step 4.
9. lOOpl of the diluted streptavidin-peroxidase solution was added to each well and
incubated at room temperature for 45min.
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10. The wash was repeated as in step 4.
1 l.The substrate was prepared with the chromagen, OPD. 1 OOpl of this reagent was
added to each well.
12. lOOpil of the sulphuric acid stop solution was added to each well.
13.The absorbance was measured at 492nm.
The sensitivity of the assay was lOOpg/ml.
2.7 Langerhans cell studies
2.7.1 Immunofluorescence staining
Intact whole epidermal roofs were incubated in mouse monoclonal anti-CD la
antibody (Dako T-6, Dakopatts, Denmark) diluted 1:100 in phosphate-buffered
saline/0.1% bovine serum albumin (PBS/BSA), overnight at 4 °C. The sheets were
washed in PBS/BSA and incubated in fluorescein isothiocyanate (FITC)-conjugated
sheep anti-mouse IgG (Sigma Chemical Co., St. Louis, USA) diluted 1:40 in
PBS/BSA for 1 hour at room temperature. The sheets were washed again and
mounted in Citifluor antifadent mountant (Citifluor Ltd., London, U.K.). The
coverslip was sealed with nail varnish to prevent oxidation of the FITC. Staining
was not observed in controls without the primary antibody.
2.7.2 Immunohistochemistry (performed by study co-workers R. Forsev and C.
Sands: counts additionally performed by Dr. Sarah Howie)
Six micron cryostat sections were air-dried, fixed in acetone and stained using a
standard procedure in a Sequenza semi-automated staining system (Shandon
Laboratories). Sections were preincubated with normal rabbit serum to block non¬
specific binding, incubated with monoclonal anti-CD 1 a (DAKO UK Ltd) washed
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and incubated with avidin-biotin-alkaline phosphatase complex (DAKO UK Ltd),
washed and visualised with fast red (SIGMA UK Ltd) and counterstained with
haematoxylin. The Zeiss HOME microscope was used to measure the total length of
basement membrane for each section examined.
2.7.3 Confocal laser scanning microscopy
The Zeiss LSM 10 confocal microscope was used to examine the fluorescently
labelled CDla+ LC. This system uses an argon laser (A,-488nm) to excite the FITC,
and photomultipliers to measure the signal returning from the specimen.
The sheets were optically sectioned in the z-plane and images (512x341 pixels)
were collected at a scan rate of 2 seconds per scan. The whole intensity of the laser
was used without a neutral density filter.
All sections were examined by one investigator (the author). Epidermal sheets
were stained as above and 5 low power fields (lpf) per sheet were scanned using a
Zeiss x40 water immersion lens and x20 zoom (x800 magnification). In each field 5
optical sections each of 4pm thickness were scanned and summated to produce a
composite section (see Fig 2.1 below).
For morphological assessment CDla+ LC were examined at high power using
a x40 objective lens and x80 zoom (x3200 magnification-high power field). For
each LC, 40 optical sections were scanned each of 0.5pm thickness. The first section
in the series was always positioned immediately above the cell and scanning
continued until no further fluorescence was visible.
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Fig 2.1 Optical sectioning with the confocal laser scanning microscope. Area of
interest is sectioned in five segments and added together producing a composite
image.




The images were analysed by a Kontron IBAS 20 image analysis system. A
threshold of 32-35 was set for image data (arbitrary scale 0-255). The relative
percentage of fluorescence and number ofCDla+ LC / mm2 was measured on each
composite lpf image (equal to 7.6x 10"2 mm2). The number of dendrites/LC and
lengths of dendrites were measured on each composite high power field image, after
calibrating the field using a graticule of 10pm length.
56
Statistical analysis
A two way unbalanced analysis of variance (ANOVA on SPSS for Windows
software) was used to test the difference in the number ofCDla+ LC between
patients & volunteers. This also tested for the effect of time compared with normal
healthy controls (Time=0h). The factors were time and group (patients or
volunteers) and the variable was the number of LC (log no. of LC used in analysis).
An unbalanced test was used because of the different numbers in each group. The
same method was used to look at the difference in number of dendrites/ LC and mean
length of dendrites between the same groups. 2-tailed Mann-Whitney U-tests were
used to test the difference in the number of functional CDla+ LC between the control
forearm site and the vehicle or irritant reaction site at the different time points.
2.8 Skin Window chambers
2.8.1 Background
It was during the search for an in-vivo technique to allow the evaluation of the role
played by lymphocytes and monocytes in acute inflammation, that Rebuck,
published his skin 'window' method (Rebuck, 1955). The volar part of the forearm
was cleaned with alcohol and a scalpel used to abrade 3-4mm of the skin. The
abrasion was continued until fine bleeding points were seen. This was felt to occur
at the level of the papillary dermis. The inflammatory test agent was placed over the
denuded area and a sterile glass cover slip placed over it. This was kept in situ with
cardboard and surgical tape.
The inflammatory cell exudate migrates to the under surface of the coverslip.
After 30-60min the coverslip is rapidly air-dried and a new coverslip is placed over
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the abrasion. The coverslips were stained with May-Grunwald or Wright-Giemsa
stains, thus allowing detailed examination of the nature of the cellular infiltrate.
Although the Rebuck skin window yielded very useful qualitative information about
the induced inflammatory cell infiltrate, little quantitative data was obtained.
Moreover, it was later believed that the method itselfmay actually represent a
foreign body reaction, rather than the early phase of the neutrophilic host response.
Several groups have since modified the technique to obtain quantitative data (see
Table 2.1 below). The use of scalpel abrasion was gradually phased out and dental
drill abrasion substituted. Another modification of the technique was instituted to try
and reduce the wide variation in the leucocyte mobilisation rate (Mass et al, 1975).
In their method, the skin of both forearms was pre-hydrated with wet gauze for one
hour prior to tape stripping. The skin was sterilised and a Transpore template with
two holes, attached to the skin. Blenderm tape stripping was repeated 50-100 times
until the skin glistened. Plastic skin chambers were securely fixed to the stripped site
and ports at either end of the chamber, enabled culture medium to be withdrawn and
inserted at different time points.
The variables that have been studied in the mobilisation of leucocytes include the
sampling time and the nature of the chamber medium. Gowland (1964) sampled
several chambers in healthy volunteers and found negligible leucocytes in the first
5hours. However all of the above groups have shown that 24hours is sufficient to
pick up the maximum yield of leucocytes. The different chamber media used by
Senn included autologous serum, buffered normal saline and saline with
streptokinase/streptodornase. The maximum yield was from 100% autologous
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serum. The predominant cell in the leucocytic infiltrate was the neutrophil (90-
95%).














5 plastic 0.6ml autologous
serum
scalpel 2.5-6.3 x 106 / 7h




73.1 x 106 / 24h
Mass et al,
1975





1.43 x 106 / 24h
Wandall,
1980
21 plastic 2ml diluted
autologous
serum
scalpel 69 x 106 / 24h
The skin window technique has been adapted to study many different in-vivo
physiological and disease processes. Lawlor et al (1990) examined cytokine levels in
chamber fluid of lesional and non-lesional skin of patients with mycosis fungoides.
Brain et al investigated leukotriene activity in psoriatic skin (Brain et al, 1984). Of
particular interest to the field of contact dermatitis was the investigation of the
influence of nickel sulphate when added to the autologous serum just before insertion
into the chamber (Lerche et al, 1981). The subjects used were both nickel sensitive
(confirmed by patch testing) and normal volunteers. Their results showed that the
LMR (predominantly polymorphs) in the control chamber of Ni-sensitve patients
was no different from the LMR of healthy volunteers. There was however, an
increase in the LMR of the nickel containing chambers ofNi-sensitive subjects
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compared with their own control arm, but only after 15hours. Lerche et al concluded
that for the nickel concentration used, only local LMR is altered and that the method
is an effective way of investigating the cytological nature of the exudate in the
evolution of a contact eczematous reaction.
2.8.2 Sellotape stripping
The method has been adapted from Mass et al (1975). Volunteers were used to refine
the technique. A 12mm Finn® chamber containing 34jlx1 of 5%SLS was applied
under occlusion to the volar aspect of the forearm. This was removed after different
times and then covered by a Tegaderm® template with 12mm hole, which ensured a
consistent stripping site. The site was repeatedly stripped with Sellotape™ and an
effort made to ensure new tape came into contact with the skin. Tape stripping was
continued until the skin glistened. The variables which were changed, included the
number of strippings, the volume of irritant in the patch and the duration of irritation.
A similar area of non-irritated forearm skin was stripped as a control.
2.8.3 Skin window chambers
The skin 'windows' were purchased from FAR Italia (Verona, Italy). These are
plastic chambers which have an adhesive seal on the base and a detachable stopper in
the roof, allowing the withdrawal and insertion of chamber medium. The diameter of
the base of the chamber was 11mm which ensured that the whole of the tape-stripped
site would be covered. After the chamber was stuck down, it was secured with more
adhesive tape and finally bandaged with Coband. Once the chamber was in-situ the
subject could move around freely (see Plates 2.7 and 2.8).
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PLATE 2.8 Skin window chambers bandaged with Coband allowing free movement
of arms
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The skin window chamber was filled with 1ml of autologous serum and left in-situ
for upto 24h. The chamber medium was sampled at various time intervals and
washed out with a 1ml aliquot of 0.9% saline to remove all possible cells. Fresh
autologous serum was then added after each wash.
2.8.4 Preparation of peripheral blood neutrophils
Twenty millilitres of venous blood was removed into a citrated bottle and 5ml
dextran added to it. The cells were allowed to sediment for 30minutes and the upper
layer withdrawn into a separate tube. 5ml of normal saline was added and left for
5minutes before the solution was spun (lOOOrevs/min for 5min). The cells were
resuspended and 5ml hypotonic (0.18%) saline added for 30secs followed by
hypertonic (1.8%) saline for 30secs. The latter steps ensured lysis of any
erythrocytes that may have been present. The solution was spun again as before.





European collection for Animal Cell Cultures Neat
CD1 la (WAC70) Dr J. Ross, Royal Infirmary, Edinburgh 10pg/ml
CDllb Dr. N Elogg, ICRF, London 1/10
CD35 (Ell) Dr. N Elogg, ICRF, London Neat
CD16 (3G8) Dr. JC Unkeless, Mt Sinai School of Medicine,
New York
Neat
CD62L (L-selectin) Becton-Dickinson, Oxford, UK 1/10
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2.8.5 Neutrophil surface marker immunoassays
1. The cells were spun and resuspended in 1ml of phosphate buffered saline (PBS).
2. lOOpl of the test sample was added to each well (>50,000 cells) in duplicate.
3. 50pl of the monoclonal antibody was added to each well and left to incubate at
4° C for 30min.
4. The plate was washed with lOOpl of PBS and spun at lOOOrevs/min for 90secs.
The excess was discarded and resuspended with a vortex mixer.
5. The wash was repeated as in step 4.
6. 50pl of fluorescein isothiocyanate (1:20) was added and incubated at room
temperature for 30min.
7. Repeated wash as in 4.
The sample was placed in a test tube with sufficient buffer wash to enable it to be
read in the flow cytometer.
2.8.6 Flow cytometry
Cytometry is defined as the measurement of physical and/or chemical characteristics
of cells. Flow cytometry is a process in which these measurements are made while
the cells or particles pass, preferably in a single file, through the measuring apparatus
in a fluid stream as shown below.
Fluorescently labelled cells
LASER Forward scatter (FS)
Side scatter (SS)
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This provides quantitative data for determination of cell surface molecule expression.
Cells for analysis were gated on the basis of the distinct forward and side scatter
characteristics for neutrophils (see Fig 2.2 below).
Fig 2.2a) Flow cytometry profile for peripheral blood FS= forward scatter; SS=side
scatter; b) Histogram of the observed fluorescence for neutrophils which allows







CHAPTER 3. A STUDY OF THE HISTOPATHQLOGY OF
EXPERIMENTAL IRRITANT CONTACT DERMATITIS
3.1 Introduction
It is often very difficult to distinguish between allergic and irritant dermatitis on
clinical grounds and this is also true histologically (Lever, 1975). Irritant reactions
are more variable than allergic reactions. Early studies with guinea pigs found that
high concentrations of dinitro-chlorobenzene (DNCB) induced partial necrosis and
epidermal separation by 12 hours, and vesiculation with a neutrophilic infiltrate by
48 hours (Nater, 1976). A previous human study using Dettol as the irritant, found a
predominantly lymphocytic infiltrate at 24 hours and 48 hours (Turk et al, 1966). It
was Bjorneberg who significantly advanced the knowledge in this field. In his study
of irritants and hand dermatitis he suggested that the histopathological changes vary
in accordance with the mode of action of the irritant (Bjorneberg, 1968).
A summary of some of the important human studies are shown in
Table 3.1 below. In most of these studies the focus has been on histopathological
changes after 48 hours of irritation. We therefore decided to investigate
systematically, the cutaneous histopathological changes between 1-48 hours after
experimental irritation with nonanoic acid, sodium lauryl sulphate and dithranol.
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Table 3.1 Summary of the relevant previous studies on the histological changes in
ICD



























































To characterise the histopathological changes in the skin of patients with chronic
ICD after the induction of experimental irritant reactions.
3.3 Materials and methods
Patients
Sixty-six patients who had been diagnosed as suffering from chronic ICD were
recruited (see section 2.1) from the departments of Dermatology at the Royal
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Infirmary of Edinburgh and the Victoria Hospital, Kirkcaldy. The breakdown of
their specific diagnoses is shown in Appx. 2. The majority of patients had hand
dermatitis. Atopic individuals were diagnosed by the UK Working Party's
diagnostic criteria (Williams et al, 1994) as detailed in section 2.1
Irritant reactions
These were induced as described in section 2.2.2
Punch biopsies
These were taken as described in section 2.5.1 and coded so that laboratory staff
were blinded to the timing of sampling and type of irritant used.
Assessment of erythema
The initial 27 patients had their reactions assessed clinically, prior to the use of the
Minolta Chroma meter. Each irritant patch test site was read in triplicate.
Assessment of biopsies
As described in section 2.5.1
The appraisal of all the biopsies was carried out by 3 observers (C. Sands, R.Forsey
and the author) who were unaware of the source of the biopsies, as these were coded.
To reduce the inter-observer variation, 30 test sections were graded using a semi¬
quantitative method. In order to aid this task, a special proforma was devised, which
was refined after collaboration with other members of the research team (see Appx.
3). This also facilitated the storage of results on a computerised database.
The main features of interest in the epidermis included oedema (intracellular
and spongiosis/vesiculation), parakeratosis, apoptosis and any cellular infiltrate. For
oedema, this ranged from no visible oedema (grade 0) to a maximum of grade 3,
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which implied involvement of greater than 3/4 of the test section. A binary system
was used to record the presence or absence of a cellular infiltrate. The numbers of
apoptotic cells were arbitrarily ranked with the highest grade reserved for greater
than 10 cells. Apoptotic cells were defined as those cells in the epidermis below the
granular layer with 2 or more chromatin clumps. The three observers had received
prior tuition from Dr. M. Arends, Department of Pathology, University of Edinburgh,
who has a special interest in apoptosis.
The main dermal changes recorded were the nature and site of any
inflammatory infiltrate. The site (if periappendageal) was felt to be relevant because
it has previously been believed that irritants acted by traversing down the hair
follicles on the skin.
The 3 assessors, using a triple-headed microscope, reviewed all sections with any
doubtful or unusual features.
Statistics
The chi-squared test with Yates' continuity correction was applied to compare the
distribution of a parameter in sections between irritants. In cases where numbers in a
group was less than 5, Fisher's exact test was used, p values < 0.05 were considered
to be statistically significant.
3.4 Results
Assessment of irritant reactions
All values for irritated sites are expressed as the Aa* value for erythema of the patch
test site compared with the adjacent normal forearm skin. For raw data see Appendix
4.
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Patch test
Fig. 3b. Colorimetric assessment of SLS irritation with time
























Normal Vehicle DL-lh DLr6h DL-24h DL48h
control Patch test
The different time-points were divided into two groups for ease of analysis: early (1
and 6h) and late (24 and 48h). To ensure irritant reactions between these groups were
of a similar magnitude, the mean erythema values for each group were calculated.
Mean a* value (+/-SEM)
NA n SLS n
Early 2.8(+/-0.5) 14 2.5(+/-0.7) 14
l,6h
Late 4.6(+/-0.5) 18 5.2(+/-1.0) 18
24,48h
Assessment of biopsies
A total of 4 biopsies from each patient was taken which generated a total of 264
biopsies. One of these was lost due to the processing leaving 263 for analysis. The




Atopic Non-atopic Atopic Non-atopic Atopic Non-atopic
Early- l,6h 7 10 6 10 6 10
Late- 24,48h 3 4 3 5 0 2
Vehicle controls
The main histological changes seen in 24 biopsies for the vehicle propanol (for NA)
were mild intracellular oedema at all time points, a mild upper dermal perivascular
mononuclear infiltrate and 1 -5 apoptotic cells in 5 biopsies.
Distilled water (vehicle for SLS) caused negligible epidermal changes with mild
spongiosis in 8/24 biopsies and a mild perivascular infiltrate in 14/24 biopsies.
Yellow soft paraffin (vehicle for dithranol) induced minimal change except for mild
intracellular oedema in 13/18 biopsies.
Nonanoic acid - see Plates 3.1-3.3
The major epidermal change seen with NA was mild spongiosis at the early time-
points, which became marked in all sections by 48 hours (Table 3.2). Parakeratosis
was not a feature ofNA irritation. There was no epidermal infiltration but there was
a dermal inflammatory infiltrate. NA induced intravascular accumulation of
neutrophils soon after irritation; these cells migrated into the papillary dermis (Table
3.2) at all time subsequent points. Eosinophils were seen in vessels and the papillary
dermis but in smaller numbers than neutrophils.
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Plate 3.1 Nonanoic acid irritation at 24h showing an epidermal mononuclear
infiltrate (inf) x216
Plate 3.2 Nonanoic acid irritation at 6h showing a perivascular/intravascular
neutrophilic infiltrate x270
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Plate 3.3 Nonanoic acid irritation at 24h showing more marked apoptosis (apop)
xl080
Plate 3.4 Sodium lauryl sulphate irritation at 48h showing parakeratosis (pk)
x216
73
Sodium lauryl sulphate - see Plates 3.4-3.6
SLS induced a basketweave hyperkeratosis and parakeratosis, the latter becoming
evident at 24 sand 48 hours (Table 3.2). The other major epidermal feature of SLS
irritation was epidermal intracellular oedema and marked spongiosis progressing to
vesicle formation at 24 and 48 hours. Basal layer apoptosis was seen in just 9% of
the early biopsies, a feature which contrasted with NA irritation at the equivalent
time point (p<0.005). However apoptotic cells were found in 31% of the late
biopsies. The pattern of epidermal infiltration contrasted with NA in that SLS
induced greater numbers of inflammatory cells at both early and late phases of
irritation. The dermal inflammatory cellular infiltrate was once again predominantly
mononuclear. However, the time course and pattern differed from NA. Neutrophils
were rarely seen early, unlike NA (p<0.025), but were observed by 48 hours
(p<0.05). This was reflected by the neutrophil migration to the upper dermis, mainly
in the perivascular region. Upper dermal eosinophilia was found mainly in the later
stages of irritation.
Dithranol - see Plate 3.7
Dithranol evoked very few histopathological changes with the main feature being
intracellular oedema. It induced little or no inflammatory infiltrate in either the
epidermis or dermis.
From the erythema results and the lack ofhistological change, it was clear that the
concentration of dithranol used in this study did not induce significant irritant
reactions. The main objective of the whole study was to investigate inflammation in
the early stages of irritation. Since this was not being achieved (despite the results
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Plate 3.6 Sodium lauryl sulphate irritation at 24h showing basal mononuclear
inflammatory infiltrate. x216
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Plate 3.7 Dithranol irritation at 6h showing intracellular oedema (ic) x216
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from pilot studies which indicated 0.6% dithranol should induce irritant reactions), it
was decided at this stage, that dithranol should be dropped from further study.
Table 3.2 Histological parameter assessment for nonanoic acid and sodium lauryl
sulphate at 1, 6 hours (early) and 24, 48 hours (late) post irritation. Comparisons
between irritants at a time point which are statistically significant are shown in bold.
* £1
yp<0.05. using Fishers exact test.
Histological
parameter
% of positive biopsies
EARLY
% of positive biopsies
LATE
NA (n=32) SLS (n=32) NA (n=14) SLS (n=16)
Parakeratosis 3 8 7 44*'a
Basal cell
apoptosis
44* 9 64 31
Spongiosis
(severe)
6 3 14 44
Vesiculation 9 9 0 31*'a
Intravascular
neutrophilia




38* 13 43 50
Intravascular
eosinophilia




16 13 7 38*'a
For raw data see Appendix 5.
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Atopics and non- atopics
NA-induced basal apoptosis was more common in atopic subjects (p<0.02) at the
early phase of irritation. All other parameters tested were not statistically significant
between the two groups.
When analysing atopic and non-atopic subjects after SLS irritation, there was no
significant difference at 1 &6 hours for all the parameters examined, but vesiculation
occurred more frequently in atopics at 24&48 hours (not significant).
3.5 Discussion
This study has investigated early histopathological changes in the development of
irritant contact dermatitis. The three irritants were chosen because of their different
modes of action. Nonanoic acid alters the skin lipid profile and appears to have a
consistent irritant effect (Stillman et al, 1975). Sodium lauryl sulphate, an anionic
detergent, has multiple modes of action including denaturation of keratins and
surface glycoproteins, removal of surface lipids and the impairment of barrier
function by increasing the permeability to water (Kligman 1967, Middleton 1969).
Dithranol, if applied to the skin, is oxidised by air, which results in the generation of
free radicals such as superoxide anions. The latter are believed to be responsible for
its irritation (Ashton et al, 1983).
A prominent feature ofNA irritation in our study was marked spongiosis
between 24 and 48 hours, contrary to previous reports (Willis et al, 1989). We did
not observe the 'tongues of dyskeratotic cells' following NA irritation as described by
Willis and her co-workers (Willis et al, 1989). A finding in experimental ICD on
which there have been no previous comments is apoptosis. Apoptosis is a form of
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programmed cell death which does not provoke an inflammatory response. Basal
cell and prickle cell apoptosis was a common finding in NA irritation (Plate 3.4).
Polymorphonuclear leucocytes are seen commonly in ICD induced in animals
(e.g. guinea pigs), but have only been found, to any significant extent, in irritant
reactions in humans induced by SLS and croton oil (Willis et al, 1993). The lack of
neutrophil recruitment noted by Willis et al, who studied benzalkonium chloride,
propylene glycol and the irritants used in our study, may reflect the timing of their
biopsies as neutrophil migration takes place soon after irritation. This would be
missed if biopsies are taken at 48 hours- the time Willis' group chose to study. In our
study, NA induced the accumulation of both neutrophils (perivascular and papillary
dermis) and to a lesser extent, eosinophils by 6 hours. The latter cell type is said to
be found only in allergic patch test reactions and not in irritant reactions (Lachapelle,
1992).
We can confirm that SLS induces parakeratosis in the latter phase of
irritation. This may in part be due to stimulation of epidermal mitosis (Fisher, 1975)
or accelerated keratinisation. Sodium lauryl sulphate also produced epidermal
vesiculation after 6 hours, which would be in keeping with the findings ofWillis et al
(1989). The degree of apoptosis, while not as marked as with NA, was observed at
all phases of irritation due to SLS. The pattern of cellular infiltration after SLS
contrasts sharply with that after NA. The former induces recruitment of neutrophils
(and to a lesser extent, eosinophils) both into the vessels and into the papillary
dermis, but not until 24 hours. Frosch showed that SLS can act as a chemoattractant
in-vitro at concentrations of 1(F3 to 10"8% (Frosch, 1987). This would suggest that
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despite 5%SLS being applied topically, the resulting in-vivo concentration of SLS
was significantly lower than 5%.
The influence of atopy on irritation has been noted in many previous studies
(Agner, 1991a;Van der Valk et al, 1985; Tupker et al, 1990) but surprisingly had
little effect on the histopathological changes between the three irritants. It is possible
that the numbers in the subgroups were too small to demonstrate any true
differences.
Our study has thus revealed some important differences in the
histopathological changes elicited when irritants are applied to the skin under patch
tests. These differences are probably due to the varying chemical nature of the
irritants. The different patterns of epidermal damage and inflammatory cell infiltrate
induced by irritants imply that the inflammation may be mediated in different ways.
In Chapters 4 and 5 the findings from the analysis of some key cytokines and
antigen-presenting Langerhans cells in biopsies from this study and suction blisters at
irritated sites, will be discussed.
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CHAPTER 4. A STUDY OF THE CYTOKINES IN SUCTION BLISTER
FLUID FOLLOWING INDUCTION OF AN IRRITANT REACTION
4.1 Introduction
As there were no previous known studies which had investigated the cytokines
relevant to the mediation of inflammation in ICD, pilot studies were performed. The
cytokines chosen were the key primary cytokines ILl-a, IL-2, IFN-y and TNF-a.
The results from the histological study had shown a mononuclear infiltrate in the
majority of irritant biopsies and a neutrophilic infiltrate in the later SLS and NA
biopsies. This prompted the inclusion of the macrophage cytokine MlP-la and the
chemotactic cytokine IL-8 in the screening panel.
The irritant reactions (erythema scores) elicited in the histopathology study showed
that the most consistent dose-time response occurred with the irritant NA. This
irritant was used for most of the suction blister studies.
4.2 Pilot study
Aim
To determine the level of cytokines in the suction blister fluid of volunteers after the
induction of irritant reactions with 80% NA.
Materials and methods
Subjects: normal healthy volunteers from the departments of Dermatology and
Pathology.
Irritant reactions: Reactions were elicited in the manner described in Chapter 2.2.2
Suction blisters: Suction blisters were raised and fluid withdrawn as outlined
previously (see Chapter 2.5.2)
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Cytokine assays
Solid phase cytokine ELISA (see Chapter 2.6) assays were performed for the
following: Source
IL-la, IL-2, TNF-a, MlP-la, IL-8 R&D Systems, Abingdon, U.K.
IFN-y Genzyme, Cambridge, USA.
Results (see summary below)
The following shows the volumes of fluid obtained:

















Table 4.1 Cytokine protein levels detected after NA irritation ;
n= no of volunteers ; N.D. not detected; - assay not done
Time after NA irritation
0 6h 24h
IL-la pg/ml N.D. 97.8 -
n 2 1 -
sensitivity <0.2
IFN-y pg/ml - 3.2ng/ml 1.8, N.D., N.D.
n - 1 3
sensitivity <100
TNF-a pg/ml - N.D. N.D.
n - 1 1
sensitivity <15.6
IL-2 pg/ml - - N.D.,N.D.,N.D
n - - 3
sensitivity <31.3
MlP-la pg/ml N.D. N.D.,N.D.,N.D N.D.
n 1 3 1
sensitivity <46.9
IL-8 pg/ml - 0.6,1.6,2.5 -




There appeared to be no appreciable levels of IL-2, TNF-a or MlP-la detectable
between 1 and 24 hours of irritation with 80% NA. Even though the numbers of
volunteers were small, significant amounts of IL-la, IFN-y and IL-8 were detected in
blister fluid. Therefore these three cytokines were analysed in the main suction
blister study as described below.
4.3 Suction blister cytokine experiments
Aim:
To determine any differences in cytokine protein levels between patients and controls
following experimental irritation with nonanoic acid.
Subjects
Patients with chronic ICD were recruited as stated previously and informed consent
obtained prior to the study. Normal healthy volunteers were recruited from the
general public and from within the department ofDermatology.
Irritant reactions
These were induced on the forearm as outlined above. NA was applied under patch
test occlusion for 1, 6 or 24h.
Suction blisters
These were induced on the forearm as outlined above. The blister fluid was stored at
-40 °C for the cytokine assays.
Cytokine assays
The cytokine protein levels of IL-la, IL-8 and IFN-y, in suction blister fluid, was
assayed by ELISA. The differences in cytokine levels at the different time points
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were compared with the control (Time Oh) level by the non-parametric Mann-
Whitney U-test.
Results
Thirty-six patients with ICD and thirty volunteers were studied. The breakdown of
the irritant reactions and assays on these two groups is shown in Appendix 6. The
majority of patients were tested after 1 hour ofNA irritation. The clinical grading of
the irritant reactions in patients, varied from a negative reaction (grade 0) to a well-
defined erythema (grade 2) by 6 and 24 hours. The irritant reactions in volunteers
were more even, with grade 1 in all subjects after 1 hour, and grade 2 after 6 and 24
hours.
As with the pilot studies, the volume of suction blister fluid obtained from all
subjects was limited, ranging from no blisters to 240pl. The two patients in whom
blisters could not be raised (after 2 hours suction) were both atopic with lichenified
forearm skin. The small volumes restricted the number of test samples for each
cytokine assay.
IFN-y
There was no detectable IFN-y in patients or volunteers at 1 or 6 hours.
Unfortunately no comment can be made for the 24 hour time point because the
ELISA kit was found to be faulty at the end of the assay.
IL-la
Following irritation at 1 hour both patients and volunteers had detectable levels of
IL-la. This fell slightly by 6h more in volunteers (not detectable in 3/4 subjects)
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than in patients. However by 24 hours there was consistent detection of IL-lot in
both patients and volunteers.
IL-8
There was no detectable IL-8 in the normal skin of both patients and volunteers. By
1 hour, IL-8 protein was found in only 2/8 patients and not detected in any
volunteers. At 6 hours there was more IL-8 in volunteers, but by 24 hours there was
no detectable IL-8 in patients and in only 2/8 volunteers.
Tables 4.2, 4.3 and 4.4 Cytokine levels in suction blister fluid after NA irritation
IL-la pg/ml
Oh lh 6h 24h
Patient Volunteer Patient Volunteer Patient Volunteer Patient Volunteer
n.d. 275 319 246 324 155 63
n.d. 296 38 352 n.d. 136 1017
141 73 n.d. n.d. 170 33






n.d. = not detected
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IL-8 pg/ml
Oh lh 6h 24h
Patient Volunteer Patient Volunteer Patient Volunteer Patient Volunteer
n.d. n.d. 565 n.d. 1200 454 n.d. 650
n.d. n.d. 454 n.d. n.d. 624 n.d. 910
n.d. n.d. n.d. n.d. n.d. n.d. n.d. n.d.
n.d. n.d. n.d. n.d. n.d.
n.d n.d. n.d. n.d. n.d.
n.d. n.d. n.d. n.d.





Patient Volunteer Patient Volunteer Patient Volunteer
n.d. n.d. n.d. n.d. n.d. n.d.
n.d. n.d. n.d. n.d. n.d. n.d.
n.d. n.d. n.d. n.d. n.d. n.d.
n.d. n.d. n.d. n.d. n.d. n.d.
n.d. n.d. n.d. n.d.








The results for patients and volunteers appeared to be very similar and were thus
combined for both groups.
IL-la Time Oh v. Timelh p=0.35 not significant (n.s.)
Time Oh v. Time 6h p=0.50 n.s.
Time Oh v. Time 24h p=0.07 n.s.
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There appeared to be no observable difference between atopic and non-atopic
subjects and hence the groups have been combined for analysis of data. Similarly the
patients and volunteer results were combined for statistical analysis.
The IFN-y data was not totally surprising as previous groups have not been
able to show the presence of IFN-y in keratinocytes. However, our research group
have demonstrated the presence of IFN-y mRNA and protein in keratinocytes from
patients with allergic contact dermatitis who have been challenged, in vivo, with a
relevant antigen (Howie et al, 1996). One should note this only applied to biopsies
taken at 6h and that these results cannot be extrapolated to irritant reactions.
The IL-la results could be explained by the release of pre-formed IL-
1 a from keratinocytes at 1 h, the stores being depleted by 6h. Furthermore at 24
hours the consistent production of IL-la would suggest the induction of 'new' IL-
1 a secretion by the irritant.
The IL-8 data are rather more difficult to explain. There was minimal, if any
IL-8 secreted in blister fluid from patients at all time points. In 3/5 volunteers there
was detectable IL-8 by 6h but this was not maintained by 24h. The histopathology
study results showed a different effect on granulocyte induction between NA and
SLS. The latter induced an epidermal neutrophilia, whereas NA induced a
perivascular and intravascular dermal infiltrate. Since the major effect of IL-8 is on
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neutrophil chemotaxis, this might be reflected in the cytokine expression in irritated
skin. The following experiment was performed to test this hypothesis.
4.4 IL-8 secretion with SLS
Aim:
To determine the level of IL-8 protein in patients with ICD and healthy normal
volunteers.
Subjects
6 patients with ICD; 26 healthy normal volunteers
Methods
As for above suction blister experiments but using 5% SLS as the test irritant.
Results (see Table 4.5 and Fig 4.3)
The data for controls at Time Oh from NA irritation have been combined. There was
no significant difference between the groups prior to SLS irritation. At lh, 2/3
volunteers were inducing IL-8 secretion, which was being maintained at 6h and 24h.
By 24h patients were also inducing IL-8.
Table 4.5 IL-8 secretion after SLS irritation
IL-8 pg/ml
Oh lh 6h 24h
Pt Vol Pt Vol Pt Vol Pt Vol
n.d. n.d.,n.d. 1153 1398 606 826
n.d. n.d.,n.d 492 522 1109 315
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The limited number of samples from patients greatly affects the valid interpretation
of the results. The trend, however, suggests there is little, if any, IL-8 in the
uninvolved skin of patients and volunteers. IL-8 is then rapidly produced by 1 h (2/3
volunteers) and found in most samples at 6h and 24h post SLS irritation, in both
patients with ICD and volunteers.
If the data for SLS irritation is compared with NA irritation, there is a marked
difference with SLS inducing IL-8 secretion in blister fluid in the first 24h of
irritation, this being significant at both 6h and 24h in volunteers and at 24h in
patients. This differential induction of IL-8 secretion would explain the presence of
a neutrophilic infiltrate in the epidermis after SLS irritation seen in the earlier
histopathology study.
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CHAPTER 5. THE QUANTITATIVE AND QUALITATIVE ANALYSIS OF
LANGERHANS CELLS IN CUTANEOUS NONANOIC ACID IRRITATION BY
CONFQCAL MICROSCOPY
5.1 Introduction
The investigation of changes in epidermal Langerhans cells (LC) by conventional
microscopy has been beset by problems of distortion of the tissue sample due to
sectioning and fixation. It has been suggested that confocal laser scanning microscopy
(CLSM) is a better method for investigating not only the morphology but also the
numbers of epidermal LC (Scheynius, 1990; Van Oostveldt, 1990). In CLSM, a high
intensity light source (usually a laser) is focused via an objective lens onto the specimen.
The light emanating from the focal plane on the specimen, passes through a detector
pinhole and the signal is amplified to produce a digital image. The optical system is
used to scan the specimen in the x and y axis thereby building up an image, point by
point i.e. an optical section (see Fig 5.1 below).









Optical sectioning has the following advantages:
• better contrast by rejecting light from out of focus planes (Hall, 1991)
• spatial relationships between cells to be examined by three-dimensional (3-D)
reconstruction of such optical sections
• digital images may be stored.
In the present study, CLSM was used to determine qualitative and quantitative
changes in the epidermal LC population during the first 24hours of induction of irritant
reactions in both healthy volunteers and patients with chronic irritant dermatitis.
Conventional immunohistochemistry was also used to quantify epidermal LC and to
examine the direction of any movement of LC after irritation.
5.2 Materials and methods
Subjects
Forty six patients with chronic irritant dermatitis (for diagnostic criteria see Table 2.1,
p.38) were recruited from the Contact Dermatitis clinic at the Royal Infirmary of
Edinburgh. Twenty-three healthy volunteers with no past history of any skin disease or
atopy were additionally recruited. There were 3-9 subjects in each group of patients and
volunteers at all time points, for both quantitative and morphological analyses.
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Experimental irritant reactions (see section 2.2.2 for details)
6 volunteers had no irritant applied. The remaining patients and volunteers had 120pl of
80% nonanoic acid in propan-l-ol applied under occlusion to normal looking skin of the
volar aspects of the forearms (with standard 8mm Finn chambers®) for either 1, 6 or 24
hours.
Patients having biopsies were divided into an "early"(n=16) and "late" (n=6) groups.
Three patch test chambers (one with 15pf of the vehicle, two with 15 pi of nonanoic
acid) were applied to the forearms for 1-6 hours in the early group and for 24-48 hours
in the late group. All patients had a time zero biopsy taken from clinically normal
forearm skin.
Suction blisters and biopsies (see sections 2,5.1 and 2,5.2 for full details)
Suction blisters were raised at the site of irritant reactions using plastic chambers based
on the Dermovac® (Kiistala, 1968). Epidermal roofs were carefully excised and snap-
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frozen in liquid Nitrogen and stored at -196 C.
A 6mm punch biopsy from untreated normal forearm skin was taken (with 1 %
lignocaine) as a control and the three remaining patch test sites were assessed visually
and similarly biopsied one hour after the various time points.
Immunofluorescence staining as described in section 2.7.1
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Immunohistochemistry as described in section 2.7.2
Positively stained epidermal LC (cell body with a minimum of 2 dendrites) were
counted simultaneously by three co-workers using a multi-headed microscope and
expressed as the total number of positive cells/mm basement membrane.
Confocal laser scanning microscopy and statistical analysis
As described in section 2.7.3
5.3 Results
Confocal laser scanning microscopy (see Tables 5.1, 5.2 , 5.3 and Figs. 5.3, 5.4)
A representative low power field from a normal volunteer is shown in Plate 5.1. In
patients one hour after irritation the number of LC fell (Plate 5.4) and continued to
decrease at both 6 hours (Plate 5.5) and 24 hours. In contrast, in normal volunteers 1
hour after irritation, there was no significant change in the number of LC (Plate 5.2) and
only started to fall 6 hours and 24hours post NA irritation (Plate 5.3). Statistical
analysis of variance showed a highly significant difference between the LC numbers in
patients and volunteers, p<0.001 as well as a significant effect of time ofNA irritation,
p<0.001. There was no significant interaction between time and group (i.e. patients or
volunteers, p=0.152).
Normal healthy volunteers had a mean of 6.0 dendrites per LC with a mean length
of 15.4pm prior to application ofNA. The morphology of a typical LC (high power
field) is shown in Plate 5.6. Following irritation there was a reduction in the number of
dendrites at all time points (p<0.05). This effect was coupled with a decrease in the
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mean length of each dendrite at 6 hours (p<0.001) and 24 hours (p<0.001). Patients
however, had a mean of 4.5 dendrites per LC with a mean length of 12.0pm prior to
application ofNA. There was a significant fall in the number of dendrites in patients but
this did not occur until 6 hours (p<0.05,) and 24 hours (p<0.05). A closer inspection of
the cell showed a more rounded cell body and retraction of the remaining dendrites
(Plate 5.7). In addition there was a highly significant reduction in the length of
dendrites by 24hours.
Table 5.1 Langerhans cell counts and standard errors by confocal microscopy.
Time-Oh Time-lh Time-6h Time-24h




421 323.6 225.7 116 389.8 444.2 334.3 156.4
SEM 3 17.4 25.2 14.8 53.5 33.9 14.8 26
n 3 9 6 6 10 9 6 5
For raw data see Appendix 7
Table 5.2 Number of dendrites per LC counts and standard errors by confocal
microscopy.
Time-Oh Time-lh Time-6h Time-24h





4.5 6.0 5.2 4.0 3.8 4.1 2.8 3.5
SEM 0.3 0.9 0.6 1.2 1.4 1.1 1.8 1.6
n 3 9 6 6 6 6 6 6
For raw data see Appendix 8
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Table 5.3 LC dendrite lengths and standard errors by confocal microscopy.
Time-Oh Time-lh Time-6h Time-24h
Pts Vol Pts Vol Pts Vol Pts Vol




SEM 0.8 1.2 2.6 0.8 3.5 6.6 6.7 7.3
n 3 9 6 6 6 6 6 6
For raw data see Appendix 8
Table 5.4 Numbers ofCDla+ve Langerhans cells/mm basement membrane after
irritation with nonanoic acid.
Patient No. Control 24h 48h
1 9.2 5.8 0.5
2 11.2 5 4.3
3 19.0 5.6 5.4
4 21.3 9 2.1
5 13.5 9 3.5
6 10.6 2.9 0.8
7 11.7 10.2 5





Basement membrane lengths were measured using the HOME microscope, the number of
CDla+ve LC (cell body plus a minimum of 2 dendrites) were counted and expressed as the
median number of cells/mm basement membrane. The early and late time points were












□ No. of LC Volunteers
T
0h lh 6h 24h
Time afterNA irritation
Fig. 5.2 Bar chart showing the number ofCDla+ve Langerhans cells (+ s.e.m) after








Oh 1h 6h 24h
Time after irritation
Fig. 5.3 Bar chart showing the changes in length of dendrites (+ s.e.m.) after irritation
with nonanoic acid.
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PLATE 5.1 Confocal microscopy image of CDla+ LC in a volunteer
non-irritated skin (x 800) showing typical dendritic (D) appearance.
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PLATE 5.2 CDla+ LC -volunteer at lh post NA irritation (x 800) showing little
change in number or morphology of LC
PLATE 5.3 CDla+ve LC - volunteer at 24h post NA irritation (x800) showing
marked reduction in number of LC
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PLATE 5.4 CDla+ LC - patient at lh post NA irritation (x 800)
PLATE 5.5 CDla+ve LC -patient at 6h post NA irritation (x800) showing
reduction in number of LC
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PLATE 5.6 High power confocal microscopy image clearly showing morphology of
dendrites (D) ofCDla+ LC in patient prior to irritation (x 3200)
PLATE 5.7 CDla+ LC in patient at 6h post NA irritation (x 3200) showing
reduction in length and number of dendrites (D)
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Immunohistochemistry for CD la staining
The results of counting CDla+ve cells in frozen sections are shown in Table 5.4 above.
The distribution pattern ofCDla+ve cells is shown in Plates 5.8 and 5.9.
The median number ofCDla+ve LC in untreated, uninvolved forearm skin from the
patient group was 11.7/mm basement membrane. The number ofCDla+ve LC in the
uninvolved forearm skin of volunteers was significantly lower at 8.6/mm basement
membrane, p<0.01. CDla+ve LC in both control groups showed a normal even
distribution throughout the epidermis. The effect ofNA at 6h was to induce a
redistribution ofCDla+ve LC to a basal pattern (Plate 5.9) which was still present at 24
and 48h.Vehicle alone at all time points had no effect on the number or distribution of
CDla+ve LC.
5.4 Discussion
The function of Langerhans cells as antigen presenting cells in allergic contact
dermatitis has been studied extensively (Stingl et al, 1978; Toews et al, 1980; Braathen,
1980) but their role in irritant contact dermatitis is poorly understood. Previous data
using conventional immunohistochemical methods have shown increased (Scheynius et
al, 1984; Lindberg, 1986), unchanged (Kanerva et al, 1984; Avnstorp et al, 1987) and
decreased (Ferguson et al, 1985; Gawkrodger et al, 1986;Willis et al, 1990; Mikulowska,
1994) numbers of LC in experimental irritant contact dermatitis. The importance of the
chemical nature of the irritant itselfwas highlighted by examining the different changes
with several irritants (Willis et al, 1990). Willis and her colleagues, using standard light
microscopy and immunohistochemistry, found there was a significant reduction in
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Plate 5.8 Normal distribution of epidermal CDla+ LC ( stained red) x216
Plate 5.9 CD la +LC moving to a basal distribution 6h post NA irritation x216
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epidermal LC density with 80% NA but no difference with sodium lauryl sulphate or
croton oil. The quantification of CDla+ LC by light microscopy of perpendicular
sections using morphometric methods is open to misinterpretation due to variations in
the thickness of tissue sections (Yu et al, 1994). The use ofCLSM showed that
experimental irritation does induce a significant reduction in epidermal LC density and
that this trend is in keeping with the immunohistochemical data. Unlike previous work
this study has focused on the early time course of irritation i.e. the initial 24 hours after
application ofNA. This is also the first study to my knowledge, which has investigated
patients with a clinical irritant dermatitis. This may be relevant because it has been
noted that CD la reactivity is different between patients and volunteers. This study
showed that patients have increased numbers of epidermal LC in clinically normal skin
compared with skin from normal healthy volunteers with a greater median number of
CDla +ve LC per mm basement membrane (see Table 5.4). The results show that this is
not only a quantitative difference but that the LC also behave differently with an earlier
and more rapid reduction in patients after NA irritation. Volunteers initially have an
increased number of LC after 1 hour before exhibiting a similar stepwise fall. This
increase at 1 hour may be through recruitment of LC. In patients, their LC may be more
sensitive to external stimuli with a lowered threshold for activation and movement out of
the epidermis. The question must be asked as to whether the reduction in CDla+ LC is a
true migration of LC out of the epidermis or simply due to loss ofCDla expression. The
immunohistochemical staining ofCDla+ LC in perpendicular sections supports our
belief that this is a true migration through the epidermis. This has been recently shown
for sodium lauryl sulphate irritation (Mikulowska, 1994). An alternative hypothesis
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based on our results suggest that NA not only causes migration of the LC out of the
epidermis, but also induces apoptosis of LC which would not be picked up with CD la
staining (Forsey et al, 1998). The apoptosis has been seen on both on Fl&E staining
(see Chapter 3) and confirmed by TUNEL immunostaining (Forsey et al, 1998).
In normal human epidermis LC form a monolayer of cells located suprabasally
with 5-9 dendrites and the number of LC/mm2 varies depending on the body site with a
lower number in sun-exposed sites (Yu et al, 1994). Morphological changes in the
dendrites of epidermal LC following NA irritation have been determined by semi¬
quantitative analysis by arbitrary grading (Willis et al, 1990). CLSM has allowed a
more accurate definition of these changes in dendritic length. Other groups have looked
at morphological alterations with CLSM in normal skin and after experimental irritation
in volunteers (Scheynius et al, 1992). The latter study showed a marked reduction in the
number of LC (CDla fluorescence) after 80% NA but not SLS.
It has been shown that samples of lymph from vessels draining the region of a
SLS- induced irritant dermatitis in human volunteers, contained an increase in LC, T and
B cells (Brand et al, 1995) and cytokines (Hunziker et al, 1992), suggesting
immunological activation. Conventional teaching defines irritant contact dermatitis as
an inflammatory reaction pattern which follows non-immunological damage to the skin
(Mathias, 1987). However, it is now believed irritants may activate keratinocytes non-
specifically, inducing them to express adhesion molecules and to produce chemotactic
factors and cytokines (Bos, 1993), including TNFa, which has been shown to promote
LC migration (Cumberbatch, 1995).
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These results confirm earlier reports that the number of epidermal LC are
decreased in one type of experimental irritant reaction. CLSM provides a sensitive
technique which allows both quantitative and structural analysis of tissue specimens. It
gives that added third dimension of volume not possible with standard
immunohistochemical techniques. The choice of the threshold value is important as this
discriminates between the true CD la staining and non-specific background. The
analysis of stored images in one sitting enabled the same threshold to be used. The
fading of staining is another possible source of error but antifadents such as Citifluor and
p-phenyldiamine (Bieber et al, 1998; Horton et al, 1984) keep this to a minimum.
On the basis of this work alone it is not possible to comment on the degree of
immunological activation of LC, but studies which investigate cytokine induction (see
chapter 4), T cell recruitment and expression of adhesion molecules after the application
of irritants (future studies) may help to gain a better insight into the mechanisms of
inflammation which they produce.
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CHAPTER 6. THE USE OF SKIN WINDOWS TO EXAMINE THE
ACTIVATION OF NEUTROPHILS IN-VIVO FROM INFLAMED SKIN
6.1 Introduction
Human polymorphonuclear leucocytes (predominantly neutrophils) are the primary
effector cells in acute inflammation. They are rapidly recruited from the bloodstream in
large numbers and pass through the vascular endothelium to the inflamed site, where
they are able to release a battery of toxic metabolites and enzymes with microbicidal
activity. The resolution of inflammation is dependent on the balance between the need
for clearance of the inflammatory stimulus and the protection of the host tissue.
Neutrophils are short-lived cells which have been shown, both in-vivo and in-vitro, to
die by apoptosis- a process that prevents inappropriate release of inflammatory
mediators (Haslett, 1992) and provides signals which lead to phagocytic clearance from
the inflamed site.
We were particularly interested in the role of neutrophils in cutaneous
inflammation induced by irritants. Skin window chambers permit the in-vivo collection
of extravasated neutrophils and thus allow the study of the fate of neutrophils in irritant-
mediated inflammation. Analysis of surface molecule expression on neutrophils can
provide important clues about their activation state and whether the neutrophils have
undergone apoptosis. Upregulation of CD1 lb/CD 18, CD35, and CD 16 with loss of
CD62L indicates neutrophil adhesion to vascular endothelium (See Chi p35).
Neutrophil apoptosis is characterised by upregulation of CD1 lb/CD18 and marked
downregulation of CD16 and CD62L.
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6.2 Aims
1. To determine the leucocyte mobilisation rate in human forearm via skin windows.
2. To determine the expression ofCDllb/CD18, CDllc/CD18 and CD62L (L-
Selectin) on neutrophils in irritated and normal forearm skin by flow cytometry.
3. To determine if neutrophil apoptosis occurs in irritated skin.
6.3 Experiment 1: Leucocyte mobilisation rate
Materials and Methods
Subjects
Healthy normal volunteers were recruited and 20ml blood venesected and spun to
remove the cellular component. The serum was removed and stored at 4°C.
Irritant reactions
Mild reactions were induced with SLS on the forearm as in section 2.2.2. The irritant
patch was left in place for 24h. SLS was chosen because of the results from the
histopathology study indicated a greater epidermal neutrophilic infiltrate with this
irritant than with any other irritant.
Tape stripping
The patch was removed and the area sellotape stripped as detailed in section 2.7.2.
Skin windows
Skin window chambers were placed over the stripped site and filled with autologous
serum and left in situ for different time periods. The chamber fluid was sampled and
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normal saline used to wash out the chamber to ensure the greatest possible retrieval of
leucocytes.
The variables tested included the following:
• Number of sellotape strips : 90-150
• Duration of irritation : 24h
• Volume of irritant : 34-60pl
• Time chamber affixed to arm : 24-5lh
Flow cytometry-see Section 2.8.6 Materials and Methods
Results
The sellotape stripping technique yielded 0.25 x 106 - 1 x 106 neutrophils (the latter
value on one occasion only). This poor yield of neutrophils was insufficient for the
immunoassays of neutrophil activation/apoptosis surface markers. An alternative
technique was employed in an attempt to increase the yield of neutrophils. The
experience from the suction blister studies suggested that removal of the epidermis
would allow a more predictable contact of serum with the dermal vasculature than
sellotape stripping.
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6.4 Experiment 2: suction blister skin window
Method
The irritant patch was removed and a suction blister cup placed above the site. A
suction blister was raised as described previously (see section 2.5.2). The contralateral
forearm of each subject was used as a control without any irritant.
See Plates 6.1 and 6.2
Results
Table 6.1 Leucocyte (neutrophils) harvested from skin windows chambers following
SLS irritation
Chamber fixation time - No. of eucocytes (x 106)
Subject No. 6h 24h
Test Control Test Control
1 - - 1.74 5.64
2 0.28 1.29 0.39 2.64
3 1.14 0.78 1.15 1.55
4 1.37 1.56 1.71 1.02
5 0.85 2.14 3.02 2.50
Conclusion
The suction blister skin window yielded sufficient neutrophils for the immunoassays.
6.5 Experiment 3: Neutrophil activation and apoptosis in irritant reactions
Subjects and Methods - as in expt. 1. The neutrophils were harvested and kept on ice.
Immunoassays and flow cytometry (for details see section 2.7.5)
Peripheral blood cells were prepared as described previously (see section 2.7.4).
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Plate 6.1 SLS and control site irritant reaction after suction blister roof removed.
Plate 6.2 Close up of control site prior to skin window placement
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The expression of the neutrophil surface markers CD1 la, CD1 lb, CD62L, CD 16 and
CD35 was determined for test sites, control sites and from subjects' peripheral blood
neutrophils. Flow cytometric analysis was performed by the EPICS Profile II (Coulter
Electronics, Luton, UK).
Cytocentrifuge spins
Cell counts were performed manually with a haemacytometer and cytospins of
leucocytes were stained with haematoxylin to look for morphological signs of apoptosis,
i.e. nuclear condensation/vacuolation.
6.6 Results
The first flow analysis (Fig 6.1) showed that more than one cell population was present
in the skin window chamber fluid, namely neutrophils and lymphocytes. The overlay
shows that these groups have distinct profiles that allowed them to be distinguished
easily for separate analysis.
Fig. 6.2 shows the analysis of neutrophil surface molecule expression from a volunteer
following SLS irritation for 24hours. The non-binding mouse antibody (negative
control) showed negligible fluorescence but there was an increase in both CD1 la,
CD1 lb and CD35 antibodies, indicating surface expression comparable to that on
freshly isolated peripheral blood neutrophils. Together with a higher level ofCD 16
expression and lack of L-Selectin (CD62), these results suggest that the neutrophils
collected have become activated. Somewhat surprisingly the neutrophil surface marker






Fig 6.1 A representative histogram of the two populations of cells in a flow sample,
lymphocytes and neutrophils, with overlay showing the clear separation between them.
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CD62L.
Fig. 6.2 24h SLS irritation
Fluorescence histograms showing the expression of neutrophil surface markers CD1 la.
CD1 lb. CD35, CD62L, CD 16 and control for neutrophils from a volunteer. Data from
one representative experiment of four that were performed.













Fig. 6.3 24h control site
Fluorescence histograms showing the expression of neutrophil surface markers CD1 la.
CD1 lb. CD35. CD62L, CD 16 and control for neutrophils from a volunteer. Data from
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forearm) were also virtually identical to the test site -Fig.6.3. The flow profiles for 6h
SLS irritant and controls were virtually identical and are not shown here.
To confirm that the L-Selectin antibody was working properly, peripheral blood T cells
were harvested in a similar fashion to the neutrophils and examined for L-Selectin
expression. Fig 6.4 shows high levels of T-Selectin expression when compared with the
T cell negative sample. This is typical of T cells and confirmed that the assay was
functioning adequately.
The unexpected similarity of the profiles for neutrophils from control and test
sites suggested that the irritation had little effect on neutrophil activation in the skin
window chamber. In order to test this hypothesis, a further experiment was performed.
Peripheral blood from a volunteer was withdrawn and the neutrophils harvested as
described by Haslett et al (1985). The neutrophils were placed in a skin window
chamber with autologous serum, overlying intact, non-irritated normal forearm skin.
Fig. 6.5 shows the profiles for the various markers. The results once again show high
levels of CD1 la/CD 18, CD1 lb/CD 18 and CD 16 and no detectable L-Selectin (CD62L)
expression.
Apoptosis
The cytocentrifuge spins of the collected chamber fluid showed the cells were nearly all
neutrophils and the occasional mononuclear cell (Plates 6.3 and 6.4). There was no
morphological evidence of apoptosis in the SLS or control site neutrophils. However,
the peripheral blood neutrophils did show some apoptotic cells with vacuolation and






Fig. 6.4a Peripheral Tcells; 6.4b Tcell negative preparation
Fluorescence histograms (with overlay) showing the expression of the surface marker














Fig. 6.5 Peripheral blood neutrophils placed on non-irritated site
Fluorescence histograms showing the expression of neutrophil surface markers from a
volunteer. Data from one representative experiment of two that were performed.
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Plate 6.3 Cytospin of chamber fluid stained to show neutrophils with the occasional
mononuclear cell (mo) - control site at 24h x216
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Plate 6.5 Cytospin of chamber fluid stained to show peripheral blood neutrophils
with the occasional apoptotic cell (apop) x216
Plate 6.6 Same preparation as above at higher magnification showing apoptotic cell
with nuclear condensation and vacuolation. x512
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Conclusions
The above experiments indicate that neutrophils collected in skin window chambers are
activated at both control and SLS irritated sites. This activation appears to be
independent of the suction blister or irritant, as a similar surface marker profile was
observed with peripheral blood neutrophils placed on non-irritated skin. SLS induced no
apoptosis in the samples examined.
6.7 Discussion
Neutrophils have been linked to the pathogenesis of a variety of diseases (Malech, 1988)
but little is known about their role in irritant contact dermatitis. Neutrophil influx during
inflammation is dependent upon the coordinated regulation of different adhesion
molecules (McEver, 1992). Cytokines induce endothelial activation at an inflammatory
site, which leads to an increase in a selectin-dependent adhesion (P- and E-selectin).
Neutrophils are arrested by adhesion via integrins (mainly (L integrins and their ligands)
and the expression and function of neutrophil adhesion molecules such as CD1 lb/CD 18
and CD62-L determines whether or not neutrophils pass through the endothelial barrier
(Condliffe et al, 1996). The above experiments demonstrate that in-vivo studies of
neutrophils in irritant reactions is possible, allowing quantitation of the rate of influx
into skin window sites and phenotypic analysis of recruited cells.
The initial study attempted to duplicate the results obtained by Morris et al
(1985) by using sellotape stripping and skin window chambers. This failed to produce
the numbers of neutrophils required for the neutrophil activation marker immunoassays,
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despite altering variables such as the number of sellotape strips and volume of irritant.
The reason for the lower yield may be related to the variability in the sellotape stripping.
The pressure applied at each strip was not uniform and would have lead to variable
removal of epidermal layers. The use of a suction blister prior to affixing a skin window
chamber bypassed this problem and the subsequent increase in neutrophil yield
confirmed the benefit of this method.
The apparent lack of difference between the neutrophil yield from SLS irritation
and control (no irritant) implied that the irritant had little bearing on the influx of
neutrophils (see Table 6.1). This could be that insufficient irritant was being applied or
the method of application was incorrect. Previous work in the histopathology study
(Chapter 3) had shown that a similar volume of SLS applied under patch test occlusion
did induce an epidermal neutrophilic infiltrate, although this was in patients with irritant
contact dermatitis. One may speculate that patients' neutrophils may be activated to
migrate more readily than in volunteers. A previous study by Lerche et al (1981) had a
different approach to contact of the skin with the test substance. This group mixed the
nickel sulphate solution in with the autologous serum before injecting the resultant
mixture in to the chamber. We were rather reluctant to do the same with SLS aqueous
solution as the absorption characteristics and scarring possibilities were unknown and
potentially hazardous.
The assessment of neutrophil activation using flow cytometric analysis in both test and
control sites did not reveal significant differences. There was evidence of neutrophil
activation with high levels of expression of CD1 la/CD18, CD1 lb/CD18, CD35, CD16
and no expression ofCD62L expression. One conclusion could be that neutrophil
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migration into the chamber leads to activation. This, however, would be incorrect since
the experiment using the neutrophils harvested from peripheral blood and applied to
intact non-irritated skin, showed identical results. The importance of this experiment
cannot be overemphasised. The removal of neutrophils from blood itself causes
activation and activation is independent of epidermal removal and independent of SLS
irritation.
There was little evidence of neutrophil apoptosis in the cells of both irritant and
control samples. This may be due to the temperature at the point of contact i.e. the skin
surface blister site. Dransfield et al (1994) showed that neutrophil apoptosis is
associated with a reduction in CD16 expression . Unpublished data from the same group
indicate that neutrophil apoptosis is inhibited at low temperatures. Further evidence of
the importance of temperature in progression to apoptosis is shown in Fig. 6.6. It is
clearly shown that the percentage of apoptosis increases (the higher left-sided peak) with
the greater the time the neutrophils are left at 37°C. It would therefore be of interest to
determine the skin surface temperature under the skin window chambers although one
would expect it to be less than 37°C.
In summary, it was possible to harvest neutrophils in vivo by a combination of
suction blisters and application of autologous serum over the eroded site. The activation
of neutrophils, as determined by immunoassay of neutrophil surface markers, is a very
easily triggered event. In our hands, at least, there was no difference in neutrophil
activation between irritated and control sites. In addition neutrophil apoptosis was not
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Fig. 6.6a Cdl6 expression. Fluorescence histogram ofCD16 expression of neutrophils
left on the bench overnight-
Fig. 6.6b Temporal changes in expression ofCD16 with temperature showing the
increasing percentage of apoptotic neutrophils with an increasing temperature.
("personal communication from Dr. I. Dransfield)
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CHAPTER 7 : DISCUSSION
7.1 Histopathology of ICD
The histopathological changes associated with a primary irritant vary with the
chemical nature of the irritant (Bjorneberg, 1968; Willis et al, 1992). The latter
group systematically investigated the action of structurally unrelated irritants and
studied changes in volunteer's normal skin after 48hour patch test occlusion. They
found that SLS irritation induced characteristic epidermal changes with parakeratosis
and vesiculation. Nonanoic acid was noted to induce effects on epidermal
keratinocytes which was attributed to premature keratinisation or possibly
irreversible cellular injury (Willis et al, 1992). The results presented in Chapter 3
have differed from previous work in two ways. Firstly the uninvolved skin of
patients with ICD and volunteers has been biopsied. Secondly the early events in
irritant reactions have been examined. The latter has allowed a clearer understanding
of the evolution of histological changes in experimental ICD.
The findings of the study have confirmed certain findings but also highlight
the differential effects of SLS and NA. The induction of parakeratosis by SLS was
confirmed in the later stages of irritation (24 and 48h). In addition SLS induced
spongiosis which proceeded to frank vesiculation. NA by contrast, induced minimal
spongiosis, which is in accord with Willis et al. A new finding was the effect ofNA
on apoptosis. NA induced basal cell apoptosis from the early phases of irritation and
although SLS did induce apoptosis in a few biopsies, the proportion never reached
that ofNA (see Table 3.2). Further work from our research group has now defined
many of these apoptotic cells as apoptotic LC (Forsey et al, 1998). This suggests that
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this is a direct toxic effect ofNA since it occurs early in the development of the
irritant response.
The dermal changes associated with experimental ICD were also analysed in
some detail. SLS induced a dermal neutrophilic infiltrate of a greater magnitude than
NA by 48 hours. Some of these neutrophils had migrated to the epidermis being
located in the infiltrate in SLS induced epidermal vesicles. Both irritants induced a
mononuclear infiltrate on routine haematoxylin and eosin sections, and like previous
work this has been the commonest finding in the histopathological studies of
experimental ICD (Nater, 1976; Willis et al, 1992). The most interesting aspect of
this infiltrate is that it is common to not only the model irritants but also to the
vehicle control biopsies (water and propanol). This implies that patch test occlusion
itself affects normal skin homeostasis without necessarily being apparent on clinical
examination.
Dithranol irritation in this study did not produce any significant clinical
irritation despite the encouraging pilot study. The only consistent finding due to
dithranol was epidermal intracellular oedema which occurred throughout the time
course of irritation.
7.2 Cytokines and inflammation
The mechanisms of inflammation in ICD are poorly understood. The analysis of
cellular infiltrates in skin biopsies from subjects who have had an experimental ICD
has shed some light on the above. Nonanoic acid has previously been shown to
induce minimal exocytosis of inflammatory cells into the epidermis (Willis et al,
1993). SLS, however, induces a marked neutrophilic infiltrate (see Chapter 3). In
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clinical practice one of the major unresolved issues is how to differentiate allergic
from irritant contact dermatitis. The in-vivo assay of cytokines may provide an
answer. In Chapter 4 an attempt was made to study the early and therefore primary
pro-inflammatory cytokine profiles in experimental ICD.
IL-1 and TNF-a production can be induced by stimulating keratinoctyes.
TNF-a has already been shown to provide one signal for LC migration during
cutaneous immune and inflammatory responses (Kimber, 1992). Similarly, in
immunological responses, IL-1 appears to be involved in the process of antigen
presentation to T lymphocytes by LC and other antigen presenting cells (Kurt Jones,
1985). More recently Enk (1992) investigated IL-1 mRNA in both ACD and ICD in
mice. They found an upregulation of IL-1 p mRNA only in irritant reactions. The
extrapolation of such a result to humans must be done with caution. Brand et al
(1996) assayed IL-ip in skin lymph from volunteers. They induced an ICD (n=6)by
applying 10% SLS for 48 hours and ACD (n=5) using either diphencyprone or
DNCB. Two control volunteers had no irritant or allergen applied. Lymph samples
were collected by cannulating the draining lymphatics on the lower limb. They found
IL-ip protein (assayed by ELISA) in lymph from both ACD and ICD volunteers,
although the amount varied widely between volunteers. In mice the IL-1 P mRNA
signal was believed to be almost exclusively produced by epidermal LC (Enk, 1992).
In humans epidermal, dermal and circulating lymph cells may all contribute to IL-
1P protein production.
The importance of keratinocytes in the initiation of an inflammatory response
was demonstrated by Nickoloff et al (1994). This group used a non-immunological
stimulus- tape stripping. This was chosen for its inherent reproducibility compared
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with delipidisation, which is often used in mice. Tape stripping induces epidermal
hyperplasia with removal of non-viable stratum corneum and minimal damage to the
underlying keratinocytes. Polymerase chain reaction was used to amplify RNA from
the epidermal layer of skin sections. An increased message was found for TNF-
ot, IL-8, IL-10, IFN-y and ICAM-1. These molecular events preceded any movement
of inflammatory cells from the circulation into the epidermis or dermis and probably
represent changes that occur in normal human skin. Nickoloff et al (1994) concluded
that epidermal keratinocytes have an important contributory role in the cytokine
milieu following the abrogation of the epidermal barrier.
The results presented in Chapter 4 mainly refer to the two pro-inflammatory
cytokines, IL-1 and IL-8. NA was initially chosen for this study because of its even
and predictable clinical irritant response. There appeared to be a heterogeneous
response to NA irritation in both patients and volunteers. The lack of data at time Oh
makes it difficult to be conclusive. The most likely explanation is that
IL-1 a production is intrinsic to both patients and volunteers and independent of
irritation. The IL-1 a protein detected is likely to represent constitutively produced
IL-1 a by epidermal keratinocytes. This returns to the argument put forward by
Nickoloff et al (1994) stating that disruption of the epidermal barrier was sufficient
to stimulate the cytokine cascade. In the present studies IL-8 and IFN-y was
essentially unaffected by NA irritation up to 6hours post irritation. Upon changing
the irritant stimulus to SLS, IL-8 was detected, consistent with the neutrophilic
infiltrate in SLS biopsies (Chapter 3) and the previous report of the neutrophil
chemoattractant effect of SLS (Frosch, 1987). To the best ofmy knowledge only
one group has published data (carried out after the experiments in this thesis) on in-
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vivo cytokine profiles taken from biopsies of skin following SLS-induced ICD
(Hoefakker et al, 1995). This group applied 10% SLS in 5 volunteers under patch
test occlusion for 72 hours, describing the clinical reactions as intense erythema and
moderate infiltration (equivalent to grade 3, see page 41). They examined the
expression of IL-la, IL-2, TNF-a, and IFN-y by mRNA in-situ hybridisation and
direct immunohistochemistry with monoclonal antibodies. The results showed an
upregulation of both IL-2 and IFN-y (i.e.protein) in the mononuclear dermal
infiltrates compared with uninvolved normal skin. There was a significant increase
in IL-la producing cells and TNF-a producing cells in irritated skin. The
localisation of these cells in the epidermis by in-situ hybridisation revealed that
IL-la protein was found in all epidermal cell layers whereas the TNF-a protein was
located in the lower epidermis and basal layer adjacent to the dermal infiltrates. Our
research group is currently undertaking in-situ hybridisation on the skin biopsies
from the histopathology study which should provide an opportunity to compare the
results with the above.
In summary the cytokine blister fluid assays have shown that in NA irritation,
IL-la is detected and most probably produced from epidermal keratinocytes and
dermal mononuclear cells (predominantly T cells). IFN-y was undetectable at
6 hours following NA irritation, which may be due to induction ofmilder reactions
than in experiments carried out by Hoefakker et al (1995). IL-8 protein was not
detected after NA irritation but was found after SLS irritation.
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7.3 Langerhans cells in ICD
The function of LC in ICD is relatively unknown compared with ACD. The study
presented in Chapter 5 has shown changes in human epidermal LC during cutaneous
irritation with NA. The results from a number of different groups have revealed
conflicting data. In SLS irritation for example, the density of epidermal LC during
experimental ICD has been shown to be increased (Scheynius et al, 1984),
unchanged (Kanerva et al, 1984) or decreased (Ferguson et al, 1985; Mikulowska,
1994). The reasons for these differences could be due to basic inter-individual
variation in SLS-induced ICD. Another source of error could result from using skin
sections instead of epidermal sheets. Bieber et al (1988) highlighted the wide
variation in counting of LC in vertical sections. A very important source of error is
due to the pharmacokinetics of SLS irritation. The rate of absorption of SLS and
total dose penetrating the skin barrier has not been fully determined. A problem
common to all of these studies has been the small numbers of volunteers willing to
have skin biopsies. In this thesis even though a large number of patients were
recruited, the number at each time point (especially time Oh) was small.
If one examines studies with similar methods to our own, some interesting
findings emerge. Mikulowska et al (1994) showed that 1% SLS only lowered LC
counts after the area of irritation (from 8-to 12 mm Finn chambers) and volume of
irritant was increased. Willis et al (1990) had already found that the chemical nature
of the irritant is a major determinant of any effect on LC. Moreover, a recent study
by Proksch et al (1996) has developed this concept further. They disrupted the skin
barrier by acetone (rolling with impregnated cotton wool balls), tape stripping or
SLS. Biopsies of the skin revealed no evidence of cell damage or spongiosis. At
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24h, there was an increase in epidermal LC with a concomitant rise in TEWL
(confirming barrier disruption) with both SLS and tape stripping. Thus a mild
irritant stimulus may lead to an increase in LC. Our study used NA, which has many
characteristics of a model topical irritant, and the confocal laser microscopy findings
did highlight some important points. Firstly there were significant morphological
changes in LC after 6 and 24 hours ofNA irritation, with a reduction in the number
of dendrites/LC and secondly a reduction in the mean lengths of dendrites. The
initial assumption was that these LC were migrating to the dermis. The
immunohistochemical CD la staining in sections from irritated skin (Plates 5.8 and
5.9) showed a very definite redistribution to a basal location within the epidermis.
This was backed up by data from Brand et al (1995) who analysed skin lymph at the
site of SLS-induced ICD in human volunteers. They found, both during and after
irritation, an increase in the number ofCDla+ LC in skin lymph.
Willis et al (1990) performed an electron microscopic (EM) study of LC after
irritation with NA and commented that 'some LC had evidence of cellular injury
including damaged organelles, condensed nuclear chromatin and lipid accumulation'.
Our research group (in work carried out subsequent to the experiments in Chapter 5)
has now put forward an alternative hypothesis regarding the fate of these LC (Forsey
et al, 1998). The histopathology study had revealed the presence of basal apoptotic
cells on H&E staining after NA irritation. These sections were stained for CD la and
combined with TdT-mediated dUTP-biotin nick end-labelling (TUNEL) which
proved that many apoptotic cells were CDla+ (85 -100%). In contrast, SLS
irritation revealed no CDla+ apoptotic cells. This effect ofNA on CDla+ cells was
restricted to the epidermis with the dermal CDla+ population remaining unaffected,
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even after 48 hours exposure to NA. Therefore NA irritation causes a reduction of
CDla+ epidermal LC not only through their migration out of the epidermis but also
through induction of apoptosis. The EM changes observed by Willis et al (1990)
probably reflect morphological signs of apoptosis.
Confocal microscopy has been criticised for its expense and problems with
thick sections. It is a useful method for quantifying labelled structures and has the
added benefit of allowing structural analysis because of its ability to section in 3-D,
but there are a few points which ought to be borne in mind of undertaking CLSM
work:
• single person analysis reduces the chance of bias
• the threshold at which cells are deemed positive should be stated clearly
• analysis of cell numbers and morphological data can be done at leisure if the
images are stored in one sitting.
Unfortunately the technique is not suitable for routine use as it is labour intensive
and prone to hardware breakdown. The former relates to morphology e.g. dendrite
lengths whereby 40 optical sections are taken for each LC. Our microscope was
temperamental with valuable time lost waiting for the company engineer to fix the
hardware.
The confocal results indicated patients with ICD had a higher number of
epidermal CDla+ LC in unaffected skin than volunteers, a finding substantiated by
immunohistochemistry of identical sections. The exact reason for this is unclear,
since it appeared to be unrelated to age, sex or atopic status. One explanation would
be that the development of ICD leads to an intrinsically higher number of epidermal
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LC. Our experiments may be criticised on two accounts. Firstly the lack of data
points at time Oh and secondly the measurement of LC in affected dermatitic skin.
These points are addressed later.
7.4 Irritant susceptibility and atopy
Patients with atopic dermatitis are generally considered to be more sensitive to
irritants than normal individuals (Van der Valk et al, 1990; Agner, 1990b; Tupker et
al, 1990). Despite this body of evidence, Gollhausen et al (1991) believe the concept
of a lowered threshold to irritancy in AD remains putative, based on clinical
impressions rather than on hard data. Nassif et al (1994) proposed that irritancy in
atopics is due to inflammatory cell hyper-reactivity and that the impaired skin barrier
(reflected by an increased TEWL) may be a secondary feature. This group
demonstrated this by applying increasing concentrations of SLS under patch test
occlusion to both atopic and non-atopic subjects. They had two groups, one normal
(n=19) and an atopic group (n=20) and calculated the concentration of SLS which
would induce an irritant reaction in at least 50 % of that group. They found it was
0.6 % SLS for normals compared with 0.28% SLS for atopics, a result which reached
statistical significance. They concluded that the lowered irritancy 'threshold' in
atopics may be due to increased cytokines and other mediators present in peripheral
blood, mucosal tissue and skin, although they presented very indirect evidence for
this hypothesis. Berardesca (1994), however, found an increased TEWL in the
uninvolved skin of atopic individuals, suggesting that atopics have a damaged barrier
which is not clinically apparent. The findings in Chapter 3 have shown that there
were no detectable differences between atopics and non-atopics with ICD when
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analysing the various histopathological parameters except for apoptosis. This may
imply insufficient numbers of patients to detect any real differences between the two
groups.
A novel hypothesis for explaining irritant susceptibility has recently been
described by Wakelin et al (1997). This group studied the promoter region
polymorphisms in the TNF-a gene. TNF-a is a pro-inflammatory cytokine and any
predisposition to switching on this gene may induce irritant inflammation. The
volunteers who had a low threshold (i.e. those who showed clinical erythema with a
low concentration of SLS) had a statistically significant higher allele frequency of
the polymorphism which favoured TNF-a production. They suggest that
heterogeneity of this cytokine production may be an important determinant of
susceptibility to ICD, a feature which may also be applicable to other cytokines.
7.5 Problems in this project
The following points apply to all aspects of the studies in this thesis.
1 .Numbers of subjects
The initial submission for the grant application to support the study of the molecular
and cellular mechanisms of ICD envisaged greater numbers of patients with ICD. 66
patients were eventually recruited for the histopathology and immunohistochemistry
study (target 120). For the suction blister cytokine study, 35 patients were recruited
(target 60). The full complement of volunteers was recruited for the latter. Does this
imply unrealistic or overambitious figures? These numbers were chosen to allow
comparisons between the different subgroups e.g. atopics versus non-atopics. The
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final figures were such that some of these comparisons were done with too few in a
group, resulting in a lower statistical power.
It was certainly not easy to persuade patients to undergo four punch biopsies
and the group felt relieved that there were no complaints following the procedures.
However, when some patients were retraced to see if they would volunteer for the
Time Oh suction blister and LC studies, none were forthcoming.
2. Dithranol
One of the major problems and therefore disappointments was the lack of clinical
irritation from dithranol. Despite the results from the pilot study and use of a
concentration similar to other groups, it was not possible to elicit any significant
irritant reaction (see Fig 3c). From clinical experience, it is known that dithranol
causes staining as a delayed response and perhaps investigating early changes i.e. 6-
24h did not take sufficient account of the pharmacokinetics of this compound.
3. Langerhans cell study
The qualitative study of LC (chapter 5) with irritation used an approach with
different patients for each time from 0-24h. The results were pooled for each time
point. An alternative and statistically more powerful design, would have been to
study subjects with suction blisters raised at all four time points. This of course may




The major drawbacks in this study were the faulty IFN-y kit (something beyond our
control) and lack ofmaterial. The yield of suction blister fluid ranged from 10-
240pl. These volumes allowed at best no more than three cytokine assays but
realistically two cytokine assays per subject. This automatically reduces the data
points on the subsequent graphs (see Figs 4.1, 4.2 and 4.3). In retrospect the
volumes required for the assay should have been calculated prior to raising suction
blisters. This might have encouraged us to apply four suction blister cups although it
seems unlikely that patients and volunteers would have consented to this extra
inconvenience.
7.6 Experimental ICD as a model for clinical chronic ICD
Unlike many previous studies of chronic ICD an attempt was made to define the
criteria for a diagnosis of ICD. One of the novel aspects of this work was to examine
the effects of different irritants in patients with ICD rather than volunteers. The
cytokine responses seemed to differ little but some differences were observed in the
number of LC in epidermal sheets. The irritant SLS had little bearing on the
outcome of neutrophil collection and activation in the skin window experiments.
Experimental ICD is by definition supposed to mimic chronic ICD. The once
only patch test application has been the most widely used method for inducing
irritation, but Allenby has advocated the repetitive arm immersion model (1993) as a
more appropriate model for the clinical situation. Our results showed that the
irritants produced different and distinctive effects, which also means that
extrapolation to the patient with ICD must be done with caution. SLS has been the
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standard irritant for a number of decades because of its detergent effect and because
it is found in many products that are likely to come into contact with the skin of
affected individuals (e.g. cleaners and other wet work occupations). The variables in
any experimental model such as the volume of irritant, time of application and area
to which it is applied must be kept constant if studies are to be of any benefit. Thus
the diversity of effects of different irritants e.g. epidermal changes, barrier disruption
implies that experimental irritant contact reactions are only a very basic model for
chronic ICD in humans.
Summary
This work has shown that irritants have different pathological effects despite
producing a similar clinical endpoint i.e. erythema.
Nonanoic acid induced a reduction in epidermal LC and alteration in morphology of
LC. This was probably due to LC apoptosis- a result of direct toxicity of the irritant
and increased migration out of the epidermis. NA irritation stimulated the
production of IL-la but had no effect on IL-8 production.
Sodium lauryl sulphate induced epidermal oedema and parakeratosis. It also had
effects on the dermis with induction of a neutrophilia. IL-8 production was a feature
of SLS irritation but activation of neutrophil surface molecules appeared to be
independent of irritation.
7.7 Suggestions for future work
1. The problem of studying unaffected skin of volunteers could be remedied by
biopsying skin from affected sites of ICD and control sites from the same
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patients. These biopsies could then be examined for pro-inflammatory cytokine
profiles by immunohistochemistry and monoclonal antibodies. The LC numbers
as well as their function e.g. class II MHC expression, could be studied in the
same biopsies.
2. The control mechanisms which prevent inflammation may also provide clues
about chronic ICD. For example, one could investigate the expression or
production of inhibitory molecules at irritated sites such as
• IL-10- which inhibits IFN-y induced MHC Class II expression
• TGF-p - a molecule which reduces KC proliferation.
3. The confirmation of apoptosis induced by NA by electron microscopy would be
further evidence of the mode of action of this topical irritant.
4. The concept of an autoantigen being responsible for chronicity in ICD needs
further examination. Do specific T cells recognise this autoantigen? Is this
putative autoantigen a structural protein or even a bacterial antigen located in the
epidermis? Work has already commenced to answer these questions.
5. The use of an arm immersion test (Allenby, 1993) prior to patch testing with
irritants should prove to be a clinically relevant model. The forearm is pre-
irritated by immersion in a solution of SLS for ten minutes. This is repeated 2-3
times before patch tests are applied. Biopsies and suction blisters could then be
undertaken on the affected and normal forearms.
141
REFERENCES
Agner T. Non-invasive measuring methods for the investigation of irritant patch test
reactions. Acta Derm Venereol (Stockh) 1992; Suppl.173: 1-26.
Agner T. Susceptibility of atopic dermatitis patients to irritant dermatitis caused by
sodium lauryl sulphate. Acta Derm Venereol (Stockh) 1991a; 71: 296-300.
Agner T, Damm P, Skouby SO. Menstrual cycle and skin reactivity. JAm Acad
Dermatol 1991b; 24: 566-570.
Agner T, Serup J. Sodium lauryl sulphate for irritant patch testing. A dose response
study using bioengineering methods for determination of skin irritation. J Invest
Dermatol 1990a; 95: 543-547.
Agner T, Serup J. Individual and instrumental variations in irritant patch test reactions
clinical evaluation and quantification by bioengineering methods. Clin Exp Dermatol
1990b; 15: 29-33.
Agner T, Serup J, Handlos V. Different skin irritation abilities of different qualities of
sodium lauryl sulphate. Contact Derm 1989; 21: 184-188.
Allenby CF, Basketter DA, Dickens A, et al. An arm immersion model of compromised
skin. (I). Influence on irritation reactions. Contact Derm 1993; 28: 84-88.
Ansel J, Perry P, Brown J, et al. Cytokine modulation of keratinocyte cytokines. J Invest
Dermatol 1990; 94: 101S-107S.
Ashton RE, Andre P, Lowe NJ, et al. AnthralimHistorical and current perspectives. J
Am AcadDermatol 1983; 9:173-192.
Austyn JM, Wood KJ. Principles ofCellular andMolecular Immunology
Oxford:Oxford University Press, 1993; 555.
Avnstorp C, Ralfkiaer E, Jorgensen J, et al. Sequential immunophenotypic study of
lymphoid infiltrate in allergic and irritant reactions. Contact Derm 1987; 16: 239-245.
Baurle G, Hornstein OP, Diepgen TL. Professionelle Handekzeme und Atopie.
Dermatosen 1985; 33: 161-165.
Berardesca E, Distante F. The modulation of skin irritation. Contact Derm 1994; 31:
281-287.
142
Berardesca E, Fideli D, Borroni G, et al. In-vivo hydration and water retention capacity
of stratum corneum in clinically uninvolved skin in atopic and psoriatic patients. Acta
Derm Venereol 1990; 70: 400-404.
Berardesca E, Gabba P, Farinelli N, et al. Skin extensibility time in women. Changes in
relation to sex hormones. Acta Derm Venereol 1989; 69: 431-433.
Berardesca E, Maibach HI. Racial differences in sodium lauryl sulphate induced
cutaneous irritation: black and white. Contact Derm 1988; 18: 65-70.
Bieber T, Ring J, Braun-Falco O. Comparison of different methods for enumeration of
Langcrhans cells in vertical cryosections of human skin. Br JDermatol 1988; 118: 385
392.
Bjorneberg A. Skin reactions to primary irritants. 1968 (Thesis, Goteburg, Sweden)
Blank JH. Factors which influence water content of the stratum corneum. J Invest
Dermatol 1952; 18: 433-440.
Blanken R, Van der Valk PJM, Nater JP. Laser-Doppler flowmetry in the investigation
of irritant compounds on human skin. Dermatosen 1986; 34: 5-9.
Blaylock WK. Atopic dermatitis: Diagnosis and pathobiology. JAllergy and Clin
Immunol 1976; 57: 62-79.
Blondeel A, Achten G, Dooms-Gossens A et al. Atopic et allergie de contact. Ann
Dermatol Venereol 1987; 114: 203-209.
Bos JD, Kapsenberg ML. The skin immune system. Immunol Today 1993; 14: 75-78.
Braathen LR, Thorsby E. Studies on human epidermal Langerhans cells. I.
Alloactivated and antigen presenting capacity. Scan J Immunol 1980; 11: 401-408.
Brain S, Camp R, Dowd P, et al. The release of Leukotriene Belike material in
biologically active amounts from the lesional skin of patients with psoriasis. J Invest
Dermatol 1984; 83: 70-73.
Brand CU, Hunziker T, Yawalkar N, et al. IL-10 protein in human skin lymph does not
discriminate allergic from irritant contact dermatitis. Contact Derm 1996; 35:
152-156.
143
Brand CU, Hunziker T, Shaffner T, et al. Activated immunocompetent cells in human
skin lymph derived from irritant contact dermatitis : an immunomorphological study. Br
JDermatol 1995; 132: 39-45.
Burrows D. Prognosis and factors influencing prognosis in industrial dermatitis. Br J
Dermatol 1981; 105(Suppl 21): 65-70.
Condliffe AM, Chilvers ER, Haslett C et al. Priming differentially regulates
neutrophil adhesion molecule expression/function. Immunology 1996; 89: 105-111.
Cronin E. Clinical patterns of hand eczema in women. Contact Derm 1985; 13: 153-
161.
Cronin E, Bandmann H, Calnan CD. Contact dermatitis in the atopic. Acta Derm
Venereol 1970; 50: 183-187.
Cua AB, Wilhelm KP, Maibach HI. Cutaneous sodium lauryl sulphate irritation
potential: age and regional variability. Br JDermatol 1990a; 123: 607-613.
Cua AB, Wilhelm KP, Maibach HI. Frictional properties of human skin: relation to age,
sex and anatomical region, stratum corneum hydration and trans-epidermal water loss.
Br JDermatol 1990b; 123: 473-479.
Cumberbatch M, Kimber T. Tumour necrosis factor-a is required for accumulation of
dendritic cells in draining lymph nodes and for optimal contact sensitization.
Immunology 1995; 84: 31-35.
Davies JHT, Barker AN. Textile dermatitis. Br JDermatol 1944; 56: 33-43.
Davies NV, Teasdale P. Costs to individuals. The costs to the British economy ofwork
accidents and work-related ill-health. HSE Books, 1994; 23
de Boer EM, Bezemer PD, Bruynzeel DP. A standard method for repeated recording of
skin blood flow using laser Doppler flowmetry. Dermatosen in Berufund Umwelt 1989;
37: 58-62.
de Groot AC. The frequency of contact allergy in atopic patients with dermatitis.
Contact Derm 1990; 22: 273-277.
Diepgen TL, Coenraads P. What can we learn from epidemiological studies on Irritant
Contact Dermatitis? Irritant Dermatitis. New Clinical and Experimental Aspects.
(Eisner P, Maibach H, eds), BasekKarger, 1995; 18-27.
144
Dransfield I, Buckle A, Savill JS, et al. Neutrophil apoptosis is associated with a
reduction in CD 16 (Fey RIII) expression. J Immunol 1994; 153: 1254-1263.
Enk AH, Katz SI. Early molecular events in the induction phase of contact sensitivity.
Proc Natl Acad Sci USA 1992; 89: 1398-1402.
Epstein S, Mohajerin AH. Incidence of contact sensitivity in atopic dermatitis. Arch
Dermatol 1964; 90: 284-287.
Fartasch M, Diepgen TL, Hornstein OP. Morphological changes of epidermal lipid
layers of stratum corneum in SLS induced dry skin: a functional and ultrastructural
study. J Invest Dermatol 1991; 96: 617
Ferguson J, Gibbs JH, Swanson-Beck J. Lymphocyte subsets and Langerhans cells in
allergic and irritant patch test reactions: histometric studies. Contact Derm 1985; 13:
166-174.
Finnen MJ, Lawrence CM, Shuster S. Inhibition of dithranol inflammation by free
radical scavengers. Lancet 1984; ii: 1129-1130.
Fisher LB, Maibach HI. Effects of some irritants on human epidermal mitosis. Contact
Derm 1975; 1: 273-276.
Fitzgerald DA, English JSC. The Long-Term Prognosis in Irritant Contact Hand
Dermatitis. Irritant Dermatitis. New Clinical and Experimental Aspects. (Eisner P,
Maibach HI, eds), BasekKarger, 1995; 73-76.
Forsbeck M, Skog E, Asbrink E. Atopic hand dermatitis: A comparison with atopic
dermatitis without hand involvement especially with respect to influence ofwork and
development of contact sensitisation. Acta Derm Venereol (Stockh) 1983; 63: 9-13.
Forsey RJ, Shahidullah H, Sands C, et al. Epidermal Langerhans cell apoptosis
induced in vivo by nonanoic acid but not by sodium lauryl sulphate. Br JDermatol
1998 (in press).
Freeman S, Maibach HI. Study of irritant contact dermatitis produced by repeat patch
testing with sodium lauryl sulphate and assessed by visual methods, transepidermal
water loss and laser Doppler velocimetry. JAm Acad Dermatol 1984; 11: 477-479.
Fregert S. Occupational dermatitis in a 10 year material. Contact Derm 1975; 1: 96-107.
Frosch PJ. Cutaneous irritation. Textbook ofContact Dermatitis (Rycroft RJG, Menne
T, Frosch PJ, Benezra C, eds), Berlin: Springer, 1992; 42
145
Frosch PJ, Czarnetzki BM. Surfactants cause in-vitro chemotaxis and chemokinesis of
human neutrophils. J Invest Dermatol 1987; 88: 52S-55S.
Frosch PJ, Wissing C. Cutaneous sensitivity to ultraviolet light and chemical irritants.
Arch Dermatol Res 1982; 272: 269-278.
Frosch PJ, Kligman AM. The soap chamber test. J Invest Dermatol 1979; 1: 35-41.
Fulmer AW, Kramer GJ. Stratum corneum lipid abnormalities in surfactant-induced dry
scaly skin. J Invest Dermatol 1986; 598-602.
Gawkrodger DJ, McVittie E, Carr MM, et al. Phenotypic characterization of the early
cellular responses in allergic and irritant contact dermatitis. Clin Exp Immunol 1986; 66:
590-598.
Gehring W. Effects of irritants in atopic dermatitis. Contact Derm 1990; 22: 292-293.
Gollhausen R. The phenomenon of irritable skin in atopic eczema. Handbook ofAtopic
Eczema (Ruzicka T, Ring J, Przybilla B, eds), New York:Springer-Verlag NY Inc, 1991;
306-318.
Gottlieb AB, Fleftler NS, Gilleaudeau P, et al. Short-contact anthralin treatment
augments therapeutic efficacy of cyclosporin in psoriasis: A clinical and pathological
study. JAm Acad Dermatol 1995; 33: 637-645.
Gottlieb AB, Khandke L, Krane JF, et al. Anthralin decreases keratinocyte TGF-a
expression and EGF-receptor binding in vitro. J Invest Dermatol 1992; 98: 680-685.
Gowland E. Studies on the emigration of polymorphonuclear leucocytes from skin
lesions in man. JPath Bacteriol 1964; 87: 347
Hall A, Browne M, Howard V. Confocal microscopy- the basics explained. Proc Roy
Mic Soc 1991; 26: 63-70.
Halloran PF. Interferon-gamma, prototype of the proinflammatory cytokines
importance in activation, suppression and maintenance of the immune response. Transpl
Proc 1993; 25(Suppl 1): 10-15.
Hanifin J. Clinical and basic aspects of atopic dermatitis. Semin Dermatol 1983; 2: 5-
19.
146
Hanifin JM, Rajka C. Diagnostic features of atopic dermatitis. Acta Derm Venereol
(Stockh) 1980; 92(Suppl): 44-47.
Haslett C. Resolution of acute inflammation and the role of apoptosis in the tissue fate
of granulocytes. Clin Sci 1992; 83: 639-648.
Haslett C, Savill JS, Meagher L. The neutrophil. Curr Opin Immunol 1989; 2: 10-18.
Haslett C, Guthrie LA, Kopaniak MM et al. Modulation ofmultiple neutrophil
function by preparative methods or trace concentrations of bacterial
polysaccharide. Am JPathol 1985; 119: 101.
Health and Safety Commission. Health and Safety Statistics 1995/96. HSE Books,
1996;151-153.
Health and Safety Commission. Health and Safety Statistics 1996/97. HSE Books,
1997a; 89.
Health and Safety Commission. Health and Safety Statistics 1996/97. HSE Books,
1997b; 107-109.
Hjorth N, Fregert S. Contact Dermatitis. Textbook ofDermatology (Rook A, Wilkinson
DS, Ebling FJG, eds), 3rd edn., Oxford:Blackwell, 1979; 363-341.
Hoefakker S, Caubo M, Van't Erve EHM, et al. In-vivo cytokine profiles in allergic and
irritant contact dermatitis. Contact Derm 1995; 33: 258-266.
Horton JJ, Allen MH, MacDonald DM. An assessment of Langerhans cell
quantification in tissue sections. JAm Acad Dermatol 1984; 11: 591-593.
Howie SEM, Aldridge RD, McVittie E et al. Epidermal keratinocyte production of
interferon-y immunoreactive protein and mRNA is an early event in allergic contact
dermatitis. J Invest Dermatol 1996; 106: 1218-1223.
Hunziker T, Brand CU, Kapp A, et al. Increased levels of inflammatory cytokines in
human skin lymph derived from sodium lauryl sulphate-induced contact dermatitis. Br J
Dermatol 1992; 127: 254-257.
Imokawa G, Abe A, Jin K, et al. Decreased level of ceramides in stratum corneum of
atopic dermatitis: an aetiolgical factor in atopic dry skin? J Invest Dermatol 1991; 96:
523-526.
147
Jensen JR. Reduction of active natural killer cells in patients with atopic dermatitis
estimated at a single cell level. Acta Derm Venereol 1985; 114: (Suppl) 105-8.
Jones HE, Lewis CW, McMarlin SL. Allergic contact sensitivity in atopic dermatitis.
Arch Dermatol 1973; 107: 217-222.
Kanerva L, Ranki A, Lauharanta J. Lymphocytes and Langerhans cells in patch tests.
An immunohistochemical and electron microscopic study. Contact Derm 1984; 11: 150-
155.
Kiistala U. Suction blister device for separation of viable epidermis from dermis. J
Invest Dermatol 1968; 50: 129-137.
Kimber T, Cumberbatch M. Stimulation of Langerhans cell migration by tumour
necrosis factor a (TNF-a). J Invest Dermatol 1992; 99: 48S-50S.
Kligman AM, Wooding WM. A method for the measurement and evaluation of irritants
on human skin. J Invest Dermatol 1967; 49: 78-94.
Kupper TS. Mechanisms of cutaneous inflammation. Arch Dermatol 1989; 125: 1406-
1412.
Kurt-Jones EA, Beller DI, Mizel SB, et al. Identification of membrane associated
interleukin-1 in macrophages. Proc Natl Acad Sci USA 1985; 82: 1204-1208.
Lachapelle J. Histopathological and immunohistopathological features of irritant and
allergic contact dermatitis. Textbook ofContact Dermatitis (Rycroft RJG, Menne T,
Frosch PJ, Benezra C, eds), Berlin:Springer-Verlag, 1992; 98
Lammintausta K, Kalimo K, Fagerlund V. Patch test reactions in atopic patients.
Contact Derm 1992; 26: 234-240.
Lammintausta K, Maibach HI, Wilson D. Irritant reactivity in males and females.
Contact Derm 1988a; 17: 276-80.
Lammintausta K, Maibach HI, Wilson D. Susceptibility to cumulative and acute irritant
dermatitis. Contact Derm 1988b; 19: 84-90.
Lane CJ, Dennie CC, Downing JG, et al. Industrial dermatoses. JA MA 1942; 118:
613-615.
148
Lawlor F, Smith NP, Camp RDR, et al. Skin exudate levels of interleukin 6,
interleukin-1 and other cytokines in mycosis fungoides. Br JDermatol 1990; 123: 297-
304.
Lee CH, Maibach HI. The sodium lauryl sulfate model: an overview. Contact Derm
1995; 33: 1-7.
Lerche A, Bisgaard H, Christensen JD, et al. Human leukocyte mobilization and
morphology in nickel contact allergy using a skin chamber technique. Acta Derm
Venereol (Stockh) 1981; 61: 517-523.
Leveque JL, De Rigal J, Saint-Leger D, et al. How does sodium lauryl sulphate alter the
skin barrier function in man? A multiparametric approach. Skin Pharmacol 1993; 6:
111-115.
Leveque JL, Corcuff P, De Rigal J, et al. In-vivo studies of evolution of physical
properties of human skin with age. Int JDermatol 1984; 23: 322-329.
Lever WF, Schaumberg-Lever G. Histopathology ofthe Skin. 7th edn., Philadelphia:
Lippincott, 1990;
Lever WF, Schaumberg-Lever G. Non infectious vesicular and bullous diseases. In:
Histopathology ofthe Skin. 5th edn., Philadelphia: Lippincott, 1975; 95
Lindberg M, Emtestam L. Dynamic changes in the epidermal OKT6 positive cells at
mild irritant reactions in human skin. Acta Derm Venereol (Stockh) 1986; 66: 117-120.
Lisby S, Baadsgaard O, Cooper KD, et al. Decreased number and function of antigen
presenting cells in skin following application of irritant agents: Relevance for skin
cancer1J Invest Dermatol 1989; 92: 842-847.
Luger TA, Schwarz T. Evidence for a epidermal cytokine network. J Invest Dermatol
1990; 95: 100S-104S.
Magnusson B, Moller H. Contact allergy without skin disease. Acta Derm Venereol
1979; 59(Suppl 85): 113-115.
Magnusson B, Fregert S, Hjorth N. Routine patch testing. V. Correlations of reactions
to the site of the dermatitis and history of the patient. Acta Derm Venereol 1969; 49:
556-563.
Mahrle G, Bonnekoh B, Wevers A, et al. Anthralin: How does it act and are there more
favourable derivatives? Acta Derm Venereol (Stockh) 1994; Suppl.186: 83-84.
149
Malech HD, Gallin JI. Neutrophils in human diseases. NEngl JMed 1988; 37:687
Malten KE. Thoughts on irritant contact dermatitis. Contact Derm 1981; 7: 238-
248.
Marghescu S. Patch test reactions in atopic patients. Acta Derm Venereol (Stockh)
1985; Suppl. 114: 113-116.
Marks JG, Zaino RJ, Bressler MF, et al. Changes in lymphocyte and Langerhans cell
populations in allergic and irritant contact dermatitis. Int JDermatol 1987; 26: 354-357.
Mass MF, Dean PB, Weston WL, et al. Leucocyte migration in vivo: a new method of
study. J Lab Clin Med 1975; 86: 1040-1046.
Mathias CJT. Prevention of occupational contact dermatitis. JAm Acad Dermatol
1990; 23: 742-748.
Mathias CJT. Clinical and experimental aspects of cutaneous irritation.
Dermatotoxicology (Maibach HI, Marzulli HI, eds), 3rd edn., 1987; 173-189.
McEver RP. Leucocyte-endothelial cell interactions. Curr Opin Cell Biol 1992; 4: 820
McKenzie RC, Sauder DN. The role of keratinocyte cytokines in inflammation and
immunity. J Invest Dermatol 1990; 95: 105S-107S.
Meding B. Epidemiology of hand eczema in an industrial city. Acta Derm Venereol
1990;(Suppl. 153)
Middleton JD. The mechanism of action of surfactants on the water binding properties
of isolated stratum corneum. JSoc Cosmet Chem 1969; 20: 399-412.
Mikulowska A, Falck B. Distributional changes of Langerhans cells in human skin
during irritant contact dermatitis. Arch Dermatol Res 1994; 286: 429-433.
Moller H, Rorsman H. The role of cutaneous absorption in atopic dermatitis. Acta Derm
Venereol (Stockh) 1959; 39: 212
Morris JS, Meakins JL, Christou NV. In vivo neutrophil delivery to inflammatory
sites in surgical patients. Arch Surg 1985; 120: 205-209.
Mustakallio KK. Irritation, staining and antipsoriatic activity of 10-acyl analogues of
anthralin. Br JDermatol 1981; 105(Suppl): 23-27.
150
NassifA, Chan SC, Storrs FJ, et al. Abnormal skin irritancy in atopic dermatitis and in
atopy without dermatitis. Arch Dermatol 1994; 130: 1402-1407.
Nater JP, Hoedemaekar PJ. Histological differences between irritant and allergic patch
tests in man. Contact Derm 1976; 2: 247-253.
Nethercott JR, Holness DL. Disease outcome in workers with occupational skin disease.
JAm Acad Dermatol 1994; 30: 569-574.
Nickoloff BJ, Naidu Y. Perturbation of epidermal barrier function correlates with
initiation of cytokine cascade in human skin. JAm Acad Dermatol 1994; 30: 535-546.
Nickoloff BJ, Turka LA. Keratinocytes: key immunocytes of the integument. Am JPath
1993;143:325-331.
Nickoloff BJ, Griffiths CEM, Barker JNWN. The role of adhesion molecules,
chemotactic factors, and cytokines in inflammatory and neoplastic skin disease-1990
updatq. J Invest Dermatol 1990; 94: 151S-157S.
Nikitakis J, McEwen GN, Wenninger JA. CTFA International Cosmetic Ingredient
Dictionary. The Cosmetic, Toiletry, and Fragrance Association Inc. 1991; 549-550.
Nilsson GE, Otto U, Wahlberg JE. Assessment of skin irritancy in man by laser Doppler
flowmetry. Contact Derm 1982; 8: 401-406.
Nilzen A, Voss-Lagerlund K. Epicutaneous tests with detergents and a number of other
common allergens. Dermatologica 1962; 124: 42-52.
Office of Health Economics. Skin disorders. Studies on current health problems. 1973;
46: 1-32.
Panisset F, Treffel P, Faivre B, et al. Transepidermal water loss related to volar forearm
sites in humans. Acta Derm Venereol 1992; 72: 4-5.
Proksch E, Brasch J, Sterry W. Integrity of the permeability barrier regulates
Langerhans cell density. Br JDermatol 1996; 134: 630-638.
Rebuck JW, Crowley JH. A method for studying leukocytic functions in man. Ann NY
AcadSci 1955; 59: 757-804.
151
Reitamo S, Tolranen E, Kontinnen YT, et al. Allergic and toxic contact dermatitis:
inflammatory cell subtypes in epicutaneous test reactions. Br JDermatol 1981; 105:
521-527.
Rhein LD, Robbins CR, Fern K, et al. Surfactant structure effects on swelling of
isolated human stratum corneum. JSoc Cosmet Chem 1986; 37: 125-139.
Rietschel RL. Diagnosing irritant contact dermatitis. Irritant Contact Dermatitis
(Jackson EM, Goldner R, eds), New York:Marcel Dekker Inc. 1990; 167-171.
Rostenburg A, Sulzberger MB. Some results of patch tests: compilation and discussion
of cutaneous reactions to about 500 different substances as elicited by over 10,000 tests
in approximately 1000 patients. Arch Derm Syph 1937; 35: 433-454.
Rudzki E, Grzywa Z. Contact sensitivity in atopic dermatitis. Contact Derm 1975; 1:
285-287.
Rystedt I. Contact sensitivity in adults with atopic dermatitis in childhood. Contact
Derm 1985a; 13: 1-8.
Rystedt I. Atopic background in patients with occupational hand eczema. Contact Derm
1985b; 12: 247-254.
Sauder DN. The role of epidermal cytokines in inflammatory skin diseases. J Invest
Dermatol 1990; 95: 27S-28S.
Savill JS, Wyllie AH, Henson JE, et al. Macrophage phagocytosis of aging neutrophils.
JClin Invest 1989; 83: 865-875.
Scheynius A, Dalenbring M, Carlsson K, et al. Quantitative analysis of Langerhans cells
in epidermis at irritant contact reactions using confocal laser scanning microscopy. Acta
Derm Venereol (Stockh) 1992; 72: 348-351.
Scheynius A, Lundahl P. Three-dimensional visualization of human Langerhans cells
using confocal scanning laser microscopy. Arch Dermatol Res 1990; 281: 521-525.
Scheynius A, Fischer T, Forsum U, et al. Phenotypic characterisation in situ of
inflammatory cells in allergic and irritant contact dermatitis in man. Clin Exp Immunol
1984;55:81-90.
Seidenari S, Di Nardo A. B-scanning evaluation of irritant reactions with binary
transformation and image analysis. Acta Derm Venereol (Stockh) 1992; Suppl.175: 9-13.
152
Senn HG, Jungi WF. Neutrophil migration in health and disease. Semin Haematol 1975;
12: 27-45.
Serup J, Staberg B. Differentiation of allergic and irritant reactions by transepidermal
water loss. Contact Derm 1987; 16: 129-132.
Shmunes E. The role of atopy in occupational diseases. Occup Med :State Art Rev
1986; 1: 219-228.
Shmunes E. Contact dermatitis in atopic individuals. Dermatol Clin 1984; 2: 561-566.
Silberberg I. Apposition of mononuclear cells to Langerhans cells in contact allergic
reactions. Acta Derm Venereol (Stockh) 1973; 53: 1-12.
Springer TA. Traffic signals on endothelium for lymphocyte recirculation and
leukocyte emigration. Annu Rev Physiol 1995; 57: 827-872.
Staberg B, Serup J. Allergic and irritant skin reactions evaluated by laser Doppler
flowmetry. Contact Derm 1988; 18: 40-45.
Stillman MA, Maibach Ell, Shalita AR. Relative irritancy of free fatty acids of different
chain length. Contact Derm 1975; 1: 65-69.
Stingl G, Katz SI, Clement L, et al. Immunological functions of la bearing epidermal
Langerhans cells. J Immunol 1978; 121: 2005-2013.
Stingl G, Katz SI, Sherach EM, et al. Analagous functions of macrophages and
Langerhans cells in the initiation of the immune response. J Invest Dermatol 1978; 71:
59-64.
Turk JL, Rudner EJ, Heather CJ. A histochemical analysis of mononuclear cell
infiltrates of the skin. II. Delayed hypersensitivity in the human. Int Arch Allerg
1966;30:248-56.
Toews GB, Bergstresser PR, Streilein JW, et al. Epidermal Langerhans cell density
determines whether contact hypersensitivity or unresponsiveness follows skin painting
with DNFB. J Immunol 1980; 124: 445
Tupker RA, Pinnagoda J, Coenraads P, et al. Susceptibility to irritants: role of barrier
function, skin dryness and history of atopic dermatitis. Br JDermatol 1990; 123: 199
205.
153
Uehara M, Sawai T. A longitudinal study of contact sensitivity in patients with atopic
dermatitis. Arch Dermatol 1989; 125: 366-368.
Van der Valk PJM, Nater JP, Bleuminke E. Vulnerability of the skin to surfactant in
different groups of eczema patients and controls as measured by water vapour loss. Clin
Exp Dermatol 1985; 10: 98-103.
Van Oostveldt P, Bauwens S. Quantitative fluorescence in confocal microscopy. J
Microsc 1990; 158: 121-132.
Wahlberg JE, Wrangsjo K, Ehetsalo A. Skin irritancy from nonanoic acid. Contact
Derm 1985; 13: 266-269.
Wahlberg JE, Maibach HI. Nonanoic acid irritation- a positive control at routine patch
testing? Contact Derm 1980; 6: 123-130.
Wakelin SH, Allen MH, Holloway D, et al. TNFa promoter region polymorphisms &
irritant susceptibility. J Invest Dermatol 1997; 109: 412.
Wandall J. Leucocyte mobilization to skin lesions. Acta Path Microbiol Scand Sect C.
1980; 88:255-261.
Ward PA, Marks RM. The acute inflammatory reaction. Curr Opin Immunol 1989; 2: 5-
9.
Wilhelm KP, Cua AB, WolffH, et al. Surfactant-induced stratum corneum hydration in
vivo: prediction of the irritation potential of anionic surfactants. J Invest Dermatol 1993;
101: 310-315.
Wilhelm KP, Surber C, Maibach HE Quantification of sodium lauryl sulphate dermatitis
in man: Comparison of techniques: skin color reflectance, transepidermal water loss,
laser Doppler flow measurement and visual scores. Arch Dermatol Res 1989; 281: 293-
295.
Wilkinson DS. Contact dermatitis in the house. Current concepts in contact dermatitis.
(Verbov J, ed), Lancaster:MTP Press Ltd, 1987; 8-11.
Wilkinson JD, Rycroft RJG .Contact Dermatitis. Textbook ofDermatology (Champion
RH, Burton JL, Ebling FJG, eds), 5th edn., Oxford:Blackwell Scientific Publications,
1992; 611-612.
154
Williams HC, Burney PJG, Pembroke AC, et al. The UK Working Party's Diagnostic
Criteria for Atopic Dermatitis. III. Independent hospital validation. Br JDermatol 1994;
131: 406-416.
Willis CM, Stephens CJM, Wilkinson JD. Differential patterns of epidermal infiltration
in patch test reactions to structurally unrelated chemical irritants. J Invest Dermatol
1993; 101: 364-370.
Willis CM, Stephens CJM, Wilkinson JD. Selective expression of immune-associated
surface antigens by keratinocytes in irritant contact dermatitis. J Invest Dermatol 1991;
96: 505-511.
Willis CM, Stephens CJM, Wilkinson JD. Differential effects of structurally unrelated
chemical irritants on the density and morphology of epidermal CDla+cells. J Invest
Dermatol 1990; 95: 711-716.
Willis CM, Stephens CJM, Wilkinson JD. Epidermal damage induced by irritants in
man: a light and electron microscopic study. J Invest Dermatol 1989; 93: 695-699.
Willis CM, Young E, Brandon BR, et al. Immunopathological and ultrastructural
findings in human allergic and irritant contact dermatitis. Br JDermatol 1986; 115: 305-
316.
Wood LC, Jackson SM, Elias PM, et al. Cutaneous barrier perturbation stimulates
cytokine production in the epidermis. J Clin Invest 1992; 90: 482-487.
Yu RC, Abrams DC, Alaibac M, et al. Morphological and quantitative analyses of
normal epidermal Langerhans cells using confocal scanning laser microscopy. Br J
Dermatol 1994; 131: 843-848.
155
APPENDIX 1. Subject information sheet (Chapter 2)
SUBJECT INFORMATION SHEET
As you know we are trying to unravel the complicated ways in which skin
irritants cause dermatitis. This involves the application of three well-known irritants
(sodium lauryl sulphate, dithranol and nonanoic acid) of which we have considerable
experience. These irritants have been chosen because their action is confined to skin and
they have no longterm ill-effects.
Weak concentrations of the irritants will be applied on a small area of your skin
to either your forearm or abdominal wall for a period of up to 24 hours. They will
produce slight redness and possibly some discomfort. After removal of the irritant your
skin will be sampled using *skin biopsy/suction blister/skin windows.
* Elliptical Skin Biopsies (not exceeding 1.5cm in length), or 4-6mm punch biopsies
will be carried out under local anaesthetic (2% lignocaine) - a routine procedure in the
Department of Dermatology. Biopsies will be taken from the test sites exposed to the
irritants (or controls) on your forearm or abdominal wall. The small wound will be
stitched with one or two sutures. No more than 4 such biopsies will be performed and
the number will, of course, be discussed with you. Small scars (not exceeding 1.5cm in
length) will result from this procedure.
OR
* Suction Blisters - the Department of Dermatology has considerable experience
of this procedure. A suction blister device is attached to the test site on your forearm
or abdominal wall and a negative pressure applied for one hour. Five small suction
blisters are raised. After removal of the device blister fluid can be removed with a
small syringe and the roofs snipped without local anaesthesia. The denuded area will
be dressed with an anti-bacterial impregnated tulle-gras dressing. The procedure is
virtually painless and there is no residual scarring, but some temporary
pigmentation may be anticipated after it.
OR
* Skin Windows - the test site is gently abraded with a scalpel or by sellotape stripping
until there is slight oozing. A small chamber is then applied and is filled with sterile salt
water solution. The fluid in the chamber is aspirated and replaced at regular intervals up to
72 hours. The procedure is uncomfortable rather than painful. There is no residual scarring
but temporary pigmentation may occur at the site.
These samples will enable us to study ways in which irritants cause dermatitis and, hopefully,
may eventually lead to better treatment of this common condition.
We must emphasise that, if you do not wish to continue at any stage of the
investigation, you are fully free to withdraw. Should you choose to do so, it would, in
no way, alter your future management in our department.
Dr. H. Shahidullah,
Clinical Research Fellow in Dermatology.
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APPENDIX 2. Diagnoses of patients used in histopathology and suction blister
studies, (see Chapter 3)
Histopathology study
Subject No. Age Sex Diagnosis Atopic/Non-atopic
Tl 48 M Hand dermatitis non
T2 44 M Leg dermatitis non
T3 19 F Hand dermatitis non
T4 26 F Facial dermatitis At
T5 20 M Hand dermatitis At
T6 29 F Hand +face derm At
T7 20 F Hand dermatitis At
T8 31 F Hand dermatitis At
T9 25 F Hand dermatitis non
T10 61 M Hand dermatitis non
T11 23 M Facial dermatitis At
T12 18 M Hand dermatitis At
T13 57 M Hand dermatitis non
T14 46 F Hand dermatitis non
T15 38 M Hand dermatitis non
T16 44 F Leg dermatitis At
T17 29 M Hand dermatitis non
T18 46 F Eyelid dermatitis non
T19 58 F Hand dermatitis non
T20 39 M Facial dermatitis At
T21 28 F Hand dermatitis At
T22 53 M Hand dermatitis At
T23 35 F Hand dermatitis non
T24 56 M Hand dermatitis non
T25 42 F Hand dermatitis non
T26 47 F Eyelid dermatitis non
T27 22 M Eyelid dermatitis non
T28 55 F Hand dermatitis non
T29 18 F Hand dermatitis non
T30 65 M Hand dermatitis non
T31 59 M Hand dermatitis non
T32 35 M Hand dermatitis non
T33 40 F Hand dermatitis non
T34 21 F Hand dermatitis At
T35 20 F Hand dermatitis non
T36 24 M Hand dermatitis non
T37 48 M Hand dermatitis At
T38 24 F Hand dermatitis At
T39 28 F Hand dermatitis non
T40 52 M Hand dermatitis non
157
Subject No. Age Sex Diagnosis Atopic/Non-atopic
T41 32 F Hand dermatitis non
T42 24 M Hand dermatitis At
T43 43 F Hand dermatitis non
T44 21 F Hand dermatitis non
T45 59 M Hand dermatitis non
T46 24 F Hand dermatitis At
T47 47 M Hand dermatitis non
T48 34 F Hand dermatitis non
T49 59 M Hand dermatitis non
T50 32 M Hand dermatitis At
T51 58 F Hand dermatitis non
T52 51 M Hand dermatitis non
T53 31 M Hand dermatitis At
T54 55 F Hand dermatitis At
T55 25 M Hand dermatitis non
T56 29 M Hand dermatitis non
T57 44 F Hand dermatitis At
T58 58 F Hand dermatitis At
T59 39 F Hand dermatitis At
T60 46 F Hand dermatitis non
T61 55 M Hand dermatitis non
T62 19 M Hand dermatitis At
T63 28 M Hand dermatitis At
T64 22 M Hand dermatitis At
T65 61 M Hand dermatitis non
T66 51 M Hand dermatitis non
SUMMARY
Total no. of pts 66
Mean Age 38.5 (18-65)
Male:Female 34/32
Atopic :Non atopic 25/41
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Suction blister study
Subject No. Age Sex Diagnosis Atopic/Non-atopic
B1 27 M Fiand dermatitis At
B2 26 F Ear dermattis non
B3 26 F Facial dermatitis At
B4 59 F Hand dermatitis non
B5 35 F Hand dermatitis At
B6 52 M Hand dermatitis non
B7 19 F Hand dermatitis At
B8 28 F Hand dermatitis At
B9 50 F Hand dermatitis non
B10 24 F Hand dermatitis non
B11 60 F Hand dermatitis non
B12 23 M Hand dermatitis non
B13 31 F Hand dermatitis At
B14 58 F Hand dermatitis At
B15 26 F Hand dermatitis At
B16 30 F Hand dermatitis non
B17 22 F Hand dermatitis At
B18 41 M Hand dermatitis non
B19 63 F Hand dermatitis non
B21 24 F Hand dermatitis At
B22 26 F Hand dermatitis At
B23 57 F Hand dermatitis non
B24 18 F Hand dermatitis non
B25 20 M Hand dermatitis At
B26 47 M Hand dermatitis non
B27 18 F Hand dermatitis non
B28 54 M Hand dermatitis non
B29 58 F Hand dermatitis non
B30 31 F Hand dermatitis non
B31 47 F Facial dermatitis At
B32 32 F Hand dermatitis non
B33 23 F Hand dermatitis At
B34 35 F Hand dermatitis non
B35 23 F Hand dermatitis non
B36 46 F Hand dermatitis non
B37 34 F Hand dermatitis At
SUMMARY
Total no. of pts 36
Mean Age 35.9 (18-63)
Male:female 7:29
Atopic :Non atopic 15:21
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APPENDIX 3 : Histopathology proforma used to record details of sections
(see Chapter 3)
Date Name of assessor Section code




Stratum corneum 0-compact parakeratosis(yes)-l
1 -basketweave " (none)- 0
Granular layer 0-absent 1-present 2-thickened
Oedema 0-nil Infiltrate(overall) O-negligible Cellular infiltrate








* if v. high
Oedema
i.e. ves spon
















APPENDIX 4. Erythema scores for SLS, NA and DLtsee Chapter 3)
Erythema values for Nonanoic acid irritation
Erythema /Aa* value arbitrary units
Normal vehicle lh 6h 24h 48h
7.96 -1.18 6.05 4.38 5.57 3.5
8.29 2.67 -0.09 4.66 4.59 8.95
8.43 1.83 0.45 3.54 1.42 5.5
7.3 1.47 2.21 4.44 1.47 1.04
9.92 -0.18 1.48 3.42 5.98 6.76
10.79 -0.86 -0.07 2.08 2.47 3.37








Mean 8.1 0.67 1.67 3.94 3.78 5.10
S.E.M. 0.38 0.36 0.80 0.38 0.74 0.63
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Erythema values for Sodium laurvl sulphate irritation
Erythema /Aa* value arbitrary units
Normal vehicle lh 6h 24h 48h
7.44 5.33 0.78 4.5 3.55 6.4
6.95 -0.26 0.53 2.88 1.49 1.29
13.4 -0.96 1.35 2.83 6.01 7.36
8.73 1.74 2.39 3.9 5.94 9.87
7.76 1.44 0.31 4.6 1.68 5.71
9.9 -1.89 -1.06 7.29 8.73 0.28
9.6 -1.99 -1.54 6.18 0.27 1.07








Mean 8.57 0.42 0.39 4.60 4.07 6.13
S.E.M. 0.59 0.50 0.50 0.62 1.00 1.52
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Erythema values for Dithranol irritation
Erythema /Aa* value arbitrary units
Normal vehicle lh 6h 24h 48h
5.47 -0.78 -0.42 0.07 -0.06 -0.08
6.68 -0.34 0.83 1.86 0.94 1.18
8.68 -1.26 0.48 0.19 1.37
10.44 1.18 -0.85 0.41 2.00
6.16 -0.95 1.89 -0.23 -0.08
6.5 0.51 0.88 0.01 0.14
7.53 -0.84 0.57 -1.83
3.89 0.34
6.93 0.47
Mean 6.92 -0.18 0.48 0.07 0.44 0.76
S.E.M. 0.62 0.27 0.34 0.41 0.50 0.36
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APPENDIX 5






Early (1& 6h) Late (24 &48h) Early (1& 6h) Late (24 &48h)
Present 1 1 1 7
Absent 31 13 31 9
Total 32 14 32 16





Early (1& 6h) Late (24 &48h) Early (1& 6h) Late (24 &48h)
Present 14 9 3 5
Absent 18 5 29 11
Total 32 14 32 16
Early NA v. Early SLS %2 = 8.01 p<0.005** significant





Early (1& 6h) Late (24 &48h) Early (1& 6h) Late (24 &48h)
Present 5 6 1 11
Absent 27 8 31 5
Total 32 14 32 16
Early NA v. Early SLS y? = 2.12 p<0.1 n.s.






Early (1& 6h) Late (24 &48h) Early (1& 6h) Late (24 &48h)
Present 3 0 3 5
Absent 29 14 29 11
Total 32 14 32 16





Early (1& 6h) Late (24 &48h) Early (1& 6h) Late (24 &48h)
Present 12 1 3 7
Absent 20 13 29 9
Total 32 14 32 16
Early NA v. Early SLS x2 ~ 5.7 p<0.025* significant
Late NA v. Late SLS Fishers exact test p=0.059 n.s.




Early (1& 6h) Late (24 &48h) Early (1& 6h) Late (24 &48h)
Present 12 6 4 8
Absent 20 8 28 8
Total 32 14 32 16





Early (1& 6h) Late (24 &48h) Early (1& 6h) Late (24 &48h)
Present 4 0 2 3
Absent 28 14 30 13
Total 32 14 32 16
Late NA v. Late SLS Fishers exact test p=0.138 n.s.
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8. Papillary dermal eosinophilia
No. of
biopsies
Early (1& 6h) Late (24 &48h) Early (1& 6h) Late (24 &48h)
Present 5 1 4 6
Absent 27 13 28 10
Total 32 14 32 16
Late NA v. Late SLS x = 5.73 p<0.025* significant
Vehicle controls






Papillary derm. Infil 16/24 all mononuclear





Papillary derm. Infil 14/24
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APPENDIX 6
Tables of clinical reaction grades and assays performed in suction blister
cytokine ELISA study (Chapter 4)
1. Volunteers
Volunteer Volume of Time Irritant Assays performed
No. blister fluid/pl after irritation reaction grade IFN-y IL-la IL-8
BV2 80 lh 1 +
BV3 120 lh 1 + +
BV4 100 lh 1
BV7 120 lh 1 + +
BV10 80 lh 1 + +
BV11 80 lh 1 +
BV13 60 lh 1 +
BV22 40 lh 1 +
BV23 60 lh 1 +
BV30 Lost lh 1
BV1 100 6h 2 + +
BV5 70 6h 2 +
BV6 80 6h 2 +
BV8 80 6h 2 +
BV12 40 6h 2 +
BV17 150 6h 2 + +
BV20 100 6h 2 + +
BV21 75 6h 2 + +
BV27 80 6h 2 + +
BV28 70 6h 2 +
BV9 100 24h 2 + +
BV14 80 24h 2 +
BV15 140 24h 2 + +
BV16 180 24h 2 + + +
BV18 140 24h 2 + +
BV19 180 24h 2 + + +
BV25 180 24h 2 + + +
BV26 150 24h 2 + +
BV29 100 24h 2 + +
BV24 180 24h 2 + + +
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B1 Atopic nil lh 0
B3 Atopic nil lh 2
B5 Atopic 50 lh 0 +
B7 Atopic 60 lh 2 +
B8 Atopic 50 lh 1 +
B13 Atopic 250 lh 0 + + +
B14 Atopic 100 lh 1 + +
B15 Atopic 150 lh 2 + +
B17 Atopic 200 lh 2 + + +
B2 Non-atopic 70 lh 0 +
B4 Non-atopic 50 lh 1 +
B6 Non-atopic 100 lh 2 + +
B9 Non-atopic 40 lh 1 +
BIO Non-atopic 90 lh 2 + +
B11 Non-atopic 130 lh 1 + +
B12 Non-atopic 100 lh 1 + +
B18 Non-atopic 10 lh 2
B19 Non-atopic 130 lh 1 +
B24 Non-atopic 100 lh 1 + +
B21 Atopic 120 6h 2 + +
B22 Atopic 100 6h 2 + +
B25 Atopic 150 6h 2 + +
B16 Non-atopic 110 6h 2 + +
B23 Non-atopic 100 6h 2 + +
B26 Non-atopic 140 6h 2 + +
B31 Atopic 180 24h 2 + + +
B33 Atopic 120 24h 2 + +
B37 Atopic 240 24h 2 + + +
B27 Non-atopic 200 24h 2 + + +
B28 Non-atopic 150 24h 2 + +
B29 Non-atopic 140 24h 2 + +
B30 Non-atopic 180 24h 2 + + +
B32 Non-atopic 130 24h 2 + +
B34 Non-atopic 150 24h 2 + +
B35 Non-atopic 140 24h 2 + +
B36 Non-atopic 200 24h 2 + + +
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APPENDIX 7 Langerhans cells/mm2 raw data for confocal study (Chapter 5)
1. Patients
prefix b= patient with ICD ; suffix a=lh b=6h c=24h nonanoic acid irritation
suffix n=patient with blister at non-irritated site
Patients-Oh LCI mm2 Patients-1 h LCI mm2
b2n 418 b10a 224
b4n 427 b11a L 326







n 3 n 9
mean 421 mean 323.6
sd 5.19 sd 52.31
sem 3 sem 17.44
Patients-6h LCI mm2 Patients-24h LCI mm2
b16b 153 b27c 97
b25b 247 b28c 76
b26b 318 b29c 132
b21b 189 b30c 174
b22b 182 b31c 129
b23b 265 b32c 88
n 6 n 6
mean 225.7 mean 116
sd 61.7 sd 36.15
sem 25.21 sem 14.76
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2. Volunteers
prefix BV, VN, JS =normal volunteers
suffix A=lh B=6h C=24h nonanoic acid irritation
Volunteer-Oh LCI mm2 Volunteer-1h LCI mm2
BV31 162 BV2A 420
BV32 259 BV3A 569
BV33 338 BV4A 450
VNO 652 BV7A 388
VN2 429 BV10A 418
VN4 444 BV11A 247
JS1 612 VN1 597
JS2 312 VN3 456
JS3 508 VN5 453
JS4 182
n 10 n 9
mean 389.8 mean 44.2
sd 169.14 sd 101.5
sem 53.49 sem 33.85
Volunteer-6h LC/ mm2 Volunteer-24h LCI mm2
BV1B 285 BV14C 118
BV5B 371 BV15C 144
BV6B 300 BV16C 241
BV8B 359 BV18C 185
BV12B 326 BV9C 94
BV17B 365
n 6 n 5
mean 334.3 mean 156.4
sd 36.3 sd 58.1
sem 14.8 sem 25.98
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APPENDIX 8. Raw data for LC dendrite lengths and no. of
dendrites /LC (Chapter 5)
Key
B= Patient with ICD
BV= Volunteer
B-number-N= patient with ICD, non-irritated skin
Number prefix= no. of LC in specimen examined at high power
Letter suffix: A=lhour B=6hours C=24hours Nonanoic acid irritation
0=non-atopic l=atopic
Specimen No. of dendrites/LC length of atopic/ non atopic
code dendrites/pm






























































1-B5A 3 7.71 1
5.44 1
32.64 1






























































































































































































































3-BV7A 3 12.2 0
7.82 0
10.39 0










1-BV11A 3 25.38 0
15.32 0
13.61 0





1-B16B 3 10 0
11.81 0
3.63 0
2-B16B 3 10.96 0
12.64 0
14.54 0




















1-B23B 2 14.07 0
14.59 0
2-B23B 3 7.62 0
15.31 0
11.1 0













2-B25B 2 4.74 1
6.22 1
1-B26B 3 6.41 0
3.62 0
8.26 0
2-B26B 3 5.47 0
4.76 0
8.36 0
3-B26B 3 17.25 0
9.93 0
5.95 0










































































































































































































































2-BV18C 2 7.58 0
7.54 0
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Epidermal Langerhans cell apoptosis is induced in vivo by
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Summary Exposure to irritants may cause chronic irritant contact dermatitis (ICD), characterized by irregular
epidermal thickening and a predominantly dermal mononuclear cell infiltrate. The mechanisms
involved, and why only certain individuals are affected, are not clearly understood. Different irritants
may trigger different cellular and molecular interactions between resident skin cells and recruited
inflammatory cells. In some individuals these interactions may become self-perpetuating resulting in
persistent inflammation in the absence of continued exposure. This study examined Langerhans cell
(LC) density in clinically normal skin of 46 patients with chronic ICD and 10 healthy individuals, and
compared the action of the two irritants nonanoic acid (NA) and sodium lauryl sulphate (SLS) on the
LCs and keratinocytes of clinically normal skin in patients with chronic ICD. There was a higher
number of LCs/mm basement membrane in patients compared with controls, although there was no
difference in the number of dendrites/LC nor in dendrite length. SLS induced keratinocyte prolifera¬
tion after 48 h exposure, had no effect on LC number or distribution, and induced keratinocyte
apoptosis after 24 and 48 h exposure. In contrast, NA decreased keratinocyte proliferation after 24 h
exposure but this returned to basal levels after 48 h, and induced epidermal cell apoptosis after only
6h exposure. NA dramatically decreased LC number after 24 and 48 h exposure, which was
accompanied by basal redistribution and decreased dendrite length. Most significantly, NA induced
apoptosis in over half of the LCs present after 24 and 48 h exposure.
Chronic irritant contact dermatitis (ICD) is a common
clinical problem which affects people in a variety of
occupations and results in a significant loss of time at
work. Chronic ICD is a non-antigen-mediated multi¬
factorial condition characterized clinically by erythema,
oedema and dryness1,2 and histologically by epidermal
thickening and a mononuclear, predominantly dermal
inflammatory cell infiltrate. Chronic ICD may follow
contact with a diverse range of irritant substances.
The differing chemical nature of these irritants is con¬
sidered to influence the type of epidermal damage such
as denaturation of epidermal keratins and stripping of
surface lipids.1 Considerable information is available
concerning the influence of factors such as age, race
and exposure site on the development of chronic ICD,4
but less is known about the effects of irritants on
epidermal cells directly and how these may relate to
severity and chronicity of the condition. In particular
the reasons why chronic ICD only occurs in some
individuals exposed to irritants remain unclear.
Correspondence: Dr Sarah E.M.Howie. E-mail: s.e.m.howie@ed.ac.uk
The histology of chronic ICD suggests that, even in the
absence of a known antigen, the immune system is being
driven by epidermal and dermal cells, or their products, to
recruit and maintain activated inflammatory cells at a
localized site over a prolonged time. This suggests inter¬
action between components of the skin immune system^
particularly Langerhans cells (LCs), activated keratino¬
cytes (KCs) and lymphocytes, resulting in the recruitment
of inflammatory cells to the affected area.
Previous studies have attempted to model ICD by
studying epidermal and dermal changes after the appli¬
cation of irritants under standard patch test conditions
to normal volunteers for 24 h or longer. The most
commonly used irritants have been nonanoic acid
(NA), sodium dodecyl (lauryl) sulphate (SLS) and
dithranol.6"4 It has been reported that NA and SLS
can cause increased epidermal cell proliferation.44'
Experimental NA irritation has been shown to decrease
numbers of epidermal LCs"4 14 and to decrease dendrite
length.1"'11 SLS also variably affects LCs in
experimental irritant reactions with decreased cell
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Tabic 1. Additional criteria used for the diagnosis of chronic irritant
dermatitis
History Occupational exposure, affected areas relatively
static
Examination Erythema, hyperkeratosis or fissuring. glazed.
scalded appearance of skin, hand dermatitis
(dorsa): ring pattern, pulpitis
Patch test result Negative (or no relevant positive reaction)
numbers,15 increased epidermal cell numbers,16
decreased dendrite length10 or minor differences1' all
being reported. SLS 10% applied to the foot has been
reported to induce migration of LCs from the skin to the
lymph.18
We investigated the effects of NA and SLS on LCs and
on epidermal proliferation and apoptotic cell death 1,6,
24 and 48 h after their application to clinically normal
skin of patients with chronic ICD.
Materials and methods
Ethical approval for the study was obtained from the
Lothian Research Ethics Committee.
Subjects
Only patients with chronic ICD of > 6 weeks duration
were recruited from the contact dermatitis clinic. Of
these patients, 91% had chronic hand dermatitis only.
Additional criteria for diagnosis are laid out in Table 1: a
minimum of one criterion from each category had to be
fulfilled before any patient was recruited for the study.
Approximately half of the recruited patients were atopic
as defined by the U.K. Working Party's diagnostic
criteria for atopic dermatitis.19 Volunteers with no
history of skin disease were recruited from the aca¬
demic, medical and technical staff of the Departments
of Pathology and Dermatology at the Edinburgh
University Medical School.
Irritants
For this study it was important to compare clinically
similar irritant reactions. A pilot study was undertaken
to establish the concentrations of both irritants which
would give moderate erythema in over 75% of subjects
tested after 24 h application as measured by Minolta
Chroma Meter CR-300 (Minolta, U.K.). There was no
significant difference in the reactions measured on
patch tested skin of normal individuals and non-
involved skin of patients. The concentrations selected
were NA 80% in propan-l-ol and 5% aqueous SLS. All
irritant solutions were prepared by the Royal Infirmary
Pharmacy.
Biopsies
Six-millimetre punch biopsies (up to a maximum of four
per person) were taken under local anaesthetic with 1%
lignocaine. Patients (25 men, 21 women, age range
18-62 years) were randomized into two groups and all
had two irritant patches applied for either 1 or 6h
(group 1, n = 32), or 24 and 48 h (group 2, n = 14), and
one vehicle control patch. A control 6-mm punch
biopsy (normal uninvolved skin) was taken from the
forearm at time zero. The irritant and vehicle control
(15 p,L) were applied to the volar aspect of the forearms
(two per arm), under 8 mm Finn chambers. One hour
after removal of the Finn chamber the degree of
erythema was measured using a Minolta Chroma
Meter CR-300 and each patch site biopsied. Half of
each punch biopsy was snap frozen in liquid nitrogen
and stored at —70 °C; the remainder was formalin fixed,
dehydrated and embedded in wax. Single volar forearm
punch biopsies from 10 normal volunteers (three men,
seven women, age range 23-58 years) were processed
in the same manner.
Blisters
Twenty-one patients (five men, 16 women) with
chronic ICD, and 22 healthy volunteers (six men, 16
women) with no past history of any skin disease or
atopy, were additionally recruited. NA was applied
under 8 mm Finn chambers to normal appearing
volar forearm skin as above. Seven volunteers had
blisters raised with no irritant application; three volun¬
teers and three patients had blisters raised after both no
irritant application and NA application; .18 patients and
17 volunteers had NA applied for 1, 6 or 24 h.
Determination of visible apoptosis in haematoxylin and
eosin stained sections
Three-micrometre paraffin sections stained with hae¬
matoxylin and eosin (H&E) were examined by two of
three observers (R.J.S., C.S. and S.E.M.H.) simulta¬
neously on a multiheader microscope at x400 magni¬
fication. The concordance rate between observer pairs
was >95%. All sections were enumerated along their
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whole length for the presence of visibly apoptotic cells in
the basal and prickle layers. An apoptotic cell was
defined by the presence of two or more apoptotic
bodies.20'21 The length of basement membrane (BM)
was determined on a Zeiss HOME computer-assisted
microscope (Zeiss, U.K.).22 Apoptotic cells were then
expressed as number of visibly apoptotic cells in the
basal and prickle layers per mm BM. Cells in the stratum
granulosum were not counted as their keratohyaline
granules made it difficult to distinguish them from
apoptotic cells.
TdT-mediated dUTP-biotin nick end-labelling
The Boehringer Mannheim 'In Situ Cell Death Detection
Kit' (Boehringer Mannheim, Mannheim. Germany, Cat.
no. 1684809) was also used to detect apoptosis on
paraffin sections. The manufacturer's protocol was
followed and in situ DNA nicks visualized with fast
red. This method is not apoptosis-specific and detects
all forms of cell death involving DNA nicks (including
apoptosis, necrosis and KC terminal differentiation). In
the epidermis this poses particular problems when
assessing the terminally differentiating cells in the
stratum granulosum as some of the cells stain positive
even in normal skin. This method was therefore used in
conjunction with apoptosis detected morphologically in
the prickle and basal layers on parallel H&E stained
sections.
Immunohistochemical staining and analysis
Three-micrometre paraffin or 6-p.m frozen sections
were stained in a Sequenza semiautomatic staining
system (Shandon Laboratories, Life Sciences Interna¬
tional, Basingstoke, U.K.) using a standard protocol and
visualized with either 3,3'-diaminobenzidine tetrahy-
drochloride or fast red. Proliferating cells were detected
using monoclonal antibody (mAb) to the Ki67 nuclear
antigen expressed by cycling cells (Dako, Glostrup, Den¬
mark, code MO722); CDla+ LCs were detected using
mAbs (Dako, code M721 on frozen sections and Immu-
notech 1590 from Beckman-Coulter, Luton, U.K., on
paraffin sections). Cells with Ki67+ nuclei and CDla+
cells (epidermal cell bodies with at least two attached
dendrites) in the epidermis were counted over the entire
section and the length of BM measured on the HOME
microscope; the results were expressed as numbers of
positive cells/mm BM. For CDla+ cells the epidermal
and dermal distribution pattern was also noted. The
distribution patterns were analysed in the epidermis as
'normal' or 'upper epidermis' or 'basal' and in the
papillary dermis as 'perivascular' or 'diffuse'.
Immunofluorescence staining and confocal laser scanning
microscopy
Intact suction blister roofs were incubated in mouse
monoclonal anti-CD la antibody (Dako, code M721)
overnight at 4°C. The roofs were washed, incubated
in fluorescein isothiocyanate-conjugated sheep anti-
mouse IgG (Sigma Chemical Co., Poole, U.K.) for 1 h at
room temperature, washed again and mounted in anti-
fadent solution (Citifluor Ltd, Canterbury, U.K.) under
glass coverslips sealed with nail varnish. The Zeiss LSM
10 confocal laser scanning microscope was used to
examine the CDla+ LCs. Blisters were optically sec¬
tioned in the z-plane and images (512x341 pixels)
were collected at a rate of 2 s/scan. The whole intensity
of the laser was used without a neutral density filter.
One investigator (H.S.) examined all sections. For mor¬
phological assessment, CDla+ LCs were examined at
high power using a x 40 objective lens and x 80. For
each LC, 40 optical sections were scanned, each of
0-5 p.m thickness. The first section was always posi¬
tioned immediately above the cell and scanning con¬
tinued until no further fluorescence was visible. The
stored images were analysed by a Kontron DBAS 20
image analysis system. A threshold of 32-35 was set for
image data (arbitrary scale 0-255), this being the level
above which no staining was seen on the negative
controls. The number of dendrites/LC (defined as pro¬
cesses visibly attached to the cell body on the composite
image) and lengths of dendrites were measured on each
composite high power field image, after calibrating the
field using a graticule of 10 p,m length.
Statistical analysis
Overall changes within groups were investigated using
the Friedman test. Any significant differences were then
further qualified using the McNemar/Sign test. Analysis
of results between groups was carried out using y2 °r
Wilcoxon signed rank test (paired data) or a Mann-
Whitney U-test (non-paired data); exact versions of
these tests were used because of the small sample sizes.
Results
Gender, atopic status and vehicle controls
No significant difference was found between men and
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Figure 1. Distribution of CDla+ Langerhans cells in (a) control volar
forearm skin from a patient with chronic irritant dermatitis and (b)
volar forearm skin after 24 h exposure to nonanoic acid in the same
patient. Bar= 50 p.m.
women or between atopic and non-atopic patients, at
time 0, or at any time point, for any measurement after
either irritant; thus data have been pooled. Vehicle
controls had no effect on any parameter measured.
Patients with chronic irritant dermatitis have more
epidermal CDla+ dendritic cells than normal volunteers
The median number of epidermal dendritic CDla+ cells
in sections of uninvolved forearm skin from all 46
patients was 12-4/mm BM (range 5-6-30-0). CDla+
cells showed a normal even distribution throughout the
epidermis. This number was significantly higher than
the median number of epidermal dendritic CDla+ cells
in the forearm skin from 10 normal volunteers: 9-8/mm
BM (range 4-8—15-5), PcO-Ol. A similar trend was
seen by confocal microscopy of blister roofs which
demonstrated that the untreated, unaffected skin of
patients had increased numbers of LCs/mm2 (median
value 418, range 224-427) compared with healthy
Table 2. Number of CDla+ dendritic cells/mm basement membrane
after 24 and 48 h exposure to nonanoic acid
Patient no. Control 24 h 48 h
1 9-2 5-8 0-5
2 11-2 5 4-3
3 19-0 5-6 5-4
4 21-3 9 2-1
5 13-5 9 3-5
6 10-6 2-9 0-8
7 11-7 10-2 5-0
Median 11-7 5-8* 3-5**
*P<0-02, **P<0-03, two-tailed Mann-Whitney U-test.
volunteers (median value 390, range 162-429),
although this was done on fewer individuals and did
not reach significance.
Nonanoic acid rapidly causes basal redistribution of
epidermal CDla+ cells followed by a decrease in their
number
By 6h after exposure to NA, the epidermal CDla+ LCs
had redistributed to a basal pattern in nearly all biop¬
sies. This pattern was maintained at 24 and 48 h
(P< 0-001 at all time points, x2-test; Fig. la,b). There
was no change in the number ofCDla+ LCs/mm BM in
the group of patients exposed to NA for 1 and 6 h, but
there was a significant decrease after 24 h and a further
drop at 48 h (Table 2).
Confocal microscopy of blister roofs confirmed these
findings in patients with the number of LCs decreasing
after 24 h NA exposure from a median of 418 to 116/
mm2. A similar effect was seen in blister roofs of normal
volunteers with a decrease from a median of 390 to
156/mm2. In the dermis, all biopsies showed a perivas¬
cular distribution of CDla+ cells, which was not chan¬
ged by NA application. There was no significant change
between the median number of 28CDla+ cells/mm2
papillary dermis at time 0 and any other time point.
The effect of nonanoic acid on Langerhans cell dendrite
number and length
The confocal microscope was used to assess the effect of
NA on the number and length of dendrites on epidermal
LCs in blister roofs. The typical appearance of a CDla+
LC from a healthy individual is shown in Figure 2(a).
Normal healthy volunteers had a median number of 5-6
dendrites/LC with a median length of 14-5 p,m prior to
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Figure 2. Confocal microscopy of CDla+ Langerhans cells in epider¬
mal sheets from suction blister roofs, (a) Normal volunteer at time 0;
(b) normal volunteer after 24 h exposure to nonanoic acid.
Bar= 5 p.m.
application of NA; patients with chronic ICD had a
median of 4-5 dendrites/LC with a median length of
11-5 pm, but neither of these parameters was signifi¬
cantly different between the two groups (Mann-Whit¬
ney U-test).
Volunteers showed a significantly decreased number
of dendrites compared with the time 0 controls at 24 h
(median 3-5 dendrites/LC, P<0-()3), whereas patients
did not show a significant decrease in number of
dendrites at any time point. In volunteers the dendrite
length was significantly decreased at 6 h (median
4-5 p,m, P<0-001) and at 24h (median 5-03 pan,
P< 0-001) after treatment. Patients showed no differ¬
ence from control values at 6 h, but the dendrite length
was significantly decreased at 24 h (median 5-0 p,m,
P< 0-001). Comparison between patients and volun¬
teers revealed that at 6 h the decrease in dendrite length
in volunteers was significantly greater than that seen in
patients (P< 0-001) but that at 1 and 24 h the two
groups were not significantly different from each other.
Figure 2(b) shows the typical appearance of an LC from
a patient after 24 h exposure to NA.
Sodium lauryl sulphate does not significantly decrease
epidermal CDla+ dendritic cells
There was a slight reduction in the number of epidermal
CDla+ LCs after 24 and 48 h exposure to SLS. but this
was not significant (Table 3), nor was there any con¬
sistent alteration in their distribution pattern at any
time point after SLS application. The difference between
the group of patients treated with NA and the group
treated with SLS was significant at both 24h(P<0-01)
and 48 h (P<0-01).
Epidermal proliferation decreases and then recovers after
nonanoic acid but increases after sodium lauryl sulphate
irritation
There was no significant difference between time 0
control biopsies and 1 and 6 h exposure to either irritant
in the numbers of proliferating (Ki67+ nuclei) cells in
the basal epidermis. Table 4 shows that there was a
significant increase in basal layer KC proliferation after
48 h SLS exposure. In contrast, significantly decreased
proliferation was seen at 24 h after irritation with NA,
which recovered to control levels by 48 h. Figure 3(a,b)
illustrates the Ki67 staining on time 0 control and 48 h
biopsies from the same patient.
Both nonanoic acid and sodium lauryl sulphate cause
apoptosis of epidermal cells
Visibly apoptotic cells were extremely rare in time 0
control biopsies, but were occasionally detected in the
prickle and basal layers. After exposure to NA, a
significant increase in prickle layer apoptosis was
Table 3. Number of CDla+ dendritic cells/mm basement membrane
after 24 and 48 h exposure to sodium lauryl sulphate
Patient no. Control 24 h 48 h
1 17-6 11-5 10-7
2 20-2 111 5-7
3 9-3 2-4 8-9
4 10-5 9-6 5-5
5 8-6 10-0 11-2
6 30-0 31-0 19-2
7 12-1 6-2 13-5
Median 12-1 10-0 10-7
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Table 4. Median (range) values of cells with Ki67+ nuclei/mm basement membrane in biopsies taken at time 0 and 24 and 48 h after exposure to
sodium lauryl sulphate or nonanoic acid
Irritant Time 0 control 24 h 48 h
Sodium lauryl sulphate (n = 6) 28-2 (12-8-45) 28-6 (8-7-46-7) 56-2 (30-2-212-1)
NS P<0-02*
Nonanoic acid (n = 6) 30-5 (13-3-128-8) 13-4 (6-9-25-1) 45-9 (38-6-82-7)
P< 0-02* NS
NS, not significant. *P-values calculated by two-tailed Mann-Whitney U-test against time 0 control values from the same patients.
detected at 24 and 48h (P<0-03) and basal layer
apoptosis at 6h (P<0-04), 24h (P<0-01) and 48 h
(P < 0-01). Prickle layer apoptosis induced by SLS
showed a similar pattern with a significant increase
at 24 and 48 h (P<0-01). In contrast, there was no
significant increase in basal layer apoptosis until 24 h
after SLS application (P< 0-025), but this was never as
strong a response as that induced by NA. Comparison
.
^





Figure 3. Immunohistochemistry of proliferating cells stained with
antibody to Ki67 nuclear antigen in (a) control volar forearm skin
from a patient with chronic irritant dermatitis and (b) volar forearm
skin after 24 h exposure to sodium lauryl sulphate in the same patient.
Bar= 50 |j.m.
of NA and SLS treatment revealed a significantly
higher incidence of basal layer apoptosis after NA
exposure at 6h (P<0-01) and 24h (P<0-05). The
appearance of apoptotic cells after 24 h exposure to
NA is shown in Figure 4 in an H&E-stained section,
and by TdT-mediated dUTP-biotin nick end-
labelling.
Nonanoic acid, but not sodium lauryl sulphate, induces
apoptosis in CDla+ Langerhans cells
To determine whether the drop in CDla+ LC numbers
seen after NA irritation was related to the increase in
apoptosis, paraffin sections were stained with anti-CDla
mAb. Figure 4(c) shows that many of the apoptotic cells
were CDla+. Overall, CDla+ epidermal cells accounted
for 8 5 -100% of the total number of apoptotic cells seen.
No CDla-f apoptotic cells were seen after exposure to
SLS.
Discussion
Chronic ICD is an important industrial concern and is
responsible for major loss of working hours per annum.
Many substances are known to induce ICD, but the
mechanisms by which they do so and why only some
individuals develop persistent disease remain poorly
understood. To model the condition previous studies
have investigated irritant responses after patch testing
of normal volunteers. We reasoned that patients sus¬
ceptible to chronic ICD might have some predisposing
feature in their skin and thus examined patients with a
history of the disease.
We found that patients with chronic ICD had a higher
median number of epidermal CDla-f- LCs in unaffected
skin than normal healthy volunteers biopsied at the
same site and that this was independent of age, gender
or atopic status. This may indicate either that indivi¬
duals with a high number of epidermal LCs have a
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Figure 4. Apoptosis in sections from a
biopsy of volar forearm skin from a patient
with chronic irritant dermatitis after 24 h
exposure to nonanoic acid, (a)
Haematoxylin and eosin stained section,
apoptotic cell arrowed; (b) TdT-mediated
dUTP-biotin nick end-labelling stained
section, apoptotic cells arrowed; (c) anti-
CDla stained paraffin section. CDla+
apoptotic cells are indicated by white
arrows; note the non-apoptotic, CDla+ cell
in the basal layer indicated by the black
arrow. Bar= 50 pm.
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predisposition to develop chronic ICD after irritant
exposure or that the development of chronic ICD itself
upregulates the number of epidermal LCs. We cannot
distinguish between these possibilities at present. How¬
ever, this finding may explain the phenomenon of
hyperirritability of the skin associated with chronic
ICD25 as patients may be quicker to respond to any
antigenic challenge as a consequence of higher local
numbers of epidermal LCs.
We then examined the patch test response to two
well-characterized skin irritants6-9'24-28 in punch
biopsies from patients with ICD. NA is a C9 free
fatty acid found in lacquers, plastics, synthetic fla¬
vours and odours, turbojet lubricants and gasoline;
SLS is a ubiquitous anionic detergent used in a
variety of cosmetics, cleaning products and pharma¬
ceuticals. Despite the fact that atopic individuals may
be more likely to suffer from chronic ICD than non-
atopies29,30 we found that there was no difference
between the response of atopic and non-atopic
patients with chronic ICD to either irritant. This
may indicate that atopy per se does not affect the
outcome of chronic ICD but that there may be a
greater chance of developing the condition in the first
place if one is atopic.
The work presented here demonstrates that NA and
SLS have very different effects on the KCs and LCs of
patients with chronic ICD, which result in clinically
similar irritant reactions at 48 h. SLS induces KC
proliferation in the basal layers, whereas NA initially
decreases the number of cycling cells, although these
appear to return to control levels after 48 h. Both
irritants induced a degree of KC apoptosis, which
presumably balanced the proliferation. SLS had no
effect on the numbers or distribution of LCs at any
time point. In contrast, NA had a dramatic effect on
LCs, inducing them to undergo apoptosis in situ with a
peak 24 h after irritant application. A basal redistribu¬
tion and a three- to fourfold reduction in numbers of
epidermal LCs accompanied this. The dermal CDla+
population appeared unaffected even after 48 h expo¬
sure of the skin to NA. Studies on suction blister roofs
raised over NA patch tests on unaffected skin from
patients confirmed the decrease in LC number and
showed that NA decreased LC dendrite length but did
not affect the number of dendrites per LC. Suction
blisters from healthy volunteers treated with NA also
showed a decrease in the number of LCs and in
dendrite length but additionally a decrease in the
number of dendrites per cell, indicating that patients
not only have a higher baseline number of LCs but that
their LCs react differently to an irritant stimulus.
Previous work has produced conflicting results
regarding the response of LCs in irritant skin reactions
in normal volunteers. Increased,16 decreased31 and
unchanged101' numbers have all been reported after
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SLS irritation and decreased numbers of LCs together
with decreased dendrite length10 have been reported
after NA application. As epidermal LCs represent a
major signalling interface between cells of the
immune system and the skin,5,32,33 damage to this
compartment may have profound effects on the subse¬
quent inflammatory response generated, both in terms
of its cellular composition and its duration.
The finding that NA can deplete the epidermis of LCs
by inducing their apoptosis without having any appar¬
ent effect on the dermal population is of great interest
from a number of points of view. First, this may
indicate that NA is unlikely to induce activation of
the immune system immediately after exposure. Sec¬
ondly, this finding might be exploited clinically and
experimentally in situations where it would be desir¬
able to deplete the epidermis of LCs. Thirdly, NA must
act specifically on LCs to activate their apoptotic path¬
way directly. This property can now be exploited to
investigate skin responses to irritants and antigens in
the absence of LCs.
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